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ABSTRACT 
Background and Study Rationale 
Being physically active is a major contributor to both physical and mental health.  More 
specifically, being physically active lowers risk of coronary heart disease, high blood 
pressure, stroke, metabolic syndrome (MetS), diabetes, certain cancers and 
depression, and increases cognitive function and wellbeing. The physiological 
mechanisms that occur in response to physical activity and the impact of total physical 
activity and sedentary behaviour on cardiometabolic health have been extensively 
studied. In contrast, limited data evaluating the specific effects of daily and weekly 
patterns of physical behaviour on cardiometabolic health exist. Additionally, no other 
study has examined interrelated patterns and minute-by-minute accumulation of 
physical behaviour throughout the day across week days in middle-aged adults.  
Study Aims 
The overarching aims of this thesis are firstly to describe patterns of behaviour 
throughout the day and week, and secondly to explore associations between these 
patterns and cardiometabolic health in a middle-aged population. The specific 
objectives are to: 
1. Compare agreement between the International Physical Activity Questionnaire-
Short Form (IPAQ-SF) and GENEActiv accelerometer-derived moderate-to-
vigorous (MVPA) activity and secondly to compare their associations with a 
range of cardiometabolic and inflammatory markers in middle-aged adults. 
2. Determine a suitable monitoring frame needed to reliably capture weekly, 
accelerometer-measured, activity in our population. 
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3. Identify groups of participants who have similar weekly patterns of physical 
behaviour, and determine if underlying patterns of cardiometabolic profiles exist 
among these groups. 
4. Explore the variation of physical behaviour throughout the day to identify 
whether daily patterns of physical behaviour vary by cardiometabolic health. 
Methods 
All results in this thesis are based on data from a subsample of the Mitchelstown 
Cohort; 475 (46.1% males; mean aged 59.7±5.5 years) middle-aged Irish adults. 
Subjective physical activity levels were assessed using the IPAQ-SF. Participants 
wore the wrist GENEActiv accelerometer for 7 consecutive days. Data was collected 
at 100Hz and summarised into a signal magnitude vector using 60s epochs.  Each 
time interval was categorised based on validated cut-offs. Data on cardiometabolic 
and inflammatory markers was collected according to standard protocol. 
Cardiometabolic outcomes (obesity, diabetes, hypertension and MetS) were defined 
according to internationally recognised definitions by World Health Organisation 
(WHO) and Irish Diabetes Federation (IDF). 
Results 
The results of the first chapter suggest that the IPAQ-SF lacks the sensitivity to assess 
patterning of activity and guideline adherence and assessing the relationship with 
cardiometabolic and inflammatory markers. Furthermore, GENEActiv accelerometer-
derived MVPA appears to be better at detecting relationships with cardiometabolic and 
inflammatory markers.  
The second chapter examined variations in day-to-day physical behaviour levels 
between- and within-subjects. The main findings were that Sunday differed from all 
other days in the week for sedentary behaviour and light activity and that a large within-
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subject variation across days of the week for vigorous activity exists. Our data indicate 
that six days of monitoring, four weekdays plus Saturday and Sunday, are required to 
reliably estimate weekly habitual activity in all activity intensities.  
In the next chapter, latent profile analysis of weekly, interrelated patterns of physical 
behaviour identified four distinct physical behaviour patterns; Sedentary Group 
(15.9%), Sedentary; Lower Activity Group (28%), Sedentary; Higher Activity Group 
(44.2%) and a Physically Active Group (11.9%).  Overall the Sedentary Group had 
poorer outcomes, characterised by unfavourable cardiometabolic and inflammatory 
profiles. The remaining classes were characterised by healthier cardiometabolic 
profiles with lower sedentary behaviour levels.  
The final chapter, which aimed to compare daily cumulative patterns of minute-by-
minute physical behaviour intensities across those with and without MetS, revealed 
significant differences in weekday and weekend day MVPA. In particular, those with 
MetS start accumulating MVPA later in the day and for a shorted day period.  
Conclusion 
In conclusion, the results of this thesis add to the evidence base regards an optimal 
monitoring period for physical behaviour measurement to accurately capture weekly 
physical behaviour patterns. In addition, the results highlight whether weekly and daily 
distribution of activity is associated with cardiometabolic health and inflammatory 
profiles. The key findings of this thesis demonstrate the importance of daily and weekly 
physical behaviour patterning of activity intensity in the context of cardiometabolic 
health risk.  In addition, these findings highlight the importance of using physical 
behaviour patterns of free-living adults observed in a population-based study to inform 
and aid health promotion activity programmes and primary care prevention and 
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treatment strategies and development of future tailored physical activity based 
interventions. 
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Problem  
The WHO now recognises physical inactivity as one of the leading global risk factors 
for morbidity and premature mortality (1). Physical inactivity is defined as “not 
achieving the recommended 150 minutes of moderate activity a week” (2) and in 2008, 
was found to cause 6-10% of all deaths from non-communicable diseases (NCDs) and 
9% of premature mortality (3). Moreover physical inactivity is thought to be responsible 
for approximately 21-25% of breast and colon cancers, 27% of diabetes and 30% of 
ischaemic heart disease burden (4). It is estimated that if physical inactivity was 
eliminated, the life expectancy of the world’s population would increase by 0.68 years, 
and in Ireland life expectancy would increase by 0.87 years (5). Even modest levels 
of physical activity are beneficial. For example, Wen et al. (2011) concluded that 15 
minutes a day or 90 minutes a week of moderate-intensity exercise are beneficial in 
terms of all-cause mortality, even for individuals at risk of cardiovascular disease 
(CVD) (6). The benefits of physical activity are extensive. Being physically active is a 
major contributor to both physical and mental health.  More specifically, being 
physically active reduces the risk of a range of conditions including coronary heart 
disease (CHD), high blood pressure, stroke, MetS, diabetes, colon and breast cancer, 
depression and increases cognitive function and wellbeing (4, 7-16). 
The relationship between sedentary behaviour, physical activity and health is complex. 
Sedentary behaviour is defined as “any waking behaviour involving little or no energy 
expenditure (1–1.5 METs) while in a sitting or reclining posture and includes sitting 
during transport, at work, in leisure time and at home” (17). Sedentary behaviour is 
associated with poor health and mortality (12, 18-21). Evidence is now emerging that 
excessive bouts of prolonged sedentary behaviour negatively impact on health (22-
19 
 
26). Avoiding these lifestyle behaviours could significantly increase total life 
expectancy and CVD–free life expectancy (27).   
The National Survey of Lifestyles Attitudes and Nutrition (SLÁN) showed that only 41% 
of Irish adults took part in moderate activity for at least 20 minutes three or more times 
a week (28). This level of activity has not changed greatly over the years with 40% of 
the population reaching these levels in 2002 and 38% in 1998 (29). In 2009 the Health 
Service Executive and Department of Health and Children produced ‘The National 
Guidelines on Physical Activity for Ireland’ (29). These existing guidelines do not 
include recommendations on light and sedentary activities. In 2011, Canadian physical 
activity guidelines included recommendations on light and sedentary activities, 
however these have only been created for children and youth (30). In addition, the 
findings to support these guidelines are based on questionnaire data. 
Questionnaires and accelerometers are widely used to assess physical activity in 
epidemiological studies. Numerous physical activity questionnaires exist, all varying in 
complexity and length. Questionnaires are inexpensive, easy to administer and 
feasible in large epidemiological studies while in contrast, accelerometers are 
expensive, time consuming and not always feasible in large studies. Nonetheless 
accurate measurements of physical activity are central to successfully determine the 
relationship between physical activity and health outcomes. The IPAQ-SF, which is 
used in this study, has been validated in multiple populations against several objective 
methods and overall results have indicated poor validity (31, 32). Despite this, the 
IPAQ-SF continues to be extensively used in epidemiological studies. Current findings 
have suggested that the IPAQ-SF is not a suitable indicator of relative or absolute 
physical activity (31).  Hence, the evidence to support the use of the IPAQ-SF to 
investigate the intricate relationships between physical activity and health when 
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examining total time spent in physical activity and physical activity guideline adherence 
is questionable. Accelerometers can record activity continuously throughout the day. 
They provide details on intensity of activity, minutes spent in activity, breaks in activity 
transition, duration of bouts of activity between activity transitions and time of day 
when activity occurred i.e. morning, afternoon or evening.  
 
Relevance to Public Health 
Physical activity and sedentary behaviour are easily and inexpensively modifiable 
lifestyle factors. As already stated physical activity impacts on both physical and 
mental health. Evidence shows that physical inactivity increases the risk of NCDs and 
shortens life expectancy. In 2008, approximately 31% of adults worldwide did not meet 
physical activity recommendations (33). Due to high levels of physical inactivity 
worldwide this presents a major global public health issue. In Europe, it is estimated 
that physical inactivity is costing €150 – 300 per citizen per year (34). In the UK in 
2006-2007, it was estimated that physical inactivity cost the health care system £0.9 
billion (35). In Ireland, the SLÁN survey of lifestyle, attitudes and nutrition showed 38% 
of Ireland's population is overweight and 23% is classed as obese. A major factor 
contributing to this is physical inactivity, with approximately 59% of Irish adults not 
meeting recommended levels (28). The scale of physical inactivity in Ireland together 
with the high economic cost of obesity alone, highlight the importance of making 
physical inactivity a national public health priority(36).  
 
Gap in Research 
To date, accelerometer-based studies in adults have examined averaged daily 
physical activity and sedentary behaviour levels during weekday and weekend days 
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or total weekly estimates (19, 37). Physical behaviour intensities are interrelated, in 
that a change in the time spent in one intensity directly affects time spent in the other 
intensities. In addition, few studies have examined all physical behaviour intensities 
combined. No study to date has examined the combined interrelated patterns of 
physical activity and sedentary behaviour levels throughout the week or daily 
distribution of activity across week days in adults. Despite the ability of accelerometers 
to investigate minute-by-minute patterns of physical activity and sedentary behaviour 
only six studies have examined physical activity patterns in adults using continuous 
hourly estimates or minute-by-minute accelerometry data (38-43). Arvidsson et al. 
(2013) investigated both the mean daily physical activity and the hour-by-
hour physical activity patterns across the day (38). Hansen et al. (2013) evaluated 
hourly physical activity patterns across body mass index (BMI) categories (39). Cooper 
et al. (2000) determined levels (minutes per day) and hourly patterns of daily physical 
activity in BMI categories using minute-by-minute data (40). Lee et al. (2012) used 
cluster analysis to identify characteristic hourly patterns of physical activity (41). 
Metzger et al. (2010) used latent class analysis (LCA) to assess weekly patterns of 
minutes spent in moderate activity, vigorous activity, and moderate-to-vigorous 
physical activity (MVPA) accumulated in bouts greater than 10 minutes using 
NHANES data (42). A previous paper by Metzger et al. (2008) examined whether 
certain patterns of continuous minutes spent in moderate and vigorous physical 
activity were associated with risk factors of MetS using LCA (43).  
Thus research on the distribution of physical behaviour using minute-by-minute data 
across days and interrelated weekly patterns of physical behaviour in middle-aged 
adults is lacking.  
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Thesis Structure 
This thesis examines and describes patterns of physical behaviour measured by the 
GENEActiv accelerometer both throughout the day and week and explores 
associations between these patterns and cardiometabolic health defined by a range 
of traditional CVD risk markers, inflammatory biomarkers and internationally 
recognised definitions. Chapter 1 provides a brief introduction to the research topic 
while highlighting the gaps in the research, and primary aims and novelty of this thesis. 
Chapter 2 presents a comprehensive review of the literature on the relevance and role 
of physical behaviour in cardiometabolic health. Chapter 3 outline the study 
methodology of the thesis. Chapter 4 investigates the levels of agreement between 
the IPAQ-SF and the GENEActiv accelerometer in determining which measurement 
method is most sensitive to capture time spent in physical activity and to ascertain 
physical activity guideline adherence in middle-aged adults. Chapter 5 determines the 
number of weekday and weekend days of accelerometer monitoring required to 
reliably capture accelerometer-measured habitual activity in our population by 
examining between and within subject variation in physical behaviour across days. 
Chapter 6 uses Latent Profile Analysis (LPA) to identify groups of participants based 
on how they accumulate weekly physical activity and sedentary behaviour and 
determines if different cardiometabolic profiles exist among these groups. Chapter 7 
explores whether daily, cumulative patterns of physical activity and sedentary 
behaviour vary by cardiometabolic health status. Finally, in Chapter 8 the overall 
results of the thesis, strengths and limitations, together with potential implications of 
these findings and future recommendations are discussed. 
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Novelty of Research 
The Mitchelstown Cohort Phase One is one of few general population-based cohort 
studies nationally to include an accelerometer-based objective measure of physical 
behaviour. This study is one of the first studies in Ireland to use tri-axial raw 
acceleration data in adults, one other study exists in adults however that study uses 
uni-axial accelerometer data. Tri-axial accelerometry data offers the potential to 
improve the accuracy of energy expenditure of activities such as cycling, a common 
leisure time activity in Ireland which a uni-axial device cannot capture. The 
Mitchelstown Cohort includes a wide array of health-related variables including 
subjective and objective physical behaviour data, dietary data, plasma biomarkers of 
diabetes and CVD including lipids and inflammatory markers, anthropometric 
measures, 24-hour ambulatory blood pressure, adverse childhood events, medical 
history, depression and well-being scores. To the best of our knowledge, the current 
body of work is the first to examine combined interrelated patterns of weekly physical 
behaviour and daily cumulative variation of minute-by-minute physical behaviour 
associated with cardiometabolic health using accelerometry data in middle-aged 
adults. 
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Aims and Objectives 
The overarching aims of this thesis are firstly to describe patterns of physical 
behaviour throughout the day and week, and secondly to explore associations 
between these patterns and cardiometabolic health. 
The specific objectives of this study are to: 
1. Compare the agreement between the IPAQ-SF and GENEActiv accelerometer-
derived MVPA activity and secondly to compare their associations with a range 
of cardiometabolic and inflammatory markers in middle-aged adults. 
2. Determine the number of weekday and weekend days of accelerometer 
monitoring needed to reliably capture weekly, accelerometer-measured, 
habitual activity in our population. 
3. Identify groups of participants who have similar weekly patterns of physical 
activity and sedentary behaviour, and determine if underlying patterns of 
cardiometabolic profiles exist among these groups. 
4. Explore variations in physical activity and sedentary behaviour throughout the 
day to identify whether daily patterns of physical activity and sedentary 
behaviour vary by cardiometabolic health status. 
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History and Epidemiology of Sedentary Behaviour and Physical Activity  
Sedentary Behaviour and Physical Activity Definitions 
Many definitions of sedentary behaviour exist. Previously Pate et al. (2008) defined 
sedentary behaviour as “activities that do not increase energy expenditure 
substantially above that of resting level and includes activities such as sleeping, sitting, 
lying down and watching television and other screen-based entertainment. However 
recently sedentary behaviour was defined in the literature by Tremblay et al. (2012) as 
“any waking behaviour involving little or no energy expenditure (1–1.5 METs) while in 
a sitting or reclining posture and includes sitting during transport, at work, in leisure 
time and at home” (25, 44). Overall, these definitions are analogous. In this thesis, 
sedentary behaviour is quantified as daily time (minutes) spent in sedentary behaviour. 
Physical activity is a complex, multidimensional behaviour. Everyone performs 
physical activity in order to sustain life. The amount of physical activity performed on 
a daily or weekly basis can vary from person to person and also for a given person 
over time e.g. throughout the day or within the week. Physical activity is most often 
defined as “any bodily movement produced by skeletal muscles that results in energy 
expenditure” (45).  However, with new technological advancements in the 
measurement of habitual behaviour, the appropriateness of this definition has started 
to be questioned. According to Bussmann et al. (2013) physical activity defined in this 
way does not cover all aspects of behaviour, such as sitting and standing, that are 
relevant to health and thus it cannot be used as an umbrella term. Bussmann et al. 
propose ‘physical behaviour’ as a suitable umbrella term, which includes the behaviour 
of a person in terms of body postures, movement and daily activities, and this is how 
physical behaviour will be referred throughout this thesis (46).  
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History of Physical Activity  
Physical behaviour levels have evolved over time. Since the Stone Age, shifts from 
hunting and gathering to agriculture and then to industry, have significantly changed 
physical behaviour patterns. During this time, human health and longevity has 
improved (47). In the past, the most common causes of death were due to 
communicable diseases such as typhoid, cholera, smallpox, polio, yellow fever and 
diphtheria. The introduction of vaccination programs in the 1800’s to present-day 
worldwide vaccination programs have led to low prevalence rates and, in some cases, 
total eradication of these diseases e.g. smallpox. Today, the most common causes of 
morbidity and mortality are associated with NCDs such as cancers and heart disease. 
Since the start of the Industrial Age, labour-saving machines have been developed. 
The adverse effects of these labour saving developments on public health became 
evident as diseases such as CHD, diabetes, osteoporosis and cancer became highly 
prevalent worldwide (47).  
In the late 1940’s and early 1950’s, Professor Jeremy Morris and his associates tested 
the hypothesis that participation in physical activity protects against CHD. They 
demonstrated an apparent protection against CHD among bus conductors in that the 
bus conductors experienced roughly half the number of heart attacks and ‘sudden 
death’ due to hear attacks as the drivers (48). Subsequent studies on civil workers 
found postmen to have increased protection against CHD compared to their less active 
counterparts, postal clerks. In both of these civil service surveys, Morris and 
colleagues demonstrated strong associations between moderate and vigorous 
exercise and reduced levels of CHD. By the 1960’s, Morris  speculated that because 
occupations were becoming more sedentary, any future role of physical activity in the 
protection of CHD would have to be related to leisure time activity outside of one’s 
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occupation (47, 48). In 1967, Morris and colleagues established the ‘Whitehall I’ study 
to test this theory. Collectively this early research laid the foundation of physical 
behaviour research examining the relationship with health outcomes. However some 
shortfalls of these studies can be identified including the use of subjective measures 
such as job classification, surveys, questionnaires, logs and diaries to quantify 
physical behaviour. Subsequently numerous weaknesses and limited research 
applications of such  measurement methods have been  identified  (49).  
 
Physical Behaviour Measurements 
Physical behaviour plays a major role in the aetiology of many NCDs (25, 50-53). Thus 
monitoring physical behaviour levels would be useful in assessing how health 
behaviours of a population influence morbidity and mortality. In current epidemiological 
studies, both self-reported questionnaires and accelerometers are widely used to 
assess physical behaviour. The most appropriate method for measuring physical 
behaviour depends on the population under study, time-frame of interest, available 
finances and outcome of interest (54). However, most of the evidence highlighting the 
role of physical behaviour on health status has come from studies using self-reported 
questionnaires which are subjective measures and prone to bias (55). Accurately 
measuring habitual physical behaviour is crucial to truly understanding the relationship 
between frequency, duration, type and amount of physical behaviour and health. In 
order to be accurate in the measurement of physical behaviour, a questionnaire needs 
to be both reliable and valid. Reliability is defined by the COSMIN (COnsensus-
based Standards for the selection of health Measurement INstruments) panel as “the 
degree to which the measurement instrument is free from measurement error” (56). 
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Validity is defined as “the degree to which the scores of a health-related-patient 
reported outcome instrument measures the construct(s) it purports to measure” (56).  
Accurately measuring physical behaviour is central to epidemiological research for 
many reasons. These include the monitoring of physical behaviour trends, measuring 
the effects of physical behaviour interventions, to estimate more accurate effect sizes, 
to specify which aspect of physical behaviour is important for a particular health 
outcome and to properly inform public health policies to develop physical behaviour 
guidelines (57, 58).  
 
Self-reported Measurements of Physical Behaviour - Questionnaires 
A physical behaviour questionnaire is a research instrument consisting of a series of 
questions with the purpose of gathering information from respondents on their physical 
behaviour levels. Physical behaviour questionnaires vary greatly in the amount of 
detail they provide and typically consist of four components (49, 59). Firstly, the time-
frame the participants are asked to remember, e.g. the last 7 days, past 2 weeks. 
Secondly, the nature and detail of the physical behaviours; participants are asked to 
report the frequency, duration and intensity of their physical behaviour or specific 
activities such as swimming or walking. The third component is the way in which data 
is collected, this could involve personal interviews, telephone interviews or self-
reported information. The final component involves the calculated summary estimate 
which could include a simple continuous variable (energy expenditure per day), an 
arbitrary summary variable (exercise units)  or an ordered ranking scaled variable 
which scores a person according to their physical behaviour level e.g. low, moderate 
and high (49, 59). Numerous physical behaviour questionnaires exist, all varying in 
complexity and length. Overall, questionnaires show limited reliability and validity (54, 
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59). The IPAQ-SF was developed in 1998 to aid in national and international 
surveillance of physical activity and to facilitate global comparisons (60, 61). The 
IPAQ-SF has been validated in multiple populations against several objective methods 
and overall results have indicated poor validity (31, 32). However, the IPAQ-SF 
continues to be extensively used as a sole, subjective measure of habitual physical 
activity in epidemiological studies (62-65) .  
 
Reliability and Validity of the IPAQ-SF 
The reliability and validity of the IPAQ-SF for physical activity assessment has been 
studied extensively. Craig et al. (2003) examined the reliability and validity of the 
IPAQ-SF in 14 samples across 12 countries (32). They reported the IPAQ-SF to be 
both reliable and valid for physical activity assessment and strongly recommended the 
use of the IPAQ-SF for national public health surveillance in middle-aged adults (32). 
More specifically they concluded that the IPAQ has “acceptable measurement 
properties, at least as good as other established self-reported questionnaires” (32). 
However, that study has a number of limitations. The study sample consisted generally 
of volunteer samples. Those who agreed to take part in the study might have been 
healthy volunteers, with different physical activity patterns from those who choose not 
to participate, leading to conflicting findings. Furthermore, the study reported a wide 
range of Spearman correlations between countries (0.02-0.47). Craig et al. (2003) 
stated that considering the diversity of the samples and countries studied; these 
results were satisfactory for the acceptance of the use of the IPAQ-SF for physical 
activity measurement in middle-aged adults. However, the wide variability between 
correlation estimates raises concerns of variability in validity across different 
populations (32).  
31 
 
A systematic review by Lee et al. (2011) on the validity of the IPAQ-SF reported the 
questionnaire to have negligible to small correlations in total activity level when 
compared to objective measuring devices including pedometers, accelerometers and 
actometers  (31). In relation to specific levels of intensity of activity by the IPAQ-SF, 
time spent walking seemed to correlate best with accelerometer counts. The study 
reported that the correlations for the overall scale on the IPAQ-SF and any index never 
reached the standard correlation (0.5) for acceptable self-reported physical activity 
questionnaires (31, 66). More specifically, values obtained for moderate and vigorous 
activity correlated weakly with measures from objective devices (31). In addition to 
weak correlations between IPAQ-SF and accelerometer data, the study by Lee et al. 
(2011) found the IPAQ-SF to over-report activity by between 36-106% while only one 
study was found to under-reported activity (67-72). Furthermore, it is important to note 
that the IPAQ-SF was not developed to study aetiological relationships with health 
outcomes. 
 
Strengths and Limitations of the IPAQ-SF 
In the past, most population-level physical behaviour data collection involved self-
reported questionnaires. As already stated, these were often used due to their low 
cost, feasibility, low participant burden and general acceptance (32, 42). Today, 
questionnaires are still used in large epidemiological studies because of the high cost 
associated with large scale use of accelerometers. Despite these strengths, 
questionnaires has numerous limitations. Questionnaires are prone to various degrees 
of measurement error and bias (42). For example, a common limitation of the IPAQ-
SF is over-reporting of physical activity levels by study participants, this is often due 
to social desirability bias (73-75). Many questionnaires suffer from floor effects, the 
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instrument does not account for activities that are less intense than brisk walking or 
that have a duration of less than 10 minutes (54, 59, 76, 77). Thus, questionnaires 
lack emphasis on light intensity activities and often do not take into account the 
fragmentation of physical behaviour episodes (78, 79). Other major limitations which 
are of particular concern for public health surveillance worldwide is the potential for 
differential measurement error between countries (question interpretation may differ 
across different cultures and languages), ‘likely question order effect’, over- and under-
reporting of physical behaviour levels and high variance between study samples 
(meaning small sample studies will be under-powered to detect group differences) (60, 
73, 80, 81).  
Additionally, if physical behaviour questionnaires are to be used to measure 
adherence to physical activity guidelines then they must be able to capture and 
summarise information on bout duration, breaks between bouts and moderate and 
vigorous activity accurately (79). However due to the previously stated limitations such 
as over-reporting and recall bias this would prove difficult. In addition, measuring 
moderate and vigorous activity is a challenge for questionnaires because of the need 
to assess many activities of short duration that occur as part of everyday habitual 
activity. Physical activity guidelines suggest physical activity to occur in bouts of 10 
minutes or more. In addition to the ‘floor effects’ these problems are amplified by 
issues with rounding-up bias and recall bias since questionnaire responses rely on the 
perception, encoding, storage and retrieval of information about previous physical 
behaviours (82). In addition many questionnaires focus on the absolute rather than the 
relative intensity of individual physical activities which may be of particular concern in 
the study between physical behaviour and health (59).  
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Objective Measurements of Physical Behaviour -Accelerometers 
Accelerometers are devices that measure the acceleration of bodily movements over 
time and provide researchers with real time, accurate and objective measures of 
physical behaviour. Most researchers are now turning to objective physical behaviour 
measurement methods due to lowering costs, coupled with the rich, accurate, time-
stamped and detailed data obtained. In the last few decades, objective measurements 
of physical behaviour have significantly improved. Devices have become smaller, data 
storage capacity has increased, battery consumption has decreased and location of 
wear has become more practical. Previous accelerometers processed recorded 
acceleration data internally and saved the data as ‘counts’. Present day 
accelerometers, such as the GENEActiv accelerometer, collect data as raw 
acceleration and store the data as g units for offline analysis. This allows for efficient 
data cleaning, management of spurious data, and the application of various known 
data processing algorithms post-data collection. These sensors detect accelerations 
in three axis (mediolateral (x), vertical (y) and  anteroposterior (z)), Figure 1 (83). 
 
 
 
 
 
 
 
 
 
Figure 1: Directions of movements measured by tri-axial accelerometers 
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In these accelerometer designs, forces created from acceleration causes crystals to 
become stressed, which in turn generate an electric charge proportional to the 
magnitude of the acceleration force. The generated electric charge is filtered and 
converted by the accelerometer into raw acceleration signals taken multiple times 
every second, depending on the chosen recording frequency (84). These signals or 
raw data are stored as g units by internal memory and then downloaded through 
computer ports.  These raw data are unitless and dimensionless and thus need to be 
processed and calibrated to be interpretable i.e. sedentary behaviour, light activity and 
MVPA.  
 
Reliability and Validity of the GENEActiv Accelerometer  
Esliger et al. (2010) examined the technical reliability and validity of the GENEA 
accelerometer using a mechanical shaker (85). The GENEA accelerometer was 
reported to be highly reliable with mean intra- and inter-instrumental coefficients of 
variation of 1.8% and 2.4% respectively. The device was also found to have excellent 
criterion validity against maximum oxygen consumption and excellent concurrent 
validity compared to the Actigraph and the RT3 (85). It should be noted that the 
GENEA accelerometer and the GENEActiv accelerometer are essentially identical 
with the exception of extended measurement frequency (GENEA accelerometer had 
a recording range of 10-80Hz while the GENEActiv accelerometer has a recording 
range of 10-100Hz) and wider recording range (GENEA had a recording range of ±6g 
whereas the GENEActiv accelerometer has a recording range of ±8g).  
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Strengths and Limitations of the GENEActiv Accelerometer 
Accelerometers allow for the objective measurement of physical behaviour and thus 
avoid reporting errors created by translation, misinterpretation and social desirability 
bias (86). The GENEActiv accelerometer measures and stores physical behaviour 
data as raw acceleration units (g), allowing for post-data collection processing of data, 
while older accelerometers processes the data internally and store data as counts 
which hinders between model comparisons and prohibits post-data processing (85).  
Accelerometers have now made it possible to examine physical behaviour over long 
periods of time. They are helpful for capturing intermittent, ambulatory activities 
preformed through the day, week and month (87). More specifically, they provide 
details on intensity of activity, minutes spent in activity, breaks in activity transition, 
duration of bouts of activity between activity transitions, time of day when activity 
occurs, i.e. morning, afternoon or evening, and have the potential to examine how 
weekly and daily patterns of physical behaviour contribute to health status. Most 
research to date has examined the relationship between physical behaviour and health 
outcomes using summary estimates (46). While summary estimates have made huge 
contributions to our understanding of physical behaviour, accelerometers now enable 
us to look at physical behaviour in more novel ways than ever before (88, 89). In 
physical behaviour studies, data are often summed or averaged over whole 
measurement periods which may lead to real effects going undetected (46, 90). This 
would suggest that examining the relationship between daily and weekly physical 
behaviour patterns may highlight relationships not previously examined. 
Accelerometers have the potential to examine how variation in daily and weekly 
patterns of physical behaviour differ by health status and thus provide an opportunity 
for more complete physical behaviour profiles to be evaluated.  
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While accelerometers are advantageous in minimising reporting bias, they are not 
without limitations. It has been suggested that wrist worn devices are poor at capturing 
lower body movement. Devices such as the activPAL and ActiGraph are placed on the 
thigh and hip and are thus better at capturing lower body movement. There are also 
concerns that excessive arm movements may lead to the overestimation of physical 
activity estimates. However, Esliger et al. 2011found that while the levels of accuracy 
of the waist mounted GENEActiv accelerometer was greatest the estimates using wrist 
worn devices were closely accurate. In addition it is worth highlighting that estimates 
from the GENEActiv accelerometer are comparable to other devices placed in the 
same position (91, 92). While wrist placement has its limitations it is worth noting that 
this position of wear has been associated with increased compliance compared to hip 
worn placement in children. Increased compliance improves the quality and quantity 
of physical behaviour data available for analysis and also increases the number of 
valid days thus increasing the power of study findings (93).  
Accelerometers are costly, data processing is time consuming and not always 
practicable in large epidemiological studies. Accelerometers cannot accurately 
measure the added energy expenditure associated with carrying a heavy load, weight-
training or walking on an incline. Moreover accelerometers cannot distinguish different 
types of physical behaviour or characterise the context under which physical behaviour 
occurs. For example, current Canadian physical behaviour guidelines for children 
recommend no more than 2 hours of screen time per day (30). This is a low energy 
expenditure activity. Similarly activities such as reading, drawing, painting and writing 
are also low energy expenditure activities, however these are not discouraged or time 
limited. Thus accelerometers will classify these activities as the same intensity type 
and therefore this information cannot be examined (84). Some accelerometers, such 
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as the GENEActiv accelerometer, use a single sensor. A limitation of this approach is 
that no distinction can be made between body postures i.e. no distinction can be made 
between sitting and standing positions (46).  Previous research has suggested that 
standing may have benefits to health (94-96). Some accelerometers, such as the 
ActivPAL, use a combined sensor (accelerometer and an inclinometer) which allows 
for both the measurement of bodily acceleration and posture.  
 
Concluding Paragraph 
Subjective and objective measures to assess physical behaviour exist and are widely 
used in epidemiological studies. Questionnaires have been sufficient to demonstrate 
basic associations with health outcomes, however uncertainties exist about which 
dimension of physical behaviour is being assessed and the degree to which it is valid 
and reliable (58). In addition, the IPAQ-SF was not developed to study aetiological 
relationships with health outcomes. Thus, comparison of self-reported physical 
behaviour measures against objective measures is crucial to identify how they differ 
and whether this matters to study associations with health outcomes. Studies have 
established that the use of activity monitors such as accelerometers, as oppose to 
questionnaires, is more likely to result in the detection of significant and meaningful 
associations with health while other studies have found stronger associations with 
health outcomes compared to questionnaires (97-100). To date the agreement 
between the IPAQ-SF and GENEActiv accelerometer-derived MVPA and their 
associations between a wide range of cardiometabolic and inflammatory markers in 
middle-aged adults have not been compared. 
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Role of Physical Behaviour in Health and Disease 
Current Physical Activity Guidelines  
Public health experts produced physical activity guidelines and recommendations to 
educate the general population on the optimal amount of physical activity needed to 
maintain and improve health. The first public health physical activity guidelines were 
released in 1995 by the American College of Sports and Medicine and the Centres for 
Disease Control and Prevention (78). These were soon followed by recommendations 
by the 1996 report of the US Surgeon General (101). These recommendations were 
similar, they recommended for adults to accumulate 30 minutes of at least moderate 
intensity activity on most days of the week and that activity should occur in bouts of 10 
minutes or more.  
In 2007, the American College of Sport Medicine and the American Heart Association 
proposed new revised guidelines. They proposed 30 minutes of moderate activity on 
at least 5 days of the week or vigorous-intensity aerobic physical activity for a minimum 
of 20 minutes on three days each week or an equivalent of both moderate and vigorous 
activity, and that activity bouts should be 10 minutes or more in duration (102). Similar 
physical activity guidelines were later adopted by other countries including Ireland and 
organisations such as the WHO and CDC (4, 103).  
Missing from these guidelines are any recommendations on light and sedentary 
activity. A panel review by the “Physical Activity Guidelines Committee” concluded that 
since a large body of the evidence to support the relationship between sedentary 
behaviour and light activity and health outcomes has come from self-reported data 
and cross-sectional observational studies,  current recommendations will not include 
guidelines on light and sedentary activity (104). As previously discussed self-reported 
measures of physical activity are subject to bias and may lead to erroneous 
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conclusions about physical behaviour levels and associations with health outcomes. 
Self-reported data for physical behaviour are more reliable and valid for MVPA 
compared to light and sedentary activity (103, 105). Light activity is often poorly 
reported while it is unclear how well screen time reflects total sedentary activity. 
Accelerometers now allow the measurement of physical behaviour objectively, 
removing some of these limitations. In addition, they allow us to examine physical 
behaviour continuously throughout the day (every second) for long periods of time (up 
to 30 days). Accelerometers allow us to look at the frequency and variability of physical 
behaviour throughout the day and week. Information such as this can contribute to the 
existing evidence that form the basis for physical behaviour guidelines so as to inform 
whether an optimal daily or weekly pattern of physical behaviour can benefit health. 
Further longitudinal research should expand on this and examine whether an optimal 
pattern exits in those who are cardiometabolic healthy compared to unhealthy 
counterparts. Previous research has demonstrated that increased breaks in sedentary 
behaviour and reduced bout duration are associated with positive health outcomes. 
These findings may be partly accounted for by increased physical activity, as time 
spent in one activity impacts on time available for a different activity or behaviour every 
break in sedentary behaviour results in an increase in overall physical activity levels. 
However, the beneficial effects of reduced bout duration or increased breaks in 
sedentary behaviour may also suggest that patterns of physical behaviour, in terms of 
how we accumulate physical activity and sedentary behaviour are also important. To 
test this hypothesis future research involving longitudinal studies focussed on 
identification of physical activity patterns which predict long term or future 
cardiometabolic health status is warranted. Such investigations should include a long 
follow-up period (5-10 years), wherein physical activity patterns and health outcomes 
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are recorded over multiple time points across this time frame (every 2 years), 
confounders such as age or other time related issues are accounted for and. Survival 
analysis used to identify associations between physical activity patterns and 
cardiometabolic health outcomes. This type of research has the potential to provide 
answers to a number of current research questions. For example, do those with 
superlative physical activity patterns throughout the study have positive health 
outcomes at the end, similarly do those with sub-optimal physical activity patterns have 
worse outcomes. Furthermore, such longitudinal analysis would allow us to consider 
changes in either physical activity pattern or health outcome i.e. whether changes in 
physical activity patterns were associated with transition from one health state to 
another (e.g from metabolically healthy to metabolically unhealthy or vice versa). While 
the limitations of observational research in terms of causality have been discussed 
such investigations may be worthwhile in terms of providing proof of concept, 
extending the knowledge base and informing subsequent intervention studies to 
further address causality. 
 
Physical Behaviour and Cardiometabolic Health 
Physical activity and sedentary behaviour are inexpensively and easily modifiable 
behaviours. As already stated, physical activity impacts on both physical and mental 
health. The physiological mechanisms that occur in response to physical activity have 
been extensively studied. Physical activity may reduce the risk of CVD by regulating 
insulin resistance, fasting blood glucose and cholesterol levels, BMI, blood pressure 
and waist circumference (37, 106-114). More specifically physical activity results in 
energy expenditure which is positively associated with weight loss and weight 
management (115, 116). It increases the transportation of glucose and reduces the 
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production of insulin, in turn preventing or delaying the onset of type 2 diabetes (117, 
118). Furthermore increased physical activity levels reduce blood pressure and 
improve blood lipid profiles (112, 119-121). Research has found total physical activity 
to be significantly associated with lower prevalence of MetS (122, 123). Sedentary 
behaviour has emerged as a major concern for the prevention of CVD and diabetes 
and has been found to be strongly related to metabolic risk (95, 96, 124-126). Since 
the majority of field-studies are cross-sectional in design one cannot ascertain the true 
direction of the association, in other words it is unclear whether being sedentary leads 
to poor health or whether poor health leads to sedentary behaviour. A large body of 
evidence supports the notion that sedentary behaviour is significantly and negatively 
associated with morbidity and mortality (127-132). One of the key mechanisms by 
which physical activity exerts favourable health effects appears to be due to its 
capacity to influence inflammatory status (133). Cardiometabolic risk factors such as 
obesity, hypertension, MetS, dyslipidemia and glucose intolerance are known 
predictors of CHD and diabetes (134). 
Most of this research is based on self-reported measures of physical behaviour which 
have many limitations, as already detailed. A major limitation of self-reported 
measures of physical behaviour is that daily and day-to-day variation in physical 
behaviour cannot be examined. To date, most research that has used objective 
measurements of physical behaviour have examined the relationship between 
physical behaviour and health using summary estimates across days or averaged 
estimates for days across all days of measurement or by weekdays and weekend 
days. However data summed or averaged across entire measurement periods may 
lead to true associations going unnoticed; for example bouts or patterns accumulated 
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during a day or across days may be missed when whole day or whole week or whole 
study period are summed (46, 90). 
Current guidelines recommend adults to accumulate 150 minutes of at least moderate-
intensity activity per week occurring on most days of the week (29, 51, 52). The rational 
for recommending activity on most days of the week is attributable to evidence from 
early intervention studies (135). However, few studies have been able to isolate the 
effect of physical activity frequency from total-time for all-cause mortality (60, 101). In 
the past decade, research has reported the emergence of the ‘weekend warrior’ who 
accumulates most of their weekly activity into 1-2 days (42, 43, 60, 66). Lee et al. 
(2004) reported that among low-risk men, this ‘weekend warrior’ pattern could 
postpone mortality (60). Metzger et al. (2010) reported the ‘weekend warrior’ pattern 
to have higher risk of obesity, low high density lipoprotein cholesterol (HDL-C), and 
high triglyceride (TAG) levels, but lower risk of high blood pressure and fasting plasma 
glucose (FPG) when compared to individuals who accumulate similar activity levels 
over a longer period (43).  
Furthermore, exploration of the association between cardiometabolic health status 
and daily variations in activity patterns has largely used hour-by-hour data. Three 
studies have examined activity patterns based on hourly data in adults and reported 
better health profiles associated with greater levels of activity for longer active days 
(39, 41, 136). Only two studies have examined within-day variation in activity using 
minute-by-minute data (137, 138). Using minute-by-minute, cumulative physical 
activity counts Schrack et al. (2014) examined within-day, age-related functional 
decline in older adults. That study demonstrated that the amount of physical activity in 
daily life is progressively lower with increased age and follows a different daily pattern 
in older adults compared with younger adults (137). Steeves et al. (2015) found that 
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while diabetics had similar daily cumulative activity patterns to non-diabetics, diabetics 
had lower daily activity levels (138). Thus optimal physical behaviour patterns (i.e. 
patterns identified in observational studies to be associated with positive health 
outcomes) may exist.  
Previous research has demonstrated that increased breaks in sedentary behaviour 
and reduced bout duration are associated with health outcomes (3) (22, 36, 122, 136, 
137). This would suggest that patterns of physical behaviour, in terms of how we 
accumulate physical activity and sedentary behaviour are important. However, these 
analyses do not examine whether accumulating total physical behaviour differently 
across the day or days of the week affects health status (22, 36, 122, 136, 137). As 
previously mentioned, the use of accelerometers permits the examination of 
associations between time-stamped physical behaviour and health outcomes, thereby 
allowing differences in daily patterns of physical behaviour (morning, afternoon or 
evening activity) among various population groups to be investigated.  Recent 
research by Schrack et al. (2014) found that older adults had different physical 
behaviour patterns compared to their younger counterparts (134). We know that 
increasing age is associated with increased risk of morbidity thus it is plausible that 
the observed differences in patterns may also contribute to risk of adverse health 
outcomes. Since most of the studies are cross-sectional in design we cannot ascertain 
the true direction of the association. While we acknowledge that cross-sectional study 
designs provide descriptive results, these results cannot infer causation.   
 
Concluding Paragraph 
To date physical behaviour research has largely focused on self-reported methods of 
physical behaviour measurement. As previously discussed, the numerous limitations 
44 
 
associated with such methods impacts on the strength of the evidence and ways to 
explore the full physical behaviour profile associated with cardiometabolic health. This 
in turn affects physical behaviour guidelines because certain relationships between 
physical behaviour and health (breaks and bouts of activity) cannot be examined using 
self-reported physical behaviour measures. More specifically, time-stamped 
associations such as time of day and day of the week cannot be associated effectively 
with health outcomes with self-reported measures.  
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CHAPTER THREE – METHODS 
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Introduction 
The following chapter outlines the methods of the Mitchelstown Cohort (Phase I) while 
specific methods are detailed in each result chapters (chapters 4 to 7). The 
accelerometer study protocol is described in detail at the end of the methods chapter 
following the structure and evidence from the literature are presented in Appendix 1.  
 
Study Detail 
The Department of Epidemiology and Public Health received funding in 2010 from the 
Health Research Board Centre for Diet and Health Research to recruit a new cohort 
as part of the Mitchelstown Cohort, Phase I. The current study is a cross-sectional 
study design and was designed to provide updated information on glucose tolerance 
status and cardiovascular health and their related factors in an Irish middle-aged 
population sample.  
Ethics, Confidentiality and Security 
The Mitchelstown Cohort, and the use of accelerometers in the study, was approved 
by the Clinical Research Ethics Committee of University College Cork. Written 
informed consent to participate in the study was requested by the field staff on 
appointment days. All information gathered was entered in MS-Excel format, 
downloaded onto password secured laptops and PCs, and was backed-up onto 
password protected external hard drives. All information gathered were treated with 
total confidentiality. 
 
Study Subjects 
A population representative random sample was recruited from a large primary care 
centre in Mitchelstown, County Cork, Ireland (139).  The primary care centre includes 
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8 general practitioners and the practice serves a catchment area of approximately 
20,000 people with a mix of urban and rural residents. Participants were randomly 
selected from all registered attending patients in the 50-69 year age group. In total 
3,807 potential participants were selected from the practice list. Following exclusion of 
duplicates, deaths and ineligibles, 3,043 were invited to participate in the study and of 
these 2,047 (49.2% male) volunteered and completed the questionnaire and physical 
examination components of the baseline assessment (response rate 67%) during the 
study period (April 2010 and May 2011). Accelerometers were introduced into the 
study in January 2011. Of the 745 cohort participants seen between January and May 
of 2011, 475 (44.6% males; mean aged 59.6±5.5 years) subjects agreed to participate 
(response rate 64%). 
 
Study Protocol  
Prior to Clinic Visit 
Once a patient agreed to participate in the study, they were contacted by phone to 
arrange an appointment. All participants were sent a pack prior to their clinic visit. This 
pack contained three questionnaires; general health questionnaire (GHQ), food 
frequency questionnaire (FFQ) and Adverse Childhood Events (ACE) questionnaire, 
two study consent forms and a urine collection container.  
Clinic Visit 
The clinic visit consisted of 2 appointments. The first involved the return of three self-
completed questionnaires, a urine sample and an 8-hour-fasting blood sample. The 
second appointment involved a physical assessment in which baseline measurements 
were taken: height, weight, blood pressure and waist and hip circumference. During 
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this appointment participants were offered a 24-hour ambulatory blood pressure 
monitor and GENEActiv accelerometer.  
 
Study Variables 
Physical Behaviour Measurements 
Self-reported Physical Activity 
Subjective physical activity levels were assessed using the self-reported, IPAQ-SF. 
The IPAQ-SF questions provide information on frequency, duration, and intensity of 
physical activity. Recommendations on data cleaning and processing were followed 
(140). Due to logistical issues, self-reported and accelerometer-measured physical 
activity data were not collected concurrently; self-reported data was collected at the 
beginning of the week the accelerometer was worn. Due to limited resources, some 
participants (N=151) wore the accelerometer device a number of weeks after 
completing the questionnaire, this was due to limited number of devices available for 
data collection on the day of their physical assessment. 
Accelerometer-measured Physical Behaviour 
The GENEActiv accelerometer was introduced latter half of the study. Objective 
physical behaviour levels were assessed using a tri-axial, GENEActiv accelerometer. 
The accelerometer (ActivInsights Ltd, Kimbolton, Cambridgeshire, United Kingdom) 
comprised a tri-axial STMicroelectronics accelerometer with a dynamic range of +/-8 
g (1 g= 9.81 m/s²), where g represents gravitational unit, and was attached to the 
participants’ preferred wrist with a strap. The technical reliability and validity of this 
accelerometer has been reported elsewhere (85). Following return of the 
accelerometer to the co-ordination centre, the data was extracted using GENEActiv 
software and then collapsed using the following, sum of the vector magnitude, 
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equation (
2 2 2 ||  x y z g    ) (85). This equation was used to calculate the sum 
(∑) of the signal magnitude vector 2 2 2x y z   with gravity subtracted (-g). The sum 
was calculated for a specific time interval (epoch) e.g. 60 second epoch. Each time 
interval was categorised based on validated cut-off points (APPENDIX 2). Cut-points 
were scaled to data measured at a frequency of 100 Hz; cut-points created for 
APPENDIX   2 were created based on data measured at 30Hz. Wear and non-wear 
time was identified by the procedure outlined by Van Hees et al. (2011) (141). Four-
hundred-and-seventy-five subjects wore the accelerometer, of which 397 have valid 
data. One-hundred-and-sixty-six participants wore the GENEActiv accelerometer on 
their non-dominant wrist, 210 wore the device on their dominant hand while 21 did not 
have this data recorded. Sixteen participants were excluded due to missing data. 
Choice of wrist was selected by the participant to ensure comfort and wear 
compliance, this did not influence study findings as the thresholds applied to data were 
created for dominant and non-dominant hand, thus removing any bias that dominant 
hand activities would have on physical behaviour estimates.. 
 
Biological Analyses 
All participants attended a physical examination at the clinic in the morning after an 
overnight fast, minimum 8 hours. Fasting blood samples were obtained on arrival. 
Plasma and serum were prepared from fasting blood samples from each subject. FPG, 
serum total cholesterol, HDL-C, LDL-C, TAG and HbA1c levels were measured by 
Cork University Hospital Biochemistry Laboratory using fresh blood samples. HbA1c 
levels were determined based on High Performance Liquid Chromatography on a 
TOSOH analyser. FPG concentrations were determined using a glucose hexokinase 
assay and serum lipids were analysed using enzymatic colorimetric tests (Olympus 
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Life and Material Science Europa Ltd. Lismeehan, Co. Clare, Ireland) on an Olympus 
5400 automatic analyser (Olympus Diagnostica Gmbh, Hamburg, Germany). Serum 
insulin, TNF-α, IL6, ACDC and leptin were determined using a biochip array system 
(Evidence Investigator; Randox Laboratories, Antrim, UK). Complement c3 (C3) was 
determined by immunoturbidimetric assay (Rx Daytona; Randox Laboratories, Antrim, 
UK). Homeostasis model assessment (HOMA), a measure of insulin resistance, was 
calculated as [(fasting plasma glucose x fasting serum insulin) / 22.5] (142). The 
quantitative insulin sensitivity check index (QUICKI) measured insulin sensitivity and 
was calculated as QUICKI=1/[log insulin (μIU/mL)+log glucose(mg/dL)] (143).  
 
Anthropometric Measurements 
Anthropometric measurements were recorded with calibrated instruments according 
to standardised protocol. Height was measured in centimetres to 1 decimal place using 
a Seca Leicester height gauge (Seca, Birmingham, UK). Body weight was measured 
in kilograms without shoes, to the nearest 100g, using a Tanita WB100MA weighing 
scales (Tanita Corporation, IL, USA). BMI was calculated as [weight (kg)/ (height (m)) 
²]. Waist circumference (defined as mid-way between lowest rib and iliac crest) was 
measured in centimetres to 1 decimal place using a Seca 200 measuring tape (Seca, 
Birmingham, UK). The average of two measures was used for analyses. Blood 
pressure was measured according to the European Society of Hypertension 
Guidelines using an Omron M7 Digital blood pressure monitor on the right arm, after 
a 5 minutes rest in a seated position. The average of the second and third 
measurements was used for analysis.  
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Covariate variables 
Age, gender and job status were self-reported.  Job status was defined based on 
European Socio-economic classification social class categories (103). Participants 
were classified into 1 of 10 classifications, for analysis this variable was dichotomised 
based on employment status (employed/unemployed). Data for season was collected 
objectively from time-stamped accelerometer data. A dichotomised variable was also 
created for season; Winter/Spring and Summer/Autumn.  
 
Cardiometabolic outcomes 
Obesity and hypertension were defined according to WHO guidelines as BMI>30kg/m2 
and systolic blood pressure ≥140mmHg or diastolic blood pressure as ≥90mmHg. 
Diabetes was defined by IDF guidelines of FBG >7.0mmol. MetS was defined 
according to International Diabetes Federation 2006 guidelines; being centrally obese 
(waist circumference ≥94 cm (males) or  ≥80 cm (females) or BMI >30.00kg/m2) plus 
2 or more of the following features:  FPG >5.6 mmol/l or previous diagnosis of type 2 
diabetes, HDL-C <1.03 mmol/l (males) or <1.29 mmol/l (females) or on specific HDL-
C treatment, TAG >1.7 mmol/l or on specific TAG treatment, systolic blood pressure 
>130 mmHg or diastolic blood pressure >85 mmHg or treatment of previously 
diagnosed hypertension) (222). 
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Figure 2: Flow Chart: Illustration of timings of physical behaviour assessments 
in the study 
Step 1 
IPAQ-SF received by participants and completed 
before physical examination at study centre 
7 days prior to physical examination appointment 
Entire Cohort: N=2,057 
 
Step 2 
Physical examination at study centre 
Accelerometer was placed on the participant’s wrist 
and worn for 7 consecutive days 
N=475 
Step 3 
Device removed by the participant at home and 
returned to the study co-ordination centre by post 
7 days after physical assessment 
Valid data (at least 10 hours wear on all 7 days): 
N=397 
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Data Management and Quality Control 
Data management involved the entering, cleaning and organisation of information 
gathered during the research project.  This process took place at the coordination 
centre (Department of Epidemiology and Public Health, University College Cork, 
Ireland). The process of data entry took place concurrently with the return of Clinical 
Report Forms (CRFs), questionnaires, accelerometers, 24-hour ambulatory blood 
pressure monitors, blood and urine results to the coordination centre. Data from CRFs, 
GHQ, FFQ and ACE were scanned using TeleformTM and information verified against 
the hard copy of the questionnaire. Data was subsequently exported to MS-Excel and 
were checked again for accuracy against the hard copy. On completion of data entry, 
a 10% random sample was cross-checked for errors.  The cleaning, identification and 
correction of corrupted data and analysis of the data occurred after the conclusion of 
the study.  
To ensure consistency in data collection among the research team, a standard 
operating procedure manual was formatted. To ensure data quality, all measuring 
tapes, blood pressure monitors and weight and height scales were calibrated by the 
research team at regular intervals. The calibration of the blood pressure monitors and 
weight and height scales took place monthly by the field staff. All results were recorded 
in the appropriate calibration logs and appropriate action taken.  Accelerometers were 
calibrated in the middle of the data collection, March 2011. A member of the 
GENEActiv team performed accelerometer calibration. All relevant figures were 
recorded and stored. These figures were applied to the data retrospectively; data that 
had already been collected were modified to include these differences in axis 
movement to ensure all data files captured movement similarly. 
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Accelerometer Study Protocol 
Development of Accelerometer Field Protocol 
Standardised accelerometer protocols ensure comparability of study results across 
studies and with future studies. To date, no other Irish study has reported physical 
behaviour levels in middle-aged adults with the GENEActiv accelerometer.  
Distribution and Collection of Accelerometer 
Accelerometers were distributed to participants on a face-to-face basis during their 
clinic visit. Because of the restricted number of accelerometers, some participants who 
agreed to wear an accelerometer were contacted at a later date to arrange a fitting at 
the study centre or, if requested, were sent the device by post.  The first group of 
participants who had devices posted to them were contacted by phone on the day they 
received the device with instructions on how to use the accelerometer. This procedure 
proved difficult and time consuming as instructions often had to be repeated, and in a 
number of cases (n=3), the task of turning the device on was unsuccessful. The 
second group of participants who were posted the device had a pre-set time delay 
start. This was a more successful procedure. A prepaid stamped addressed-envelope 
was provided to return the monitors to the co-ordination centre. Written general 
instructions were also provided. 
Placement of Accelerometer 
In this study, the GENEActiv accelerometer was positioned on the participant’s wrist. 
Choice of wrist was selected by the participant to ensure comfort and wear 
compliance.  
Selection of Sampling Frequency 
The GENEActiv accelerometer was programmed to gather data at a frequency of 
100Hz, i.e. 100 times per second.  
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Number of Days Monitoring per Week  
A review of the literature found a7 day monitoring frame to be the most commonly 
employed in accelerometer field protocols. Since no previous study examined a 
suitable monitoring frame for the GENEActiv accelerometer in middle-aged adults, a7 
day monitoring frame was employed in this study. Additionally, participants were asked 
to wear the GENEActiv accelerometer for the full 24-hour day, however for most 
analyses (except chapter 7) only day-time hours, between 6am-12am,  were analysed 
and interpreted (144).  
 
Accelerometer Data Reduction Protocol 
Selection of Sampling Interval 
Data was collapsed using sum of the vector magnitude (
2 2 2 ||  x y z g    ) into 
60s epochs (85). 
Classification of Non-wear  
Wear and non-wear time was identified by the procedure outlined by Van Hees et al. 
(2011) (145).  The estimation of non-wear time was estimated on the basis of the 
standard deviation and the value range of each accelerometer axis, calculated for 
consecutive blocks of 30 minutes. A block was classified as non-wear if the standard 
deviation was less than 3.0 mg for at least two of the three axes, or if the value range 
for at least two of the three axes was less than 50 mg. These thresholds were based 
on lab experiments which involved thirty GENEA accelerometers that were left 
motionless on a flat, stable surface for 30 minutes, showing the standard deviation of 
an acceleration signal (which has no inherent noise) is 2.6 mg during non-motion. 
Therefore, the threshold of 3.0 mg allows a maximum increase of 0.4 mg in the 
standard deviation (141). 
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Number of Minutes Considered as a Measured Day 
A valid measured day was defined as acquiring 600 minutes or more of wear-time, 
except in chapter 7 where all 24-hours of data was analysed.  
Handling of Missing data 
It was decided that non-wear/missing data would remain untouched i.e. would not be 
included in the analysis.  
Intensity Cut-off Points 
For our data, validated thresholds (unpublished) were used to categorise data into 
sedentary and non-sedentary activities; light, moderate, vigorous (Appendix 2). These 
cut-points were scaled to the sampling frequency of 100Hz and are summarised in 
Table 1. 
 
Table 1: GENEActiv cut-points for dominant and non-dominant wrist scaled to 
frequency (100Hz) 
 GENEActiv Cut points* 
Activity Intensity  Dominant Non-dominant 
Sedentary <767 <634 
Light 767-1126 634-1046 
Moderate 1127-2380 1047-1980 
Vigorous >2380 >1980 
*Units expressed as g·minutes  
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Expressing and Reporting of Data 
After all raw data was processed; two datasets were created; a dataset containing 
summary statistics for each day of the week and another containing minute-by-minute 
data across all7 days. The following variables were created:  
1) Minutes  spent in sedentary, light, moderate activity, vigorous activity and 
MVPA 
2) Number of bouts of activity lasting >10 minutes in each activity intensity   
3) Average duration of bouts of activity in each activity intensity 
4) Cumulative percentage of total day spent in each physical behaviour intensity 
 
Statistical Analysis 
Statistical analyses were conducted using Stata (version 12, Stata Corp, College 
Station, Texas, USA), Mplus software (version 6.12 for Windows), and in the R 
statistical software version 3.0.3 (http://www.r-project.org). The distribution of all 
continuous data was assessed and non-normally distributed data log-transformed. 
Descriptive statistics for non-normally distributed data was presented as median (25th, 
75th percentile). An alpha level of 0.05 was set to evaluate significance. Specific 
statistical analysis will be discussed in more detail in the relevant chapters. 
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CHAPTER FOUR – COMPARISON OF SELF-REPORT 
AND OBJECTIVE MEASURES OF MODERATE-TO-
VIGOROUS ACTIVITY WITH CARDIOVASCULAR 
DISEASE RISK FACTORS 
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Abstract 
Introduction  
Discrepancies in the measurement of physical activity may lead us to draw improper 
inferences regards the relationship between physical activity and health. The aims of 
this study are first to compare the agreement between the International Physical 
Activity Questionnaire-Short Form (IPAQ-SF) and GENEActiv accelerometer-derived 
moderate-to-vigorous activity (MVPA) and secondly to compare their associations with 
a range of cardiometabolic and inflammatory markers in middle-aged adults. 
Methods 
Data are from a subsample of the Mitchelstown Cohort; 475 (46.1% males; 
59.7±5.5years) middle-aged Irish adults. Participants wore the wrist GENEActiv 
accelerometer for7 consecutive days and completed the IPAQ-SF. Information on 
cardiometabolic and inflammatory markers; Body Mass Index (BMI), waist 
circumference, blood pressure, fasting plasma glucose (FPG), serum lipid profile 
(serum total cholesterol, triglyceride (TAG), high density lipoprotein cholesterol, low 
density lipoprotein cholesterol), complement c3 (C3), interleukin-6 (IL6), tumor 
necrosis factor-alpha (TNF-α), leptin, adiponectin (ACDC), insulin resistance (HOMA) 
and insulin sensitivity (QUICKI), were collected. Physical activity adherence was 
based on the recommended 150 minutes of weekly MVPA. Kernel-density plots and 
Cohen’s Kappa assessed agreement between self-reported and accelerometer-
derived MVPA. Adjusted-linear regression examined the relationship between MVPA 
and cardiometabolic and inflammatory markers.  
Results 
Three hundred-and-ninety-seven adults had valid accelerometer data. There was a 
low level of agreement between the two measures of MVPA in classifying participants 
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as meeting physical activity guidelines (Cohen’s Kappa (ĸ=0.011)). Accelerometer-
derived MVPA variables were inversely associated with waist circumference, BMI, 
TAG, insulin concentrations, HOMA, C3, IL6, leptin (P<0.0001), diastolic blood 
pressure, FPG and TNF-α (except MVPA bouts) (P<0.05) and positively associated 
with, serum lipid profile (except TAG), QUICKI and ACDC (P<0.04). In contrast, self-
reported MVPA was not associated with cardiometabolic and inflammatory markers.  
Conclusion 
GENEActiv accelerometer-derived MVPA appears to be better at detecting 
relationships with cardiometabolic and inflammatory markers than IPAQ-SF. Thus 
objective measures of physical activity are important to assess metabolic health to 
develop more precise physical activity recommendations.  
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Introduction 
Physical activity significantly contributes to overall health and well-being and is 
associated with decreased inflammatory status, reduced cardiovascular risk and all-
cause mortality (106, 107, 133, 146-156). More specifically, moderate and vigorous 
physical activity has been inversely associated with cardiometabolic markers including 
BMI, waist circumference, blood pressure, fasting glucose, lipid concentrations, insulin 
resistance and is positively associated with insulin sensitivity (108-114, 157-159). 
Furthermore, physical activity may decrease markers of inflammation, such as tumor 
necrosis factor-alpha (TNF-α), complement c3 (C3), interleukin-6 (IL6), leptin and 
adiponectin (ACDC) (149, 160-164). There is consensus that a dose-response 
relationship exists between physical activity and health status. However experts have 
identified a lack of understanding about the dose-response relationship as a research 
priority for the field of physical behaviour research (165). Current guidelines 
recommend adults to accumulate 150 minutes of at least moderate-intensity activity 
per week in bouts of 10 minutes (29, 47, 51, 52, 78). Only studies where several 
gradations of physical activity are reported can help address dose-response 
relationships and most using objective physical behaviour measures are 
observational. Thus the evidence to support these recommendations has largely come 
from self-reported physical activity data (166).  Furthermore, research has found that 
self-reported and objective measures have limited agreement in their measurement of 
physical activity guidelines (72, 166-168). Recent studies using objectively-measured 
physical activity have suggested that bouts of physical activity with a duration as short 
as 1 minute may be health enhancing (79). Thus there is some controversy over how 
moderate-to-vigorous activity (MVPA) should be accumulated. 
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Self-reported measurements of physical activity have been shown to have poor 
agreement with objective measures such as accelerometers (168-170). This may be 
in part because questionnaires, are prone to misclassification error and response bias 
(74). Moreover, questionnaires are thought to measure different dimensions of 
physical activity compared to accelerometers, and are most effective at measuring 
easily recalled, planned, time-structured activities (58). In addition, a major issue in 
physical activity research is that often terms such as physical activity and exercise are 
used interchangeably, thus it is hard to say what exactly is being measured in self-
reported data (55). Accurately quantifying physical activity is central to epidemiological 
research for many reasons; the monitoring of physical activity trends, measuring the 
effects of physical activity interventions, estimating more accurate effect sizes, 
specifying which aspect of physical activity is important for a particular health outcome 
and informing public health policies on physical activity guidelines (57, 58). Thus, 
comparison of self-reported physical activity measures against objective measures is 
crucial to identify how they differ and whether this matters to study associations with 
health outcomes.  
The International Physical Activity Questionnaire-Short Form (IPAQ-SF) was 
developed in 1998 to aid in national and international surveillance of physical activity 
so to facilitate global comparisons and is used extensively in epidemiological studies 
however it was not developed to study aetiology (32). The IPAQ-SF has been 
validated in multiple populations against several objective methods, including 
accelerometers, and overall results have indicated poor validity (31, 32). To date the 
comparison of the IPAQ-SF against the GENEActiv accelerometer has not been 
examined nor has the relationships between the IPAQ-SF and GENEActiv 
accelerometer-derived MVPA variables with cardiometabolic and inflammatory 
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markers been compared. Furthermore, few studies have compared different methods 
for measuring MVPA in terms of their impact on health. Such comparative analysis is 
important regards to determine if various measures of MVPA differ in the relations with 
health outcomes and thus this analysis is important to compare across studies and 
different devices  
The primary aim of this study is to assess the level of agreement between the IPAQ-
SF and GENEActiv accelerometer in achieving the recommended MVPA guidelines 
and secondly to compare the relationships between self-reported and accelerometer-
derived MVPA variables (continuously for each minute of activity and secondly across 
prolonged 10 minute bouts) with cardiometabolic and inflammatory markers.  
 
Methods  
Data are from a subsample of the Mitchelstown Cohort; 475 (46.1% males; 
59.7±5.5years) middle-aged Irish adults. Information on anthropometric measures and 
cardiometabolic and inflammatory markers were collected. Participants wore the wrist 
GENEActiv accelerometer for 7 consecutive days and completed the IPAQ-SF. 
Weekly minutes spent in walking, moderate activity, vigorous activity and MVPA was 
calculated.  IPAQ-SF MVPA (minutes per week) was categorised into 3 groups; zero 
activity, 1-599 minutes and ≥600 minutes. In addition, physical activity was categorised 
into low, moderate and high levels according to IPAQ-SF guidelines (140). Physical 
activity adherence was based on the recommended 150 minutes of weekly MVPA. 
Due to logistical issues, self-reported and accelerometer-measured physical activity 
data were not collected concurrently; self-reported data was collected at the beginning 
of the week the accelerometer was worn. Due to limited resources, approximately one 
third of the study sample (N=151) wore the accelerometer device a number of weeks 
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after completing the questionnaire, this was due to limited number of devices available 
for data collection on the day of their physical assessment. Because of seasonal 
variations in physical behaviour levels, these participants were removed from analysis 
(171). These methods for this study chapter are described in greater detail in Chapter 
3. 
Statistical analysis  
The distribution of all continuous data was assessed and non-normally distributed data 
log-transformed. Weekly minutes spent in accelerometer-measured and self-reported 
physical behaviour intensities were calculated according to gender. Data were 
presented as median and 25th and 75th percentiles. Kernel-density plots were used to 
describe the distribution of objectively-measured MVPA in categories defined by 
IPAQ-SF. Cohen’s Kappa was used to test agreement between subjective and 
objective physical activity adherence groups. Three adjusted linear regression models 
examined the associations between MVPA variables and cardiometabolic and 
inflammatory markers, adjusting for the effect of age and sex. All statistical analyses 
were conducted using Stata (version 12, Stata Corp, College Station, Texas, USA). 
An alpha level of 0.05 was set to evaluate significance. 
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Results 
Physical activity profiles according to IPAQ-SF and GENEActiv accelerometer  
The distribution of subject characteristics and accelerometer-measured physical 
activity by gender are presented in Table 2. Similar activity levels were recorded in 
males and females by both the IPAQ-SF and GENEActiv accelerometer. Significant 
differences were observed between gender by most physical behaviour variables, with 
the exception of sedentary behaviour and light activity for accelerometer derived 
MVPA and walking for IPAQ-SF derived MVPA. According to IPAQ-SF categorical 
data, approximately 49% of participants were categorised as having low levels of 
physical activity, while 30% and 21% achieved moderate and high levels of physical 
activity respectively. For IPAQ-SF variables, 22%, 73% and 74% of subjects reported 
zero-activity for walking, moderate and vigorous activity respectively. For those who 
reported having any activity, median weekly time spent in walking, moderate and 
vigorous activity was 210 minutes (3.5 hours),  290 minutes (4.8 hours) and 330 
minutes (5.5 hours), respectively.  
 
Validity of the IPAQ-SF and GENEActiv accelerometer for MVPA measurement and 
physical activity guideline adherence 
The distribution of accelerometer-derived MVPA against IPAQ-SF reported MVPA 
categories is presented in Figure 3. For IPAQ-SF measured MVPA, participants 
reporting zero minutes (0 min IPAQ-SF MVPA) had similar accelerometer-measured 
MVPA levels to those reporting any MVPA activity (1-599 min IPAQ-SF MVPA and ± 
600 min IPAQ-SF MVPA). Distribution of subjects classified as meeting physical 
activity guidelines by self-report and accelerometer-measured data is presented in 
Table 3. Overall 11.6% of subjects were classified as meeting physical activity 
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guidelines and 44.2% were classified as not meeting physical activity guidelines by 
both measurement methods. Based on accelerometer data only, 35.1% were 
classified as meeting physical activity guidelines compared to 32.2% based on IPAQ-
SF data only. Cohen’s kappa for testing agreement was close to zero (ĸ = 0.011) thus 
suggesting discordance between the methods was low. The percentage of participants 
with perfect agreement between the methods was 55.8%. The specificity of the IPAQ-
SF to identify participants who meet physical activity guidelines was 22.9% while the 
sensitivity of the IPAQ-SF to identify those not meeting physical activity guidelines was 
77.5%. 
 
Examination of association between IPAQ-SF self-reported and GENEActiv 
accelerometer-derived MVPA with cardiometabolic features  
Accelerometer-measured MVPA variables, hours per day of MVPA (measured as 
continuous minutes) and total MVPA accumulated in bouts lasting 10 minutes or more, 
were significantly related to most cardiometabolic and inflammatory markers with the 
exception of systolic and diastolic blood pressure. Higher levels in accelerometer-
measured MVPA variables were associated with lower waist circumference, BMI, 
TAG, FPG, insulin concentrations, C3, IL6, TNF-α, leptin, reduced insulin resistance, 
and higher serum total cholesterol, HDL-C, LDL-C, ACDC and improved insulin 
sensitivity. Table 4 presents ß coefficients for cardiometabolic and inflammatory 
markers associated with a 1 hour increase in both accelerometer-measured and self-
reported MVPA. No significant relationships between self-reported MVPA and any 
cardiometabolic and inflammatory markers were observed. Analysis was completed 
on the full sample (n=397) and similar conclusions were revealed.  
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Discussion  
Our study provides evidence that the IPAQ-SF and GENEActiv accelerometer do not 
agree in their measurement of weekly MVPA and the proportion of the population who 
achieved guidelines for MVPA. In addition, our study demonstrated that the IPAQ-SF 
lacks the characteristics to adequately capture significant relationships between 
MVPA and cardiometabolic and inflammatory markers in middle-aged adults.   
 
Examination of association between IPAQ-SF self-reported and GENEActiv 
accelerometer-derived MVPA with cardiometabolic features  
There are limited data comparing self-reported and accelerometer-derived MVPA with 
cardiometabolic and inflammatory markers and results are inconsistent (97, 98). 
Atienza et al. (2010) found both subjective and objectively-measured MVPA to be 
significantly related to skinfold thickness, HDL-C and C-reactive protein while systolic 
blood pressure, BMI, waist circumference, TAG, FBG, insulin concentrations, 
glycohemoglobin, C-peptide and homocysteine were only significantly related to 
accelerometer-measured MVPA. (97).  Celis-Morales et al. (2012) reported that for 
some cardiometabolic markers; glucose, insulin concentrations and insulin sensitivity, 
significant associations were observed with both the IPAQ-SF and accelerometer-
measured MVPA. However for other risk factors; TAG, total cholesterol levels, LDL-C, 
HDL-C, BMI,  waist circumference and percentage body fat,  significant associations 
with MVPA were only apparent when activity was captured with accelerometers (98).  
Our study findings reported that accelerometer-measured MVPA was significantly 
related to most cardiometabolic and inflammatory markers with the exception of blood 
pressure and total cholesterol levels, in a representative population of middle-aged 
Irish adults. Furthermore, MVPA assessed using the IPAQ-SF did not relate with any 
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cardiometabolic and inflammatory markers.  A limitation of the IPAQ-SF in this 
population was the large proportion of participants who reported no MVPA with 
approximately 75% of participants reporting no activity. This limits the power of the 
analyses as sample size decrease when non-normally distributed data is transformed 
for data analyses. In other populations where self-reported MVPA is low, the IPAQ-SF 
may be unsuitable for physical activity measurement and to study associations with 
health outcomes.  
 
Validity of the IPAQ-SF and GENEActiv accelerometer for MVPA measurement and 
physical activity guideline adherence 
The GENEActiv accelerometer has demonstrated excellent criterion validity, using 
VO2  as the criterion measure, and concurrent validity compared to the Actigraph and 
RT3 (85). Accelerometers have been suggested as one of the best measures for the 
validation of self-reported measurement instruments (172). However, this is highly 
criticised as accelerometers and questionnaires measure different aspects of activity 
(173). Thus the observed agreement between the IPAQ-SF and the GENEActiv 
accelerometer should be interpreted with this in mind. A systematic review of the 
validity of the IPAQ-SF by Lee et al. (2011) found that evidence to support the use of 
the IPAQ-SF as an indicator of relative or absolute physical activity is weak (31). 
Dyrstad et al. (2013) compared absolute values between the IPAQ-SF and the 
ActiGraph accelerometer (168). Their study demonstrated differences between IPAQ-
SF and ActiGraph MVPA to increase with higher activity and intensity level. The results 
of our study indicate the IPAQ-SF may lack the characteristics to effectively assess 
MVPA.  In contrast to these findings, Román-Viñas et al. (2013) concluded that the 
IPAQ-SF was valid at measuring total and vigorous physical activity (174).  
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To the best of our knowledge, only three studies have examined the validity of IPAQ-
SF in adequately assessing physical activity guideline adherence and results are 
conflicting (72, 174, 175). These studies involved relatively small sample numbers and 
involved broader age groups. Consistent with our findings, Wolin et al. (2008) and 
Ekelund et al. (2006) suggested the evidence to support the use of the IPAQ-SF for 
assessing guideline adherence was weak (72, 175). In contrast, Román-Viñas et al. 
(2013) recommended that the IPAQ-SF  can be used to identify adherence to physical 
activity recommendations (174). It should be noted that the Román-Viñas et al. (2013) 
study had a small sample size (n=55) of volunteers. Those who agreed to take part in 
the study might have been healthy volunteers, with different physical activity patterns 
from those who chose not to participate leading to conflicting findings.  
Lee et al. (2011), Ekelund et al. (2006) and Taber et al. (2009) reported the IPAQ-SF 
to over-estimate physical activity when compared to objective measures (31, 72, 176).  
Our study revealed that, when compared to the GENEActiv accelerometer as the 
absolute criterion gold standard, the IPAQ-SF has large measurement error, which 
both under- and over-estimated activity; with over 66% of participants under-reporting 
moderate activity while approximately 33% over-reported vigorous activity. The 
differences in reporting of moderate and vigorous activity on the IPAQ-SF may reflect 
failure to recall time, poor understanding of physical activity concepts, social 
desirability bias, inter-individual differences in intensity perception or rounding up of 
time spent in activities, thus yielding different estimates compared with accelerometer 
estimates (75, 173).  The over-reporting of activity and the large quantity of zero 
responses in our study could explain the low level of agreement between the IPAQ-
SF and GENEActiv accelerometer. Furthermore, self-reported physical activity data 
was collected a week prior to accelerometer data collection. Physical activity levels in 
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free-living adults vary seasonally and in response to environmental factors. For these 
reasons the MVPA levels measured by the IPAQ-SF and GENEActiv accelerometer 
may not be the same.  This could in turn lead to significant differences between the 
estimates thus increasing the level of disagreement between the measures in relation 
to guideline adherence and relations with cardiometabolic health markers. 
 
Strengths and limitations 
A main strength of our study is the use of a valid and reliable activity monitor which is 
capable of assessing time spent in sedentary, light, moderate and vigorous activity 
intensities (85). Furthermore, the high participation rate (64%) and range of metabolic 
health markers which were determined at a commercial laboratory ensures a high level 
of reproducibility. Notwithstanding these strengths one limitation of this study is that 
the sub-sample of the Mitchelstown Cohort for whom accelerometer data was 
collected, differed by gender in that women were more likely to agree to wear the 
accelerometer. Nonetheless it should be noted that there were no statistically 
significant differences in age, education or BMI between those included and excluded 
in the final analysis. This is a cross-sectional study, therefore cause-effect relations 
cannot be determined. Additionally, due to logistical issues,  approximately one third 
of the study sample had subjective and objective physical behaviour levels measured 
at different time-point (weeks apart). For reliability issues and the fact that physical 
behaviour levels differ significantly between seasons, these data were excluded from 
analysis. Removing these subjects from analysis decreased the sample size 
significantly thus reducing the power of the analysis to detect significant association 
with health outcomes and to measure accuracy in agreement levels between subjects 
for guideline adherence. However, despite the reduced sample size 95% confidence 
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intervals were narrow. In addition, findings including all subjects mirrored those 
obtained in the subset presented in this chapter. Furthermore it should be noted that 
the GENEActiv accelerometer is not a gold-standard method, thus conclusions about 
the precise validity of either measure are limited. It should also be highlighted that the 
arbitrary cut-point for day-time wear may lead to inaccurate estimates of sedentary 
and non-sedentary activity. For example persons who sleep later than 6am will have 
inflated sedentary behaviour estimates while those who are active after 12 midnight 
will have deflated activity estimates. Furthermore, since MVPA levels were measured 
on different occasions (a week apart) this may affect the results of this study. Activity 
levels in free-living adults have been reported to vary, seasonally and in response to 
environmental factors (177-183). IPAQ-SF and accelerometer data were not gathered 
concurrently. This could be a potential source of bias in our study findings. The IPAQ 
was developed for surveillance systems and not for aetiological purposes, yet we have 
used it to examine associations with health outcomes. While caution should be taken 
in the comparison of the two measures in respect of this, other studies have used the 
IPAQ-SF for aetiological purposes and thus our results can be compared to these 
(153, 184-187). In addition, the main aim of this chapter was the IPAQ-SF was being 
used for comparative purposes i.e. comparing the relationships between subjective 
and objective measures and cardiometabolic outcomes.  Finally, although significant, 
the co-efficients generated by adjusted regression analysis are small (β: -0.97 to 0.74). 
Whether a change of this magnitude in a metabolic risk marker will affect 
cardiometabolic health status is unknown, thus caution should be exercised in relation 
to the potential clinical significance of these findings. In addition, we need to highlight 
the existence of random error in the measurement of physical behaviour. Random 
errors in measurement of a risk factor such as physical behaviour will introduce 
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downward bias towards the null hypothesis of an estimated association to a disease 
or a disease marker, regression dilution. Bootstrap techniques in generalized linear 
models could correct for measurement error. Bootstrapping is a technique that models 
the inference about a population from sample data by resampling the sample data and 
performing regression analysis. Thus further research should apply this method. 
 
Generalizability of the study 
Generalizability of our findings may also be limited. The Mitchelstown Cohort was a 
random sample of middle-aged adults, 50-69 years of age, in an area which was 
representative of both urban and rural populations in Ireland. However, previous 
research suggests that approximately 98% of Irish adults are registered with a general 
practice (GP)  and that although a universal patient registration system is non-existent 
in Ireland, it is possible to perform a population based epidemiological study that is 
representative of the general population using GP records (188).   
 
Conclusion 
In conclusion, the results of this study, which examines the criterion validity of the 
IPAQ-SF against the GENEActiv accelerometer, suggests that the IPAQ-SF lacks 
validity for the assessment of MVPA, guideline adherence and assessing the 
relationship with cardiometabolic and inflammatory markers.  
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Figure 3: Kernel-density plot of accelerometer-measured MVPA across 
categories of IPAQ-SF reported MVPA 
 
 
For IPAQ-SF measured MVPA, participants reporting zero minutes (0 min IPAQ-SF 
MVPA) had similar accelerometer-measured MVPA levels to those reporting 1-599 
min IPAQ-SF MVPA. 
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Table 2: Characteristics of participants (N=279) 
 Male (N=147) Female (N=132)  
 Median (25th, 75th 
percentile) 
Median (25th, 75th 
percentile) 
p-values 
Age (years) 59.3 (55.0, 64.3) 60.5 (55.2, 63.6) 0.83 
Cardiometabolic Markers    
BMI (kg/m²) 29.1 (26.7, 31.9) 27.8 (25.0, 30.6) 0.01 
Waist circumference (cm) 103.2 (95.1, 
110.8) 
88.5 (81.3, 96.2) 0.0001 
Systolic blood pressure (mm 
Hg) 
128 (120, 140) 124 (116, 140) 0.29 
Diastolic blood pressure (mm 
Hg) 
78 (72, 86) 80 (74, 86) 0.25 
Cholesterol (mmol/l) 4.9 (4.3, 5.6) 5.5 (4.9, 6.2) 0.0001 
HDL-C (mmol/l) 1.24 (1.08, 1.45) 1.60 (1.39, 1.89) 0.0001 
LDL-C (mmol/l) 3.1 (2.5, 3.6) 3.2 (2.7, 3.8) 0.05 
Triglycerides (mmol/l)* 1.18 (0.92, 1.88) 1.22 (0.84, 1.60) 0.25 
Fasting blood glucose 
(mmol/l)* 
5.1 (4.8, 5.6) 4.9 (4.6, 5.3) 0.0004 
Insulin  (mU/ml)* 10.63 (5.96, 
17.04) 
8.53 (5.37, 12.89) 0.06 
HOMAIR 2.42 (1.37, 4.04) 1.88 (1.14, 3.02) 0.03 
QUICKIIS 0.25 (0.22, 0.29) 0.27 (0.24, 0.31) 0.03 
Complement c3 (g/l) 136.6 (123.2, 
151.6) 
138.3 (122.5, 
159.7) 
0.27 
Interleukin-6 (pg/ml)* 1.93 (1.37, 3.05) 1.72 (1.07, 3.06) 0.12 
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Tumor necrosis factor-α 
(pg/ml)* 
5.95 (4.92, 7.23) 5.65 (4.54, 7.11) 0.15 
Leptin (ng/ml)* 1.71 (0.99, 2.50) 2.11 (1.39, 4.02) 0.0001 
Adiponectin (ųg/ml)* 3.36 (2.15, 4.87) 6.71 (4.43, 9.67) 0.0001 
Accelerometer*     
Sedentary (mins/week) 6226 (5747, 6671) 6225 (5834, 6593) 0.84 
Light (mins/week ) 710 (478, 950) 737 (540, 899) 0.86 
MVPA (mins/week ) 489 (292, 764) 375 (192, 646) 0.02 
MVPA bouts (mins/week 
_average duration) 
138 (34, 274) 76 (16, 229) 0.03 
IPAQ-SF    
Walking (mins/week ) 180 (20, 360) 160 (50, 280) 0.52 
Moderate (mins/week ) 0 (0, 210) 0 (0, 0) 0.0001 
Vigorous (mins/week ) 0 (0, 180) 0 (0,0) 0.0013 
MVPA (mins/week ) 0 (0, 380) 0 (0, 30) 0.0001 
IPAQ-SF categorical**    
Low 60 (43.5) 66 (53.7)  
Moderate  38 (27.5) 41 (33.3)  
High 40 (29.0) 16 (13.0) 0.007 
Accelerometer data are presented as raw, non-scaled data  
* Log-transformed variables expressed as exponentiated beta co-efficients 
** Data presented as N (%). P-values were generated using non-parametric and chi-
squares tests. 
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Table 3: N (%)  of subjects classified as meeting physical activity guidelines  
according to IPAQ-SF and accelerometer-measured data 
 Accelerometer 
 Yes 
N (%) 
No 
N (%) 
Total 
N (%) 
IPAQ-SF    
Yes  28 (32.9) 50 (31.9) 78 (32.2) 
No  57 (67.1) 107 (68.1) 164 (67.8) 
Total N  85 (100)  157 (100)  242 (100) 
Pearson chi-square (P 0.862) 
Level of agreement 55.8% 
Cohen’s ĸ for test of agreement, K= 0.011 (95% CI; -0.115, -0.137) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4: Regression coefficients (ß) for relationships between IPAQ-SF self-reported  and accelerometer-derived MVPA variables 
with  cardiometabolic markers 
 IPAQ-SF* Accelerometer 
 minutes of MVPA** minutes of continuous 
MVPA** 
total minutes of MVPA in bouts 
greater than 10 minutes** 
Cardiometabolic Markers ß (95%CI) p-value ß (95%CI) p-value ß (95%CI) p-value 
BMI (kg/m²) -0.27 (-1.10, 0.55) 0.505 -1.52 (-2.12, -
0.91) 
<0.0001 -0.97 (-1.43, -0.50) <0.0001 
Waist circumference (cm) -0.62 (-2.58, 1.34) 0.535 -3.64 (-5.19, -
2.08) 
<0.0001 -2.96 (-4.21, -1.71) <0.0001 
Systolic blood pressure (mm Hg) 0.60 (-1.92, 3.10) 0.642 -0.91 (-3.15, 1.33) 0.426 0.74 (-1.10, 2.56) 0.428 
Diastolic blood pressure (mm 
Hg) 
-0.62 (-2.19, 0.94) 0.430 -1.14 (-2.04, 0.14) 0.08 0.16 (-0.89, 1.21) 0.762 
Cholesterol (mmol/l) -0.05 (-0.22, 0.13) 0.598 0.25 (0.12, 0.38) <0.0001 0.17 (0.05, 0.29) 0.005 
HDL-C (mmol/l) 0.03 (-0.02, 0.08) 0.282 0.06 (0.02, 0.11) 0.003 0.04 (0.008, 0.08) 0.016 
LDL-C (mmol/l) -0.04 (-0.20, 0.12) 0.624 0.27 (0.15, 0.39) <0.0001 0.20 (0.09, 0.31) <0.0001 
Triglycerides** (mmol/l) -0.03 (-0.08, 0.02) 0.242 -0.06 (-0.10, -
0.02) 
0.004 -0.06 (-0.09, -0.02) 0.001 
Fasting blood glucose** (mmol/l) 0.002 (-0.02, 
0.03) 
0.879 -0.03 (-0.05, -
0.01) 
0.006 -0.02 (-0.04, -0.003) 0.025 
Insulin**  (mU/ml) -0.01 (-0.14, 0.11) 0.822 -0.27 (-0.36, -
0.18) 
<0.0001 -0.22 (-0.30, -0.15) <0.0001 
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HOMAIR** -0.01 (-0.11, 0.09) 0.849 -0.21 (-0.28, -
0.14) 
<0.0001 -0.16 (-0.22, -0.10) <0.0001 
QUICKIIS 0.0005 (-0.01, 
0.01) 
0.930 0.02 (0.01, 0.03) <0.0001 0.02 (0.01, 0.03) <0.0001 
Complement c3 (g/l) -1.50 (-6.08, 3.10) 0.520 -7.96 (-11.44, -
4.47) 
<0.0001 -5.59 (-8.46, -2.71) <0.0001 
Interleukin-6 (pg/ml) -0.11 (-0.21, 
0.003) 
0.057 -0.25 (-0.33, -
0.16) 
<0.0001 -0.14 (-0.21, -0.07) <0.0001 
Tumor necrosis factor-α (pg/ml) 0.002 (-0.05, 
0.06) 
0.949 -0.06 (-0.10, -
0.01) 
0.008 -0.04 (-0.08, -0.005) 0.026 
Leptin (ng/ml)  -0.13 (-0.27, 0.01) 0.074 -0.22 (-0.33, -
0.12) 
<0.001 -0.15 (-0.25, -0.06) 0.001 
Adiponectin (ųg/ml) 0.05 (-0.06, 0.16) 0.359 0.11 (0.02, 0.19) 0.011 0.09 (0.02, 0.15) 0.012 
N=279 *N=97. **Non-normally distributed variables are log-transformed. Data presented as ß coefficients and 95%CI for change in 
cardiometabolic marker per 1 hour change in MVPA, adjusted for age, sex and zero/non-zero response (IPAQ-SF model only). P-values are 
given for ß values for each measurement method variable. 
  
 
 
 
 
 
 
 
CHAPTER FIVE – NUMBER OF DAYS REQUIRED TO 
ESTIMATE HABITUAL ACTIVITY USING GENEACTIV 
ACCELEROMETER. 
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Abstract  
Introduction  
Objective methods like accelerometers are feasible for large studies and may quantify 
variability in day-to-day physical activity better than self-report.  The variability between 
days suggests that day of the week cannot be ignored in the design and analysis of 
physical activity studies. The purpose of this paper is to investigate the optimal number 
of days needed to obtain reliable estimates of weekly habitual physical activity using 
the GENEActiv accelerometer. 
Methods 
Data are from a subsample of the Mitchelstown cohort; 475 (44.6% males; mean aged 
59.6±5.5 years) middle-aged Irish adults. Participants wore the wrist GENEActiv 
accelerometer for 7-consecutive days. Data were collected at 100Hz and summarised 
into a signal magnitude vector using 60s epochs.  Each time interval was categorised 
based on validated cut-offs. Spearman pairwise correlations determined the 
association between days of the week. Repeated measures ANOVA examined 
differences in average minutes across days. Intraclass correlations examined the 
proportion of variability between days, and Spearman-Brown formula estimated intra-
class reliability coefficient associated with combinations of 1-7 days. 
Results 
Three hundred and ninety-seven adults (59.7±5.5yrs) had valid accelerometer data. 
Overall, men were most sedentary on weekends while women spent more time in 
sedentary behaviour on Sunday through Tuesday. Post hoc analysis found sedentary 
behaviour and light activity levels on Sunday to differ to all other days in the week. 
Analysis revealed greater than 1 day monitoring is necessary to achieve acceptable 
reliability. Monitoring frame duration for reliable estimates varied across intensity 
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categories, (sedentary (3 days), light (2 days), moderate (2 days) and vigorous activity 
(6 days) and MVPA (2 days)).  
Conclusion  
These findings provide knowledge into the behavioural variability in weekly activity 
patterns of middle-aged adults. Since Sunday differed from all other days in the week 
this suggests that day of the week cannot be overlooked in the design and analysis of 
physical activity studies and thus should be included in the study monitoring frames.  
Collectively our data suggest that six days monitoring, inclusive of Saturday and 
Sunday, are needed to reliably capture weekly habitual activity in all activity 
categories. 
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Background 
Accurately measuring habitual physical activity is crucial to understanding the 
relationship between frequency, duration, type and amount of physical activity and 
health. A range of subjective and objective methods to quantify physical activity and 
sedentary behaviour exist. Objective measures such as accelerometers and 
pedometers provide information on patterns of physical behaviour within a given day 
and across several days, are feasible for large studies, are less prone to error and no 
recall is necessary. Thus in comparison to subjective methods, objective measures 
provide significantly more reliable data on habitual physical behaviour. 
Physical behaviour is influenced by a range of factors including demographic 
characteristics, emotional influences and behavioural attributes (189). As a result 
patterns of physical behaviour show substantial intra- and inter-individual variation, the 
extent of which plays a major role on data quality and reliability (190). Methodological 
issues such as duration of monitoring-frame, position of wear, accelerometer type and 
wear-time compliance may also affect data quality. Modern devices are fully 
waterproof and can be worn on the wrist, resulting in improved wear-time compliance 
as the device can be worn all day and does not need to be removed for water based 
activities (191, 192).  Minimising the number of days monitoring will likely have 
important implications on wear-time compliance. Extended monitoring periods can be 
a burden to participants and financially costly, leading to the removal of the device, 
reduced wear-time, and subsequently reduced data quality. Thus a current challenge 
is determining an appropriate monitoring frame for researchers who want to minimise 
participant burden and maximise wear-time compliance.  
Several studies have examined a suitable monitoring frame to accurately measure 
physical behaviour in adults (53, 193-195). These studies have varied in terms of 
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statistical analysis, position of wear, type of accelerometer and time-frame of interest, 
producing variable monitoring frames of 7 days, 5 days,  5-6 days and 3-5 days, 
respectively (53, 193-195). In addition, some examined the appropriate monitoring 
frames to reliably estimate habitual physical behaviour intensities individually (193, 
194). Matthews et al. (2002) concluded that 3-4 days monitoring were required to 
correctly measure moderate-to-vigorous physical activity (MVPA), and that 7 days 
were needed to reliably estimate physical inactivity (193). Findings by Scheers et al. 
(2012) recommended overall that both Saturday and Sunday in addition to at least 3 
weekdays were needed to obtain reliable estimates of habitual physical activity (194). 
Hart et al. (2011) recommended 5, 3 and 2 days monitoring for sedentary behaviour, 
light activity, moderate and vigorous activity respectively (53). Such conflicting 
recommendations highlight the need to determine an appropriate monitoring frame to 
reliably measure both habitual physical activity and sedentary behaviour for each 
accelerometer and activity intensity. Importantly no studies to date have sought to 
determine a suitable monitoring frame to accurately measure physical behaviour using 
the GENEActiv accelerometer placed on the wrist. The GENEActiv accelerometer is a 
relatively new device in the field of habitual physical activity research.  Unlike many 
other accelerometers, data is collected and stored as raw acceleration in g units (m/s²) 
for offline analysis thereby allowing a range of data processing techniques to be 
applied post data-collection. 
 Thus the aim of this study is to examine the intra- and inter-individual variability across 
days, and thus identify an appropriate monitoring frame for capturing weekly habitual 
physical behaviour in middle-aged adults using the wrist-GENEActiv accelerometer. 
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Methods  
Data are from a subsample of the Mitchelstown Cohort; 475 (46.1% males; 
59.7±5.5years) middle-aged Irish adults. Information on anthropometric measures and 
cardiometabolic and inflammatory markers were collected. Participants wore the wrist 
GENEActiv accelerometer for 7 consecutive days. Data were collected at 100Hz and 
summarised into a signal magnitude vector using 60s epochs.  Each time interval was 
categorised based on validated cut-offs. Four-hundred and seventy-five subjects wore 
the accelerometer. Of these, 397 subjects were eligible for further analysis. The 
number of participants with various numbers of valid days (days in which the 
participant recorded >10 hours of wear time data) of data are presented in Table 1. 
These methods are described in greater detail in Chapter 3. 
 
Statistical analysis  
Analysis was performed separately for each intensity category. Individual median and 
25th and 75th percentiles for minutes spent in each activity category were calculated 
for each day for non-normally distributed data. Data are reported as median and 25th 
and 75th percentiles unless otherwise stated. Kruskal-Wallis p-values assessed 
whether activity levels varied significantly across days of the week.  Spearman 
pairwise correlations determined the association between days of the week. Number 
of days required to reliably estimate habitual physical activity was assessed using 
repeated measures analysis of variance (ANOVA), intra-class correlations (ICC), and 
modified Spearman-Brown formula (196). Repeated measures ANOVA established 
whether minutes spent in activity differed across days. In the case of the violation of 
the assumption of sphericity, the Greenhouse-Geisser adjusted F was interpreted. If 
an overall significant F level was shown, post hoc tests (Tukey HSD pairwise 
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comparisons) were used to assess differences between days. Effect size was 
assessed to determine the amount of variation in the criterion (total weekly minutes) 
that was accounted for by various days of monitoring. Coefficient of variation 
((SD/mean)*100) was calculated to explain intra-individual and inter-individual 
variability. Intra-individual variability was calculated for each individual using weekly 
days of data while inter-individual variability was analysed as the group mean and SD 
for weekly minutes. ICCs were calculated to determine the reliability of using any 
single day of activity to estimate daily activity using 7 days of data. An ICC of 0.80 is 
considered standard to designated acceptable reliability (190). A modified version of 
the Spearman-Brown calculation determined the intraclass reliability coefficient 
associated with 1, 2, 3, 4, 5, 6, and 7 days of activity (193, 196, 197). The intraclass 
reliability coefficient was estimated as the proportion of total variance attributable to 
between-subject variance as follows: [(between-subject variation) ² / ((between-
subject variation) ² + ((within-subject variation) ² /n))], where n is the number of days 
monitoring. All statistical analyses were conducted using Stata (version 12, Stata 
Corp, College Station, Texas, USA), except coefficient of variation and Spearman-
Brown formula which were performed by hand. An alpha level of 0.05 was set to 
evaluate significance.  
 
Results  
Descriptive analysis 
Median time (minutes) spent in each activity type across days of the week was 
calculated separately for men and women (Table 2). Overall, differences in median 
activity levels across days were significant (P<0.05), with the exception of vigorous 
activity (P>0.05). Among all subjects time spent in sedentary activity was greatest on 
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Sunday (946 minutes). Among men, sedentary activity was higher on Sunday (956 
minutes) compared to all other weekdays (889-912 minutes), while women were most 
sedentary on Sunday through Tuesday (930-940 minutes). Both men and women were 
more physically active on weekdays. Time spent in vigorous activity was similarly low 
for men and women throughout the week.   
Pairwise comparisons 
All Spearman pairwise correlations between days of the week were significant 
(P<0.001). The range of pairwise correlations varied across days of the week and 
intensity type; sedentary (0.59-0.79), light (0.59-0.77), moderate (0.59-0.77), vigorous 
(0.37-0.60) and MVPA (0.58-0.78), (Table 17: Appendix 3). The mean pairwise 
correlations across days of the week were 0.72, 0.68, 0.69 and 0.41 for sedentary, 
light, moderate and vigorous activity respectively.   
Variance analysis 
There were significant differences between days for sedentary (P<0.01), light activity 
(P<0.01), moderate activity (P<0.01) and MVPA (P<0.01), whereas vigorous activity 
(P=0.15) was not significantly different between days. In relation to sedentary and light 
activity, Sunday differed from all other days of the week (P<0.05).  The differences in 
mean minutes between days was small; sedentary (0.7%) moderate (0.4%), vigorous 
(0.2%) and MVPA (0.4%), except for light activity (1.6%).  The mean intra-individual 
variability for each activity type were; sedentary (30.3%), light activity (45.4%), 
moderate activity (60.8%), vigorous activity (73.7%) and MVPA (61.6%), while inter-
individual variability was 1.8-178% of total variance; sedentary (3.3%), light activity 
(2.3%), moderate activity (1.8%), vigorous activity (107%) and MVPA (178%). 
Intra-class reliability coefficients 
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The ICC for any single day for sedentary, light, moderate activity, vigorous activity and 
MVPA was calculated, 0.66, 0.69, 0.69, 0.42 and 0.68 respectively. These results 
demonstrate that between 42-69% variance was accounted for using any single day 
of data collection to represent 7-day habitual activity. When ICC was calculated by 
gender, ICC did not alter, with the exception of vigorous activity (32% and 46% for 
men and women respectively). Spearman-Brown Formula calculated reliability 
coefficients for combination of days (Figure 4). These results indicate that between 
59-82%, 68-87%, 74-90% and 78-92% of the variance was accounted for using 2 
days, 3 days, 4 days and 5 days monitoring to represent 7 day habitual activity. The 
appropriate monitoring frames for each intensity of activity are 3 days, 2 days and 6 
days for sedentary behaviour, light and moderate activity and MVPA and vigorous 
activity respectively. All remaining combinations were higher than 0.80.   
 
Discussion  
Our results indicate that the number of monitoring days required to estimate weekly 
habitual activity vary according to physical behaviour intensity. Based on our findings, 
we recommend that data collection periods should be based on activity intensity; 
sedentary (3 days), light activity (2 days), moderate activity (2 days), vigorous activity 
(6 days) and MVPA (2 days). Because variability between activity intensities across 
days of the week was small any combination of days appears to be sufficient to acquire 
a stable weekly estimate of physical activity and sedentary behaviour. Our findings 
support current guidelines recommending inclusion of both weekend and week days 
in physical behaviour monitoring frames. Many large studies (e.g. NHANES and 
Biobank) using similar protocols may apply our findings to reduce monitoring time-
frames and increase device turnover in the field. Additionally our result could influence 
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the analysis of these studies, i.e. if moderate activity  is the exposure of interest a 
minimum wear period of 2 days (inclusive of one weekend day) can be implemented 
in turn decreasing the number of days and or person excluded from analysis and thus 
increasing the power to finding significant associations with health outcomes. 
While this is the first study to examine the required number of monitoring days needed 
to accurately measure physical behaviour in adults using the GENEActiv 
accelerometer, other accelerometers have been examined in this context (53, 193-
195). Overall these studies vary in terms of statistical analysis, position of wear, type 
of accelerometer and time-frame of interest, resulting in variable monitoring frames of 
7 days, 5 days,  5-6 days and 3-5 days, respectively (53, 193-195). All studies utilised 
different accelerometers; Compute Science Applications (CSA) accelerometer (193), 
SenseWear Armband (194), Caltrac accelerometer (195) and the ActiGraph (53), and 
positioned the device on multiple body positions; the hip (193), arm (194) and waist 
(53, 195). Several assessed the appropriate monitoring frames to reliably estimate 
habitual physical behaviour intensities independently (53, 193, 194). Matthews et al. 
(2002) determined that 3-4 days monitoring were required to accurately measure 
MVPA (193). Scheers et al. (2012) suggested that both Saturday and Sunday and at 
least 3 weekdays were needed to obtain reliable estimates of habitual physical activity, 
and only 3 days data collection was needed to capture light activity (194). Hart et al. 
(2011) proposed monitoring frames individually for sedentary behaviour, light activity, 
moderate and vigorous activity; 5, 3 and 2 days monitoring respectively (53). These 
inconsistent recommendations emphasise the need to establish an appropriate 
monitoring frame to reliably capture habitual physical behaviour for each 
accelerometer, activity intensity and position of wear.   
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Our results add to the current literature by reporting the number of monitoring days 
needed to reliably estimate habitual physical behaviour using GENEActiv 
accelerometers. The number of days needed to reliably estimate habitual physical 
behaviour vary according to activity intensity and statistical tests used (190). Tudor-
Locke et al. (2005) contend that  no single statistical test is considered adequate to 
fully understand the issues underlying the calculation of an appropriate monitoring 
frame (198). As recommended by Tudor-Locke et al. (2005), which employed a wide 
range of statistical techniques to determine number of days needed for an appropriate 
monitoring frame, Spearman-Brown prophecy formula has been used in the majority 
of studies investigating appropriate monitoring frames (193, 196, 199). Results of 
Spearman-Brown calculations and ICC for a single day identified consistent monitoring 
frames for all activity intensities (>1 day monitoring). 
In addition, the moderate to high pairwise correlations across days indicated a clear 
tendency for activity patterns to be consistent across the days, with the exception of 
vigorous activity where correlations were low suggesting that vigorous activity patterns 
varied throughout the week, thus explaining the longer monitoring frame. In terms of 
sedentary and light activity, Sunday had the lowest correlations, suggesting the activity 
patterns on Sunday are less consistent with other days in the week. Greater between-
subject variation and lesser within-subject variation across days results in shorter 
monitoring frames.  Light and moderate intensity activities have the shortest 
monitoring frames; this could be due to higher levels of between-subject variation and 
lower levels of within-subject variation across days of the week compared to sedentary 
and vigorous activity, and thus 2 days of monitoring is sufficient to capture variation in 
light and moderate intensity activities. In addition, light and moderate intensity 
activities are more likely to include household activities and activities such as exercise 
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which tend to be planned, structured and repetitive (45). The same could be said for 
vigorous activity, however due to the very low levels of vigorous activity measured in 
this population, variation between- and within-subjects would be hard to capture 
accurately, thus resulting in a larger monitoring frame. This is supported by the low 
pairwise correlations across days, which indicate inconsistent activity patterns across 
the days. 
 
Study strengths and limitations 
A main strength of our study is the use of a valid and reliable activity monitor which is 
capable of assessing time spent in sedentary, light, moderate and vigorous activity 
categories (85). In addition, this accelerometer collects data as raw acceleration and 
stores the data as g units for offline analysis thereby allowing for efficient data 
cleaning, management of spurious data, and the application of various known data 
processing algorithms post-data collection. Further strengths include the 24-hour 
study protocol, the high study participation rate and large sample size.  
Notwithstanding these strengths one limitation of this study is that we only examined 
the required number of monitoring days needed to reliably estimate weekly habitual 
activity. Further investigation could be expanded into how many days/weeks of 
monitoring represent a month, a season, or a year of habitual activity using the 
GENEActiv accelerometer. Kang et al. (2009) examined a suitable monitoring frame 
to capture year-round averages of pedometer measured physical activity and found 5 
consecutive days and 6 random days to be necessary (200). In addition, many studies 
have reported seasonal and monthly variations in physical activity leading to 
recommendations for physical behaviour data collection to occur during certain 
seasons and specific months of the year (179, 201, 202). Generalizability of our 
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findings may also be limited. The Mitchelstown cohort was a random sample of middle-
aged adults, 50-69 years of age, in an area which was representative of both urban 
and rural population in Ireland. The sub-sample of the Mitchelstown cohort for whom 
accelerometer data was collected, differed by gender, in that women were more likely 
to agree to wear the accelerometer.  In addition, participants were recruited from a 
primary care centre, and therefore could have more health problems or be more health 
conscious. However it should be noted that there were no statistically significant 
differences in age, gender, education or BMI between those included and excluded in 
the final analysis.  
The data for this study was collected over 7 consecutive days at a frequency of 100Hz 
and collapsed into 60s epochs. Under these conditions our results demonstrate the 
number of monitoring days required to reliably assess weekly habitual activity for each 
type of intensity. We observed marked differences between weekdays, Saturday and 
Sundays. If the outcome of interest, for further studies, involves a more detailed 
examination of patterns of activity both Saturday and Sunday should be included in 
the monitoring frame. Similarly our gender specific findings, such as comparatively 
high sedentary activity in women on Monday, should be considered. This 
consideration may be particularly pertinent when examining overweight and obese 
adults whose activity on weekend days has been shown to be particularly distinct from 
normal weight subjects across week days (203, 204). 
 
Conclusion 
This study examined the number of monitoring days needed to accurately estimate 
habitual physical activity and sedentary behaviour from the GENEActiv accelerometer 
in middle-aged adults. Our data indicates 6 days monitoring are required to reliably 
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capture weekly activity in all activity categories however a minimum number of 2 days 
plus Sunday are recommended for sedentary, light and moderate activity intensities. 
These findings may have important implications in terms of study design and data 
reduction strategies. Further study protocols employing our recommendations may 
benefit from reduced number of data collection and processing days and associated 
reductions in person-time and study cost.  
 
 
Table 5: Number of participants with valid days (>10 hours of wear time) of data 
Number of valid days wear Number of participants 
7 days 397 
6 days 27 
5 days 12 
4 days 4 
3 days 3 
2 days 4 
1 days 6 
0 days 6 
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Table 6: Daily duration (minutes) of sedentary, light, moderate and vigorous activity 
 Total (n=397) 
 
Sedentary Light Moderate 
Vigorous 
MVPA 
Monday 926 (833, 984) 94 (64, 140) 50 (24, 93) 1 (0, 5) 56 (25, 100) 
Tuesday 921 (837, 981) 98 (64, 135) 48 (24, 91) 1 (0, 6) 52 (25, 101) 
Wednesday 911 (829, 976) 100 (68, 143) 55 (25, 95) 1 (0, 5) 59 (27, 100) 
Thursday 908 (842, 977) 106 (66, 140) 56 (26, 93) 1 (0, 5) 58 (26, 100) 
Friday 903 (826, 977) 106 (68, 148) 57 (25, 100) 1 (0, 5) 62 (25, 106) 
Saturday 910 (839, 989) 100 (65, 142) 51 (23, 98) 1 (0, 5) 56 (23, 103) 
Sunday 946 (872, 1004) 77 (48, 117) 42 (17, 82) 0 (0, 3) 46 (18, 91) 
p-value 
<0.001 
<0.001 <0.001 0.81 <0.001 
95 
 
 Men (n=183) 
 
Sedentary Light Moderate Vigorous 
MVPA 
Monday 909 (798, 972) 98 (66, 154) 60 (29, 116) 1 (0, 7) 69 (29, 126) 
Tuesday 906 (813, 979) 103 (62, 146) 61 (25, 112) 1 (0, 7) 66 (27, 120) 
Wednesday 903 (802, 970) 99 (67, 156) 66 (32, 118) 1 (0, 6) 76 (33, 122) 
Thursday 901 (815, 978) 104 (66, 143) 66 (31, 107) 1 (0, 5) 71 (31, 116) 
Friday 889 (802, 977) 100 (66, 156) 65 (29, 111) 1 (0, 6) 74 (30, 121) 
Saturday 912 (840, 987) 99 (65, 135) 58 (25, 99) 1 (0, 6) 64 (25, 103) 
Sunday 956 (878, 1009) 70 (43, 108) 45 (18, 85) 1 (0, 4) 47 (19, 85) 
p-value <0.001 <0.001 0.009 0.77 0.01 
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 Women (n=214) 
 
Sedentary Light Moderate Vigorous 
MVPA 
Monday 931 (869, 990) 92 (58, 133) 40 (22, 76) 1 (0, 3) 46 (22, 82) 
Tuesday 930 (867, 985) 97 (66, 130) 43 (21, 75) 1 (0, 5) 47 (22, 84) 
Wednesday 918 (850, 980) 100 (68, 135) 49 (23, 83) 1 (0, 4) 52 (25, 87) 
Thursday 915 (854, 974) 107 (68, 138) 48 (23, 83) 1 (0, 4) 51 (24, 88) 
Friday 910 (844, 979) 110 (68, 146) 48 (23, 84) 1 (0, 4) 52 (25, 89) 
Saturday 909 (834, 990) 103 (67, 148) 46 (21, 94) 1 (0, 4) 51 (22, 104) 
Sunday 940 (862, 1002) 89 (51, 124) 38 (16, 80) 0 (0, 3) 43 (16, 85) 
p-value <0.001 <0.001 <0.001 0.84 <0.001 
Data is presented as median (25th, 75th percentile) 
P-values presented as Kruskal-Wallis, tests the difference in median activity levels across days of the week. 
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Figure 4: Reliability coefficients for number of days monitoring based on 
Spearman-Brown Formula. 
 
Figure 4 illustrates the reliability coefficient associated with different length monitoring 
frames. The results propose that between 59-82%, 68-87%, 74-90% and 78-92% of 
variance was explained for by using 2 days, 3 days, 4 days and 5 days monitoring to 
represent 7 days of habitual activity.  
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CHAPTER SIX – CROSS-SECTIONAL ANALYSIS OF 
WEEKLY LEVELS AND PATTERNS OF 
OBJECTIVELY-MEASURED PHYSICAL BEHAVIOUR 
WITH CARDIOMETABOLIC HEALTH IN MIDDLE-
AGED ADULTS. 
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Abstract 
Introduction 
Little is known how combined weekly patterns of physical activity and sedentary 
behaviour are associated with cardiometabolic health. The objective of this paper is to 
identify weekly patterns of physical activity and sedentary behaviour and to examine 
cardiometabolic health status associated with different activity patterns.  
Methods 
Data are from a subsample of the Mitchelstown Cohort; 475 (59.7±5.5 years) middle-
aged adults. Participants wore the wrist GENEActiv accelerometer for7 consecutive 
days. Data was summarised into 60s epochs and each time interval categorised based 
on thresholds. LPA defined classes based on observed clustering of sedentary 
behaviour and physical activity variables while multivariate latent class regression was 
used to compare cardiometabolic health status across classes.  
Results  
LPA revealed 4 distinct physical behaviour patterns; Sedentary Group (15.9 %), High 
Sedentary; Lower Activity Group (28.0%), Lower Sedentary; Higher Activity Group 
(44.2%) and a Physically Active Group (11.9%).  Overall the Sedentary Group had 
poorer profiles, characterised by high BMI, waist circumference, TAG, FPG, TNF-α, 
leptin, C3, insulin resistance, IL6 and insulin levels, and low insulin sensitivity, HDL-C, 
LDL-C, CHOL and adiponectin levels. The remaining classes were characterised by 
healthier cardiometabolic profiles as sedentary behaviour levels decreased.  
Conclusion 
The classification of groups of adults with similar physical behaviour patterns offers 
important information for the identification and tailoring of public health and health 
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promotion intervention strategies. Future health policy should be directed towards 
altering patterns of behaviour rather than concentrating on a single type of behaviour. 
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Introduction 
Sedentary behaviour and physical activity have been found to have significant 
associations with health however their combined association with health have not 
been extensively studied. Being physically active is a major contributor to both physical 
and mental health (10, 16, 51, 52, 106, 151, 152). Conversely, sedentary behaviour 
has been found to be associated with poor health and mortality (12, 23, 25, 205-207). 
The health benefits of regular physical activity, more specifically moderate-to-vigorous 
physical activity (MVPA), are well established (10). Current guidelines recommend 
adults to accumulate 150 minutes of moderate-intensity activity or 75 minutes of 
vigorous activity or a combination of both per week occurring on most days of the week 
(29, 51, 52). The rational for recommending activity on most days of the week is 
attributable to evidence from early intervention studies (135). However, few studies 
have been able to isolate the effect of physical activity frequency from total-time for 
all-cause mortality (60, 101). In the past decade, research has reported the emergence 
of the ‘weekend warrior’ who accumulates most of their weekly activity into 1-2 days 
(42, 43, 60, 66). Lee et al. (2004) reported that among low-risk men, this ‘weekend 
warrior’ pattern could postpone mortality (60). Metzger et al. (2010) reported the 
‘weekend warrior’ pattern to have higher risk of obesity, low high density lipoprotein 
cholesterol (HDL-C), and high triglyceride (TAG) levels, but lower risk of high blood 
pressure and fasting plasma glucose (FPG) when compared to individuals who 
accumulate similar activity levels over a longer period (43). 
Most research examining the relationship between physical behaviour and health has 
focused on summary estimates of MVPA using self-reported data (99, 100, 208, 209). 
Self-reported data are prone to various degrees of measurement error and bias (74, 
75). Objective physical behaviour measurements offer several advantages including 
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lower costs, coupled with the rich, accurate, time-stamped data obtained. 
Furthermore, the time-stamped data offers the potential to examine patterns of 
physical behaviour across time periods based on frequency, duration and intensity of 
activity and thus allow more complete physical behaviour profiles to be evaluated. 
Despite this, most research using objective physical behaviour measurements to 
identify weekly patterns of activity report summary estimates across days of the week 
(210-212). There is no doubt that summary estimates have contributed to our 
understanding of the relationship between physical behaviour and cardiometabolic 
health. However the application of summary estimates across the entire measurement 
periods may preclude us from uncovering how weekly patterns or weekly accumulation 
of physical behaviour intensities differ in their associations with cardiometabolic health 
outcomes. Thus assessing weekly physical behaviour patterns, using individual 
specific daily estimates, may highlight relationships not previously observed (46). 
Few studies have attempted to identify weekly patterns of physical activity and 
sedentary behaviour using accelerometry data in middle-aged adults (42, 43). Many 
have used self-reported data and the majority have been based on children and 
adolescents populations (213-219). The identification of weekly activity patterns, using 
LPA, has scarcely been examined in middle-aged adults (42, 43). To date only 2 
studies, based on the same study population in the US, have identified weekly patterns 
of MVPA in adults (42, 43). A major limitation of these studies are that just focusing 
primarily on MVPA disregards the important contribution of both light and sedentary 
activity to habitual activity, overlooks the compositional nature of these physical 
behaviours and thus ignores the association between these interrelated physical 
behaviours and health. Loprinzi et al. (2014) examined the interrelated association 
between physical behaviour patterns and health using predefined groups and reported 
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evidence that individuals who did not meet weekly physical activity recommendations, 
but who had higher levels of light activity than sedentary activity had more favourable 
TAG and insulin levels (220). To date, no study has examined the interrelated 
association between different physical behaviour patterns and health using continuous 
data, which LPA allows us to assess in a population sample of middle-aged adults. 
Thus the purpose of this study is to identify and describe unique patterns of physical 
activity and sedentary behaviour in a population sample of middle-aged adults and to 
assess whether cardiometabolic health indices differ between profiles of activity 
patterns.  
 
Methods  
Data are from a subsample of the Mitchelstown Cohort; 475 (46.1% males; 
59.7±5.5years) middle-aged Irish adults. Information on anthropometric measures and 
cardiometabolic and inflammatory markers were collected. Participants wore the wrist 
GENEActiv accelerometer for 7 consecutive days. Daily summaries of time spent 
(minutes) in sedentary behaviour, light activity and MVPA were calculated. All 
variables were expressed proportional to individual wear time. These methods are 
described in greater detail in Chapter 3. 
  
Statistical analysis  
Descriptive statistics 
Descriptive statistics (number (%) and median (25th, 75th percentile)) were calculated 
for all study variables and are presented in Table 7. 
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Latent profile analysis 
Firstly, LPA was used to identify coexisting classes of physical behaviour patterns 
identified by mean time (minutes) spent in sedentary behaviour, light activity and 
MVPA across each day of the week. These patterns are mutually exclusive classes 
that maximise between-group variance and minimises within-group variance based on 
model fit criteria (86). Outcomes of LPA include the number of latent classes, the mean 
of each indicator variable in each class, and probability of class membership.  
Secondly, a multivariate Latent Class Regression (LCR) model examined the 
association between class memberships and cardiometabolic health status using odds 
ratios. Latent class regression fits regression equations to coexisting classes of 
respondents exhibiting similar physical behaviour patterns. Age, gender, season and 
job status were included as covariates. These covariates were used to help predict 
class membership. The LCR model identifies a set of classes of a latent variable from 
a set of observed discrete variables (daily minutes of sedentary behaviour, light activity 
and MVPA) (104, 105). In contrast to regression models, LCR highlights the set of 
latent classes identified in the analysis, rather that considering each of the observed 
indicators separately or all possible combinations of the observed indicators (104).  
Selecting the number of classes 
In order to select the appropriate number of classes, a series of latent class models, 
with an increasing number of classes were compared. Determining the number of 
classes that adequately describe the sample was based on a combination of model fit 
indices (Akaike Information Criterion (AIC), Bayesian Information Criterion (BIC), 
Sample Size Adjusted SSA-BIC (SSA-BIC), Lo Mendell Rubin (LMR)), theoretical 
implications and distinctiveness of each latent class profile (entropy). Several models 
were fit to the data, one through 5 latent profiles. Model parameters were estimated 
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using Maximum Likelihood Estimator based on the Expectation Maximization 
algorithm. The AIC (-2 * number of model parameters), BIC (-2 * model log-likelihood 
+ log(n) * number of model parameters), and LMR were computed to compare 
competing models. To ensure maximum likelihood solution was correctly identified 
within these models, 100 iterations of each model were run using 1,000 random starts. 
The LPA model included covariates; age, gender, season and job status, to help 
predict class membership by providing more refined prior probabilities based on the 
distribution of the socio-demographic characteristics within each class (42). All 
statistical analyses were conducted using Mplus software (version 6.12 for Windows). 
An alpha level of 0.05 was set to evaluate significance. 
 
Results 
Descriptive information 
The distribution of subject characteristics and accelerometer-measured physical 
activity by gender is presented in Table 7. Similar sedentary behaviour  and light 
activity levels were observed for males and females on most days of the week, with 
the exception of Monday for sedentary behaviour, where females were significantly 
more sedentary (P=0.003), and Sunday for light activity (P<0.05) where females had 
significantly higher light activity levels. In contrast, MVPA levels were similar toward 
the end of the week and differed significantly Monday through Friday (P<0.03) with 
males accumulating higher MVPA. The mean age in the sample was 59.7 years (SD 
5.5 years) and did not differ between males (46.1%) and females, (P=0.86). 
Approximately 24.8% of women were unemployed or did home duties while more 
females wore the accelerometer during Summer/Autumn months (P<0.001). 
Cardiometabolic variables are presented in Table 8. Statistically significant differences 
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were observed between males and females (P<0.05), with the exception of systolic 
blood pressure, C3, IL6 and TNF-α. 
 
Latent profile analysis 
During the primary stage of analysis, a LPA model with covariates was fitted to the 
physical behaviour variables, starting with a 1 class model and progressing to a 5 class 
model. The Information Criteria, entropy, likelihood ratio tests are presented in Table 
9 and class probabilities of each latent class are presented in Appendix 4. AIC and 
SSA-BIC fit indices decreased as the number of profiles increased while entropy 
remained high (>0.90) for all models. BIC indices decreased up to a 4 class model 
where a slight increase was observed. All profiles seem to differ from the smaller ones 
only by separating out smaller subgroups of participants from the larger profiles. These 
smaller subgroups were increasingly difficult to interpret theoretically as they showed 
similar physical behaviour patterns but varied in predictor means. The quality of the 
resulting classification was also evaluated based on the entropy index. Values range 
from 0 to 1, and high values (>0.90) indicate that the latent classes are highly 
discriminative. Allowing for the arguments between model parsimony, statistical fit, 
and theory, the 4-class model was chosen as best fit model. 
Latent class  physical behaviour profiles are presented in Figures 5a-5d. The figures 
illustrate the differences and magnitude of the differences in physical behaviour 
patterns across the 4 latent classes. Class 1 was characterised by high sedentary 
behaviour levels and low physical activity levels. In contrast, class 2 was characterised 
by low sedentary behaviour levels and higher physical activity levels. Class 3 are 
characterised by high sedentary behaviour and lower physical activity levels while 
class 4 was highly physically active with low levels of sedentary behaviour. More 
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specifically, class 1 is characterised as having approximately 2.5hours more sedentary 
behaviour and 2.5 hours less light activity and MVPA compared to class 2. 
Additionally, class 3 is characterised as having approximately 4 hours more sedentary 
behaviour and 3 hours less light activity and MVPA compared to class 4.  
 
LPA and cardiometabolic health status 
In relation to cardiometabolic health indices, the four latent classes are characterised 
as follows: Class 2 (Lower Sedentary; Higher Activity Group) is characterised by high 
insulin sensitivity and adiponectin levels low FPG and IL6 levels; Class 3 (High 
Sedentary; Lower Activity Group) is characterised by high insulin resistance, C3, 
adiponectin and TNF-α and low insulin sensitivity; Class 1 (Sedentary Group) is 
characterised by high BMI, waist circumference, TAG, FPG, TNF-α, leptin, C3, insulin 
resistance, IL6 and insulin levels, and low insulin sensitivity, HDL-C, LDL-C,CHOL and 
adiponectin levels and Class 4 (Physically Active Group) is characterised by high 
insulin sensitivity and low FPG, insulin, insulin resistance, C3, TNF-α and leptin.  
Classes 2 through 4 have similar, BMI, waist circumference, HDL-C, LDL-C, CHOL 
and BP levels. The mean estimates for cardiometabolic predictor variables are 
presented in Table 10.  
Table 11 summarises the associations between cardiometabolic health outcomes 
(diabetes, obesity and hypertension) and class membership when controlling for the 
influence of age, gender, season and job occupation on class membership. In relation 
to class probability, diabetic persons had a 15%, 5%, 10% and 7% probability of being 
in class 1 through 4 respectively. Obese and hypertensive persons had 49%, 25%, 
38%, 24% and 29%, 26%, 67% and 26% probability of being in class 1 thru 4 
respectively. Despite these differences, regression analysis only observed significant 
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differences between classes with respect to obesity and hypertension. Compared to 
class 1, classes 2 through 4 had significantly higher odds of obesity (OR: 1.59 – 3.17; 
p<0.023) and hypertension (OR: 1.05 - 1.15; p<0.03), with the exception of class 3 
which had lower odds off hypertension 9OR: 0.84; p=0.008). Additionally, classes 3 
and 4 had lower odds of obese (OR: 0.533; p=0.004) and hypertensive persons (OR: 
0.727-0.908; p<0.02) with the exception of obese persons in class 2 (OR: 1.07; 
p=0.015). In other words, obese and hypertensive individuals were 1.59 – 3.17 and 
1.05-1.15 times more likely to be in classes 2 thru 4 when compared to class 1  
 
Discussion 
The primary aim of this study was to identify unique clusters of activity patterns among 
adults based on their weekly participation in sedentary behaviour, light activity and 
MVPA. Secondly, to explore differences in cardiometabolic health status between 
clusters patterns of activity. Our analysis identified four distinct physical behaviour 
patterns; Sedentary Group, Higher Sedentary; Lower Activity Group, Lower 
Sedentary; Higher Activity Group and a Physically Active Group. While the sedentary 
group was characterised as having the worst cardiometabolic profile, no major 
differences in cardiometabolic markers were observed between the Sedentary Group 
and the remaining three identified groups (Higher Sedentary; Lower Activity Group, 
Lower Sedentary; Higher Activity Group and a Physically Active Group). While this is 
the first study to our knowledge to identify combined, weekly physical activity and 
sedentary behaviour patterns in a population-sample of middle-aged adults using LPA 
and accelerometer data, a number of studies have previously identified combined 
patterns of habitual activities (221, 222). Metzger et al. (2007) identified weekly 
patterns of MVPA in a population sample of adults. By focusing exclusively on MVPA, 
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the potential differential effects of light activity compared with sedentary behaviour on 
health outcomes have been ignored. Buman et al. (2010) reported that both higher 
intensity-light activity and MVPA are interchangeable with respect to their associations 
with physical health in older adults; however evidence is lacking in middle-aged adults. 
Recent studies that have examined the combined, interrelated patterns of physical 
activity and sedentary behaviour have used newly proposed methods (The ATLAS 
Index and exposure variation analysis (EVA)) which have yet to be validated in large 
population samples. Marschollek et al. (2014) proposed a new method ‘The ATLAS 
Index’ to derive common measures for distinguishing different characteristic activity 
phenotypes for accelerometer data while Straker et al. (2014) suggested EVA to 
capture physical behaviour patterns (221, 222). Straker et al. (2014) reported EVA to 
be a unique and comprehensive method that is able to capture the time pattern of 
physical behaviour (221). However, this method needs variables to be categorical thus 
it does not fully capture the real-time aspects of activity. In addition, this study uses 
uni-axial or omnidirectional plane for analysis and the sample size is small (n=8). Thus 
EVA has yet to be validated for use using tri-axial data on a large population sample.   
Previous studies examining the relationship between physical behaviour and health 
have largely focused on averaged or total summary estimates across group. However 
associations can be overlooked or diluted when the focus is on the group summary 
estimate and the variation in physical activity and sedentary behaviour patterns 
throughout the week are ignored. Our results add to the current literature by identifying 
4 distinct physical behaviour patterns in middle-aged adults and examining their 
relationship with numerous cardiometabolic markers. Our data indicate that as 
physical activity levels increase cardiometabolic health status improves, suggesting 
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that even modest increases in lower intensity physical activity may have beneficial 
health effects. 
 
Study strengths and limitations 
Strengths of this study include the high participation rate (64%) and the use of 
objective measurement of physical behaviour and measurement of a wide range of 
cardiometabolic biomarkers. Compared with self-report, objective measurements are 
more precise, less biased and reduce the potential for measurement error. The recall 
and social-desirability biases that accompany self-report measures are well known 
and may lead to misclassification bias (74). The current study has a number of 
limitations that should be noted. First, this is a cross-sectional study and therefore 
cause-effect relations cannot be determined.  In addition, different data processing 
methods could result in different activity classes. Nonetheless, these analyses have 
shown the merits of LPA for the purpose of identifying and describing groups of adults 
based on their distinct physical activity and sedentary behaviour patterns throughout 
the week. Furthermore it should be noted that approximately 24.8% of women were 
unemployed or did home duties while 0% of males were unemployed. Home duty is 
very common feature of Irish societies especially in older and middle-aged female 
adults. In recent decades, more and more women have entered that workplace from 
all ages. These levels of unemployment in our study population are not representative 
for the Irish population as unemployment rates for males and females in 2011 were 
13.3% and 9.2% respectively. However for this analysis, employment status was used 
to adjust for differences in physical behaviour patterns between those who have a 
scheduled work day and those who didn’t. The sedentary group was characterised as 
having the worst cardiometabolic profile however no major differences in 
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cardiometabolic markers were observed between the groups. LPA analysis found four 
different physical behaviour patterns in the population, resulting in classes 1 and 4 
having small sample sizes (16% and 12% of the study sample respectively). These 
groups may not have large enough sample sizes for sufficient statistical power to 
detect accurate association with health outcomes. A study with low statistical power 
has a reduced chance of detecting true associations and also reduces the probability 
that a statistically significant finding exposes a true association. Thus further studies 
using larger sample sizes are required. While outcomes of this study may be 
considered a consequence of multiple testing, it is worth emphasising that this paper 
is an exploratory analysis of the association between physical behaviour clusters and 
cardiometabolic health outcomes. Thus both significant and non-significant 
associations are presented for transparency. 
 
Generalizability of the study 
Generalizability of our findings may also be limited. The Mitchelstown Cohort was a 
random sample of general practice registered, middle-aged adults, 50-69 years of age, 
in an area which was representative of both urban and rural population in Ireland.  In 
addition, participants were recruited from a primary care centre, and therefore could 
have more health problems or be more health conscious. 
 
Conclusion 
The classification of groups of adults with similar physical behaviour patterns provides 
valuable information for the identification and tailoring of specific public health and 
health promotion messages and intervention strategies. Large prospective studies are 
needed to assess the relationship between the long-term exposure or impact of 
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different clustering patterns on inflammatory and cardiometabolic status, as 
intermediate phenotypes predisposing to risk of developing obesity, cardiovascular 
disease and overt diabetes. 
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Table 7: Descriptive characteristics of study participants by gender (N=397)  
 Male (N=183) Female (N=214)  
 Median (25th, 75th 
percentile) 
Median (25th, 75th 
percentile) 
p-values 
Physical activity distal 
outcomes (minutes) 
   
Sedentary activity     
Monday 909 (798, 972) 931 (869, 990) 0.003 
Tuesday 906 (813, 980) 930 (867, 986) 0.03 
Wednesday 903 (802, 970) 918 (850, 980) 0.05 
Thursday 901 (815, 978) 916 (855, 974) 0.11 
Friday 889 (802, 977) 910 (844, 979) 0.28 
Saturday 912 (840, 987) 909 (834, 990) 0.92 
Sunday 956 (878, 1010) 940 (862, 1003) 0.29 
Light activity     
Monday 98 (66, 154) 92 (58, 133) 0.08 
Tuesday 103 (62, 146) 97 (66, 130) 0.28 
Wednesday 99 (67, 156) 100 (68, 135) 0.73 
Thursday 104 (66, 143) 107 (67, 138) 0.96 
Friday 100 (66, 156) 110 (69, 146) 0.71 
Saturday 99 (65, 135) 103 (67, 148) 0.31 
Sunday 70 (43, 108) 89 (51, 124) 0.007 
MVPA     
Monday 68 (29, 126) 46 (22, 82) 0.0003 
Tuesday 66 (26, 120) 47 (22, 84) 0.007 
Wednesday 76 (33, 122) 52 (25, 87) 0.002 
Thursday 71 (31, 116) 51 (24, 88) 0.004 
Friday 74 (30, 121) 52 (25, 89) 0.03 
Saturday 64 (25, 103) 51 (22, 104) 0.25 
Sunday 48 (19, 94) 43 (16, 85) 0.59 
Indicator variables    
Age (years) 59.4 (54.9, 64.3) 59.3 (54.8, 64.5) 0.86 
Season*    
Winter/Spring 147 (80.8) 131 (61.2)  
Summer/Autumn 35 (19.2) 83 (38.8) <0.001 
Job status*    
Employed 183 (100) 161 (75.2)  
Unemployed 0 53 (24.8) <0.001 
    
*Data presented as N (%), all other data presented as medians (25th, 75th 
percentile). P-values were generated using non-parametric and chi-squares tests. 
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Table 8: Distribution of cardiometabolic variables by gender (N=397) 
 Male (N=183) Female 
(N=214) 
 
 Median (25th, 
75th percentile) 
Median (25th, 
75th percentile) 
p-values 
Cardiometabolic distal 
outcomes 
   
BMI (kg/m²) 29.1 (26.4, 31.9) 27.8 (25.2, 30.4) 0.004 
Systolic blood pressure (mm 
Hg) 
128 (118, 140) 126 (118, 142) 0.97 
Diastolic blood pressure (mm 
Hg) 
78.0 (72, 86) 82 (74, 88) 0.03 
Cholesterol (mmol/l) 4.9 (4.3, 5.6) 5.5 (4.9, 6.2) 0.0001 
HDL-C (mmol/l) 1.25 (1.07, 1.46) 1.62 (1.39, 1.86) 0.0001 
LDL-C (mmol/l) 3.1 (2.5, 3.6) 3.3 (2.7, 3.9) 0.02 
Triglycerides (mmol/l) 1.25 (0.92, 1.85) 1.12 (0.81, 1.50) 0.01 
Fasting blood glucose (mmol/l) 5.1 (4.8, 5.6) 4.9 (4.6, 5.2) 0.0001 
Insulin  (mU/ml) 10.41 (6.03, 
15.84) 
8.17 (5.26, 
12.58) 
0.01 
HOMAIR 2.40 (1.41, 3.82) 1.78 (1.08, 2.86) 0.0025 
QUICKIIS 0.25 (0.22, 0.29) 0.27 (0.24, 0.31) 0.0025 
Complement c3 (g/l) 134.5 (120.3, 
149.4) 
137.5 (119.4, 
155.0) 
0.21 
Interleukin-6 (pg/ml) 1.87 (1.33, 3.08) 1.69 (1.09, 2.82) 0.055 
Tumor necrosis factor-α (pg/ml) 5.96 (4.92, 7.24) 5.72 (4.56, 7.10) 0.09 
Leptin (ng/ml)  1.76 2.20 (1.39, 4.08) 0.0001 
Adiponectin (ųg/ml) 3.36 (2.24, 4.95) 6.52 (4.37, 9.59) 0.0001 
P-values were generated using non-parametric tests. 
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Table 9: Latent Profile Analysis; Fit indices for 1-5 class models 
 1 Class 2 Class 3 Class 4 Class 5 Class 
Log-likelihood -58661 -60863 -59637 -59058 -58661 
AIC  131038 122022 119703 118680 118020 
BIC  131384 122612 120559 119803 119410 
SSA-BIC 131108 122142 119877 118909 118302 
Entropy - 0.984 0.985 0.974 0.980 
LMR test -  -63512 -60863 -59637 -59209 
LMR p-value - 0.000 0.7602 0.7962 0.777 
Variables included in the model: minutes spent in sedentary behaviour , light activity and MVPA 
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Figure 5 (a):  Class 1: Sedentary Group (15.9%): Weekly Distribution of 
Physical Behaviour 
  
 
Figure 5 (b): Class 2: Lower Sedentary, Higher Activity Group (44.2%): Weekly 
Distribution of Physical Behaviour 
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Figure 5 (c): Class 3: Higher Sedentary, Lower Activity Group (28.0%): 
Weekly Distribution of Physical Behaviour. 
 
 
Figure 5 (d): Class 4: Physically Active Group (11.9%): Weekly 
Distribution of Physical Behaviour 
 
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
MVPA
Light Activity
Sedentary Behaviour
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
MVPA
Light Activity
Sedentary Behaviour
118 
 
 
Table 10: Latent class regression; variable means 
  Class 1 Class 2 Class 3 Class 4 
Segment size (%) 63 (15.9) 175 (44.2) 111 (28.0) 47 (11.9) 
          
Cardiometabolic markers*     
BMI (Kg/m2) 31 28 29 28 
Waist circumference (cm) 102 95 96 95 
Systolic blood pressure (mm Hg) 128 128 132 130 
Diastolic blood pressure (mm Hg) 80 80 82 78 
Cholesterol (mmol/l) 4.88 5.4 5.38 5.20 
HDL-C (mmol/l) 1.38 1.51 1.45 1.48 
LDL-C (mmol/l) 2.8 3.3 3.2 3.22 
Triglycerides(mmol/l) 1.54 1.28 1.56 1.13 
Fasting blood glucose (mmol/l) 5.57 5.11 5.22 5.13 
Insulin  (mU/ml) 15.89 10.28 14.21 7.43 
HOMAIR 4.24 2.44 3.6 1.75 
QUICKIIS 0.24 0.28 0.26 0.299 
Complement c3 (g/l) 147.79 135.37 144.51 127.3 
Interleukin-6 (pg/ml) 4.31 2.11 2.31 2.59 
Tumor necrosis factor-α (pg/ml) 6.52 5.97 6.50 5.88 
Leptin (ng/ml)  4.40 2.39 2.84 1.79 
Adiponectin (ųg/ml) 5.10 5.99 5.83 5.53 
*All markers have equal variance 
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Table 11: Latent class regression on cardiometabolic factors 
Class comparison  Odds Ratio (p-value) 
Class 1 compared to class 2  
Diabetes  3.55 (0.059) 
Obesity 2.98 (0.004)  
Hypertension 1.15 (0.004) 
Class 1 compared to class 3  
Diabetes 1.53 (0.057) 
Obesity 1.59 (0.015)  
Hypertension 0.84 (0.008)  
Class 1 compared to class 4  
Diabetes  2.46 (0.170) 
Obesity 3.17 (0.03) 
Hypertension 1.05 (0.03)  
Class 2 compared to class 3  
Diabetes 0.431 (0.05) 
Obesity  0.533 (0.004) 
Hypertension 0.727 (0.001)  
Class 2 compared to class 4  
Diabetes 0.694 (0.166) 
Obesity 1.07 (0.015)  
Hypertension 0.908 (0.014)  
Class 3 compared to class 4  
Diabetes 1.61 (0.168) 
Obesity 1.99 (0.03)  
Hypertension 1.25 (0.02)  
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CHAPTER SEVEN - DAILY CUMULATIVE PATTERNS 
OF OBJECTIVELY-MEASURED PHYSICAL ACTIVITY 
AND SEDENTARY BEHAVIOUR BY 
CARDIOMETABOLIC HEALTH STATUS IN MIDDLE-
AGED ADULTS. 
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Abstract 
Background 
An understanding of the nature and magnitude of within- and between-day variability 
in physical behaviour is necessary to translate epidemiological findings into tangible 
public health recommendations. Metabolic syndrome (MetS) is characterised by the 
coexistence of obesity, dyslipidemia, hyperglycemia and hypertension and is 
associated with an increased risk of type 2 diabetes and cardiovascular disease. The 
aim of this paper is to compare daily cumulative patterns of minute-by-minute 
accelerometer-measured physical behaviour activity intensities across those with and 
without MetS.  
Methods 
Data are from a subsample of the Mitchelstown Cohort; 475 (59.7±5.5 years) middle-
aged adults. Participants wore the wrist GENEActiv accelerometer for 7 consecutive 
days. Data was summarised into 60s epochs and each time interval categorised based 
on thresholds. MetS was defined according to International Diabetes Federation 2006 
guidelines. Cumulative distribution plots were created for weekday and weekend day 
activity across MetS health profiles.  
Results  
Individuals with MetS had higher sedentary behaviour and lower light activity and 
MVPA relative to the subjects without MetS (those with MetS had half the MVPA levels 
when compared to those without MetS). Overall similar cumulative activity patterns 
were observed throughout the day regardless of MetS status. However substantial 
differences were observed for MVPA for both weekday and weekend days; those with 
MetS started accumulating MVPA later in the day compared to those without MetS 
and for shorter durations of the day. Individuals with MetS were older, more likely to 
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be males and were characterised by lower CHOL and LDL concentrations, greater 
insulin resistance and reduced insulin sensitivity and raised inflammatory status (p < 
0.002). 
Conclusion 
This study demonstrates ample within- and between-day variation in physical activity 
and sedentary behaviour across those with and without MetS to further research.  A 
better understanding of such patterns will aid development of future targeted 
interventions tailored to an individual’s cardiometabolic health status, which may be 
particularly important for those at increased risk of developing cardiometabolic 
disease. 
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Introduction 
Physical activity plays a major role in the prevention, management and rehabilitation 
of many chronic diseases and conditions such as metabolic syndrome (MetS), 
hypertension, diabetes and obesity (14-16, 26, 77, 223). MetS is characterised by the 
coexistence of obesity, dyslipidemia, hyperglycemia and hypertension and is 
associated with an increased risk of type 2 diabetes and cardiovascular disease (CVD) 
(15, 224). Sedentary behaviour is associated with poor health and mortality (12, 18-
21). Recently, a dose-response relationship has been found between sedentary 
behaviour and MetS (225). Sedentary behaviour and physical activity levels in free-
living adults vary throughout the day and from day-to-day (39, 136, 193, 198). An 
understanding of the nature and magnitude of within- and between-day variability in 
physical behaviour is necessary to translate epidemiological findings into tangible 
public health recommendations. Objective physical behaviour measurements, such as 
accelerometers, are now becoming more popular due to lower costs, coupled with the 
rich, accurate, time-stamped data obtained. The second-by-second, time-stamped 
data gives the potential to examine patterns of physical behaviour across minutes 
based on intensity of activity and thus allows more complete physical behaviour 
profiles to be evaluated. Understanding the differences in activity levels within days, 
across days of the week and between different cardiometabolic health profiles allows 
focussed intervention efforts to be developed, taking into account when people are 
most sedentary and thus predisposed to efforts to increase activity levels. These 
interventions could include increasing time spent in light and MVPA intensity activities 
but also reducing duration of bouts of sedentary behaviour by increasing breaks and 
time standing especially in with sedentary occupations. 
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Most studies investigating daily activity levels have focused primarily on summation 
statistics such as total or mean activity estimates for the week. However, data summed 
or averaged across entire measurement periods do not have the capacity or potential 
to detect differences between cardiometabolic risk factor subgroups and daily minute-
by-minute physical behaviour patterns. Assessing daily physical behaviour patterns, 
using participant daily minute-by-minute estimates, may highlight relationships not 
previously observed (46, 90). Most research that has examined within-day variation in 
sedentary behaviour and physical activity have averaged data across different time-
segments (morning, afternoon and evening) or summarised data across hours (38, 39, 
41, 90, 136, 211, 226-232). Furthermore, research that has examined between-day 
variation have used averaged daily estimates or arbitrary activity counts in analysis 
(138, 193, 198). Thus there is a paucity of minute-to-minute intensity variability 
throughout the day, across days of the week from large, cross-sectional sample of 
middle-aged adults.  
The majority of studies examining within-day variation in physical behaviour have been 
based on children and adolescent populations while few have examined associations 
with health outcomes (41, 136, 211, 227-232). Lee et al. (2012) determined two 
characteristic physical activity patterns based on hourly physical activity count data 
and reported better health profiles associated with those who accumulated greater 
activity levels for greater amounts of the day (41). Garriguet et al. (2012) reported 
different MVPA patterns associated with different BMI categories  using summarised 
hourly data (136).  
Thus few studies have attempted to identify daily cumulative patterns of physical 
behaviour  using minute-by-minute accelerometry data in middle-aged adults, and no 
study, to our knowledge, has examined associations between these patterns with 
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health outcomes (137, 138). Thus the aims of this paper are to explore daily cumulative 
patterns of minute-by-minute physical activity and sedentary behaviour between those 
with and without MetS. 
 
Methods  
Data are from a subsample of the Mitchelstown Cohort; 475 (46.1% males; 
59.7±5.5years) middle-aged Irish adults. Information on anthropometric measures and 
cardiometabolic and inflammatory markers were collected. Participants wore the wrist 
GENEActiv accelerometer for 7 consecutive days. Individual daily cumulative 
percentage of time spent in physical behaviour (sedentary behaviour, light activity and 
MVPA) were calculated for weekday and weekend days. MetS was defined according 
to International Diabetes Federation 2006 guidelines. All variables were expressed 
proportional to individual wear time. These methods are described in greater detail in 
Chapter 3. 
 
Statistical Analysis 
Analysis was performed separately for each intensity category. Individual daily 
cumulative percentage time spent and hours spent in all physical behaviour intensities 
were calculated. Data were presented as median and 25th and 75th percentiles.  
Distribution of cardiometabolic and inflammatory markers across each MetS profile 
were determined. Daily cumulative percentage of time spent for each weekday in all 
physical behaviour intensities were calculated. Daily cumulative distribution plots, 
using median values, were created for weekday and weekend days across MetS 
profile. All statistical analyses were conducted using Stata (version 12, Stata Corp, 
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College Station, Texas, USA) and R statistical software version 3.0 (http://www.r-
project.org). An alpha level of 0.05 was set to evaluate significance. 
 
Results 
Descriptive Characteristics 
Participant’s characteristics by MetS status are detailed in Tables 12 and 13. The 
prevalence of MetS in the study sample was 29.1%. Participant’s physical behaviour 
levels by weekday and weekend day are presented in Table 12. Significant differences 
in weekday and weekend day physical behaviour across all physical behaviour 
intensities were observed between those with and without MetS (p<0.006). Individuals 
with MetS had higher sedentary behaviour and lower light activity and MVPA on both 
weekdays and weekend days. Moreover, those with MetS had half the MVPA levels 
when compared to those without MetS on weekdays (3 and 12 minutes) and weekend 
days (15 and 39 minutes) respectively.  Individuals with MetS were older and more 
likely to be males (Table 13). 
 
Daily Cumulative Distribution of Physical Activity and Sedentary Behaviour  
Next we examined daily cumulative patterns of each physical behaviour intensity 
across week and weekend days. Overall similar cumulative activity patterns were 
observed throughout the day for sedentary behaviour and light activity between those 
with and without MetS (Figures 6a-d). Substantial differences were observed for 
MVPA during both weekday and weekend days (Figures 6e - 6f). Differences were 
observed regards how MVPA was accumulated for both weekday and weekend day. 
Those with MetS started cumulating MVPA later in the day compared to those with 
MetS. Furthermore, those with MetS accumulated MVPA for shorter durations of the 
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day, thus finished accumulating MVPA earlier in the day when compared to those 
without MetS. The most pronounced differences in daily cumulative activity between 
groups can be observed in weekday MVPA (Figure (e)). 
 
Discussion 
The results of this study suggest those with MetS had higher sedentary behaviour and 
lower light activity and MVPA when compared to those without MetS. Moreover, those 
with MetS had half the MVPA levels when compared to those without MetS. Overall 
similar cumulative activity patterns were observed throughout the day regardless of 
MetS status. However substantial differences were observed for MVPA for both 
weekday and weekend days; those without MetS started accumulating MVPA earlier 
in the day compared to those with MetS and for longer durations of the day. 
Our findings confirm previous findings in that those with MetS have lower physical 
activity levels when compared to those without MetS (233, 234). The findings also 
highlight differences in daily cumulative patterns of physical behaviour across 
weekdays and weekend days among those with and without MetS. Our results suggest 
that in the context of physical behaviour both time of day and also day of week may 
play a role in cardiometabolic health status. More specifically, our results highlight 
significant differences in weekday and weekend day MVPA whereby those without 
MetS start accumulating MVPA earlier in the day and for a longer period. Our results 
provide a better understanding of adults’ physical behaviour patterns throughout the 
day across weekdays and highlight some key issues pertinent (time of day and 
weekday may be associated with cardiometabolic health status)  to the development 
of future interventions for high cardiometabolic risk middle-aged adults.  
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A number of previous studies have shown a prospective inverse association between 
PA and MetS (233, 235-238).This inverse association between PA and MetS 
highlights the importance of physical activity in the reduction of MetS risk  Previous 
evidence suggest that participation in activities of greater intensity result in greater 
health benefits (78, 239-241). Thus participation in MVPA has the potential to 
positively impact on cardiometabolic health. This may explain why significant 
differences were observed in the current work when stratified by MetS status.  
Earlier research exploring the association between cardiometabolic health status and 
within-day variations in activity patterns has largely used hour-by-hour data. These 
studies reported better health profiles associated with greater levels of activity for 
longer active days (39, 41, 136). Only two studies to date have examined within-day 
variation in activity using minute-by-minute data (137, 138). Schrack et al. (2014) 
demonstrated that the amount of physical activity is progressively lower with 
increasing age and follows a different daily pattern in older adults compared with 
younger adults (137). Steeves et al. (2015) found that despite having similar activity 
patterns, diabetics had significantly lower total activity counts compared to non-
diabetics (138). These findings highlight the use of minute-by-minute data to fill gaps 
in understanding activity patterns and trends in subgroups of the population (137, 138). 
However data was summarised over the entire measurement period (7 days) which 
loses detail on between-day variation in physical behaviour patterns. In addition, while 
the use of activity count data in older adults whose activity primarily consists of 
sedentary behaviour is acceptable, count data lacks descriptive detail of the intensity 
of activity which is relevant to physical activity guidelines for younger populations i.e. 
physical activity guidelines for middle-aged adults recommend 150 minutes of 
moderate activity or 75 minutes of vigorous activity or a combination of both for health. 
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The results of our study demonstrate differences in daily cumulative patterns of each 
intensity of physical behaviour across time of day and weekday between those with 
and without MetS. 
 A main strength of our study is the use of a valid and reliable activity monitor which is 
capable of assessing time spent in sedentary, light, moderate and vigorous activity 
categories (85). In addition, this accelerometer collects data as raw acceleration and 
stores the data as g units for offline analysis thereby allowing for efficient data 
cleaning, management of spurious data and the application of various known data 
processing algorithms post-data collection. Furthermore, the high participation rate 
(64%) and range of metabolic health markers which were determined at a commercial 
laboratory ensures a high level of reproducibility. Notwithstanding these strengths 
some limitations can be identified. The cross-sectional design of our study prevents 
causal relations from being determined. In addition, the application of different 
thresholds could result in different activity patterns. Those with Mets were more likely 
to be males and older. However due to small sample sizes these differences could not 
be adjusted for in the current analysis. Thus results should be interpreted with this in 
mind. The sample sizes of subgroup analysis were small thus reducing statistical 
power of study findings. A study with low statistical power has a reduced chance of 
detecting a true effect, and also reduces the probability that a statistically significant 
finding exposes a true effect. Thus these groups may not have sufficient power to 
detect true association with health outcomes. Potential confounding factors were 
considered in the analysis to ensure that the study findings are true or whether they 
are due to another factor that is distorting the true association. Due to the exploratory 
nature of the statistical analysis techniques applied to the data possible confounders 
could not be adjusted for. Stratification would further decrease study power. Thus the 
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difference in physical behaviour patterns may be due to a confounding factor and not 
due the MetS status. Furthermore, participants were recruited from a primary care 
centre, and therefore could have more health problems or be more health conscious. 
Although the Mitchelstown Cohort was a random sample of middle-aged adults, 50-69 
years of age, in an area which was representative of both urban and rural population 
in Ireland, generalizability of our findings may also be limited. 
 
Conclusion 
In conclusion, those with MetS had higher sedentary behaviour and lower physical 
activity levels. In particular, weekend day physical activity levels were lower among 
those with MetS while similar cumulative activity patterns were observed throughout 
the weekdays among those with and without MetS. Examination of physical activity 
intensity revealed differences in cumulative MVPA levels across weekday and 
weekend days; those with MetS appeared to start accumulating MVPA later in the day 
and finish accumulating MVPA earlier in the day relative to those without MetS. These 
findings suggest that those who are more physically active have better cardiometabolic 
health, thus recommendations of sit less and move more should be suggested. 
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Table 12: Physical Behaviour Levels by Metabolic Syndrome Subgroups 
 Metabolic Syndrome 
No Metabolic 
Syndrome 
p-value 
 Weekday 
Weekend 
day 
Weekday 
Weekend 
day 
Weekday 
Weekend 
day 
Sedentary 
behaviour 
(mins) 
1356 
(1253-
1418) 
1329 
(1263-
1390) 
1306 
(1182-
1388) 
1278 
(1169-
1362) 
0.006 0.0002 
Light 
activity 
(mins) 
75 (19-
152) 
88 (40-
139) 
100 (42-
192) 
105 (55-
182) 
0.004 0.008 
MVPA 
(mins) 
3 (0-19) 15 (3-41) 12 (1-53) 39 (8-85) 0.0001 0.0001 
Figures presented as average figures (95% Confidence Intervals) across weekdays 
(Monday-Friday) and weekend days (Saturday-Sunday). 
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Table 13: Subject Characteristics of Study Sample by Metabolic Syndrome 
Subgroups 
 
Full 
Metabolic 
Syndrome 
No Metabolic 
Syndrome 
p-
value 
Male 183 (46.1) 59 (54.6) 109 (41.4) 0.02 
Age (years) 59.3 (55.0, 
63.8) 
61.2 (56.5, 
65.1) 
58.5 (54.6, 
63.4) 
0.01 
BMI (kg/m²) 28.3 (26.0, 
31.1) 
30.8 (27.8, 
34.0) 
27.6 (24.8, 
29.6) 
0.0001 
Waist circumference 
(cm) 
95.1 (87.1, 
105.5) 
103.9 (96.8, 
112.8) 
91.6 (84.7, 
99.9) 
0.0001 
Systolic blood 
pressure (mm Hg) 
128 (118, 140) 136 (126, 146) 126 (116, 136) 0.0001 
Diastolic blood 
pressure (mm Hg) 
80 (74, 86) 82 (76, 86) 78 (72, 86) 0.0001 
Cholesterol (mmol/l) 5.3 (4.6, 6.0) 5.1 (4.6, 5.6) 5.4 (4.7, 6.1) 0.006 
HDL-C (mmol/l) 1.43 (1.19, 
1.68) 
1.2 (1.05, 
1.49) 
1.51 (1.32, 
1.77) 
0.0001 
LDL-C (mmol /l) 3.1 (2.6, 3.8) 2.9 (2.4, 3.4) 3.3 (2.7, 3.9) 0.0001 
Triglycerides* 
(mmol/l) 
1.16 (0.86, 
1.62) 
1.84 (1.30, 
2.35) 
1.02 (0.79, 
1.41) 
0.0001 
Fasting Blood 
Glucose (mmol/l) 
5.0 (4.7, 5.4) 5.65 (5.1, 6.5) 4.9 (4.6, 5.2) 0.0001 
Insulin*  (mU/ml) 9.11 (5.48, 
14.46) 
15.24 (9.23, 
24.96) 
7.31 (4.71, 
11.7) 
0.0001 
HOMAIR* 2.03 (1.19, 
3.26) 
3.61 (2.27, 
6.83) 
1.60 (0.94, 
2.60) 
0.0001 
QUICKIIS 0.26 (0.23, 
0.31) 
0.23 (0.19, 
0.25) 
0.28 (0.25, 
0.33) 
0.0001 
Complement c3 (g/l) 136.5(120.3, 
152.01) 
148.4 (132.9, 
166.9) 
131.6 (116.7, 
147.8) 
0.0001 
Interleukin-6 (pg/ml) 1.78 (1.19, 
2.98) 
2.52 (1.59, 
3.63) 
1.53 (1.06, 
2.50) 
0.0001 
Tumor necrosis 
factor-α (pg/ml) 
5.86 (4.74, 
7.16) 
6.51 (5.29, 
8.23) 
5.56 (4.59, 
6.82) 
0.0001 
Leptin (ng/ml) 2.03 (1.25, 
3.16) 
2.39 (1.32, 
4.05) 
1.89 (1.14, 
2.85) 
0.002 
Adiponectin (ųg/ml) 4.87 (2.86, 
7.54) 
3.43 (2.37, 
5.10) 
5.59 (3.56, 
8.24) 
0.0001 
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Figure 6 (a): Metabolic Syndrome: Daily Cumulative Percentage Time Spent in 
Sedentary Behaviour across Time of Day (minutes since midnight) - Weekday 
  
Figure 6 (b): Metabolic Syndrome: Daily Cumulative Percentage Time Spent in 
Sedentary Behaviour across Time of Day (minutes since midnight) – Weekend 
day 
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Figure 6 (c): Metabolic Syndrome: Daily Cumulative Percentage Time Spent in 
Light Activity across Time of Day (minutes since midnight) – Week day 
  
Figure 6 (d): Metabolic Syndrome: Daily Cumulative Percentage Time Spent in 
Light Activity across Time of Day (minutes since midnight) – Weekend day 
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Figure 6 (e): Metabolic Syndrome: Daily Cumulative Percentage Time Spent in 
MVPA across Time of Day (minutes since midnight) – Week day 
 
Figure 6 (f): Metabolic Syndrome: Daily Cumulative Percentage Time Spent in 
MVPA across Time of Day (minutes since midnight) – Weekend day 
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CHAPTER EIGHT - DISCUSSION 
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Introduction 
This thesis explored the relationship between daily and weekly patterns of physical 
behaviour and cardiometabolic health in a cohort of middle-aged Irish men and 
women. To reiterate, the specific objectives of this thesis are:  
1) Compare the associations between subjective and objective accelerometer-
derived MVPA activity in relation to physical activity guideline adherence and 
cardiometabolic and inflammatory health 
2) Determine a suitable monitoring frame to reliably capture weekly, 
accelerometer-measured, habitual activity 
3) Identify groups of participants who accumulate similar weekly patterns of 
physical behaviour and determine differences in cardiometabolic profiles 
existing among these groups 
4) Explore the daily patterns of physical behaviour amongst different 
cardiometabolic health profiles 
In addition, important areas of further research in the area of physical behaviour 
pattern analysis and its impact on health outcomes are outlined, the strengths and 
limitations of the research carried out will be discussed and finally, the conclusion of 
this discussion will be presented.  
 
Study Findings 
The first results chapter of this thesis compared the agreement between GENEActiv 
accelerometer- and IPAQ-SF-derived MVPA and secondly compared associations 
with a range of cardiometabolic and inflammatory markers. The results suggest that 
the IPAQ-SF lacks sensitivity for the assessment of MVPA, guideline adherence and 
the relationship with cardiometabolic and inflammatory markers. These findings may 
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have important public health implications as they highlight the range in differences 
between methods with regard to associations between MVPA and cardiometabolic 
and inflammatory health markers. The second results chapter investigated the optimal 
number of days needed to obtain reliable estimates of weekly habitual activity, using 
the GENEActiv accelerometer, by examining variation in day-to-day physical 
behaviour between- and within-subjects. The main finding suggests that six days 
monitoring, four weekdays plus Saturday and Sunday, are needed to reliably estimate 
weekly habitual activity in all activity intensities. Earlier research highlights the 
important role of between- and within-subject variation in examining physical 
behaviour patterns and in determining the optimal number of days of data collection 
to accurately capture weekly habitual activity. Furthermore, an important secondary 
finding of the present study was that Sunday differed from all other days of the week 
for sedentary and light activity. This suggests that physical behaviour patterns vary 
between days of the week and that day of the week cannot be ignored in 
accelerometer data collection monitoring frames. These findings suggest that both 
weekday and weekend days need to be included in monitoring frames and that 
physical behaviour patterns across weekdays could play a role in health status. In 
addition, these findings may have important implications in terms of study design and 
data reduction strategies as they highlight that a shorter time frame of 3 days (inclusive 
of Sunday) is required in the study design to capture weekly variation in sedentary 
behaviour, light and moderate activity. In terms of data reduction this shorter time 
frame implies that all participants with 3 full days of physical behaviour data can be 
included in data analysis thus increasing sample size and power to detect statistically 
significant associations.. Further study protocols employing these recommendations 
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may benefit from reduced number of data collection and processing days and 
associated reductions in person-time and study cost.   
The third results chapter identified weekly, interrelated patterns of physical behaviour 
and to examine the cardiometabolic health status associated with these different 
behaviour patterns. LPA revealed four distinct physical behaviour patterns; Sedentary 
Group (16.6%), Sedentary; Lower Activity Group (27.5%), Sedentary; Higher Activity 
Group (43.1%) and a Physically Active Group (12.8%).  Overall the Sedentary Group 
had poorer profiles, characterised by unfavourable lipid profiles, hyperglycaemia, pro-
inflammatory profiles, greater insulin resistance and reduced insulin sensitivity. The 
remaining classes were characterised by healthier cardiometabolic profiles as 
sedentary behaviour decreased. Study findings from Chapter 6 highlight the important 
contribution of the inter-relatedness of physical behaviour activity intensities for 
physical behaviour guidelines. Chapter 6 identified four different physical behaviour 
patterns in the population and although we did not detect any significant differences in 
cardiometabolic and inflammatory markers between the extreme groups (the 
Sedentary and Physically Active Groups) this may be partly accounted for by the 
sample size. Therefore larger studies may have the necessary statistical power to 
detect associations between various clusters of individuals with similar physical 
behaviour patterns and cardiometabolic and inflammatory health outcomes. Thus our 
analysis highlights the potential for the examination of the specific effects of the 
inclusion of sedentary behaviour and light activity in public health guidelines. In 
addition, these data confirm previous findings; variations in physical behaviour across 
days exist and may play a role in cardiometabolic health.  
The fourth results chapter compared daily cumulative patterns of minute-by-minute 
physical behaviour activity intensities across those with and without MetS. MetS is 
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associated with an increased risk of CVD and is characterised by the co-existence of 
cardiometabolic abnormalities. The role of physical activity in the treatment of 
cardiometabolic disease is well acknowledged and is an inexpensive treatment option 
for cardiometabolic health. The findings from the second and third results chapters 
revealed differences between weekday and weekend days with regard to sedentary 
behaviour, light activity and MVPA patterns. Thus average weekday and weekend day 
estimates were examined in fourth results chapter.  Results highlight significant 
differences in weekday and weekend day MVPA between those with and without 
MetS. Those with MetS started accumulating MVPA later in the day and for a shorter 
day period, both on weekdays and weekend days. The results highlight differences in 
physical behaviour patterns both within and across weekdays, supporting previous 
observations in the second and third results chapters.  
 
Strengths and Limitations 
This study has many strengths: 
 The use of an objective measure of physical behaviour which is capable of 
assessing time spent in sedentary, light, moderate and vigorous activity 
intensities. Compared with self-report, objective measurements are more 
precise, less biased and reduce the potential for measurement error. The recall 
and social-desirability biases that accompany self-report measures are well 
known and may lead to higher misclassification bias.  
 The use of an accelerometer which collects data as raw acceleration and stores 
the data as g units for offline analysis thereby allowing for efficient data 
cleaning, management of spurious data, and the application of various known 
data processing algorithms post-data collection. Previous thresholds by Esliger 
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et al. (2011) estimated very high levels of MVPA for the study population. Thus 
the ability of this device to store data for offline analysis allows the data to be 
reprocessed with new thresholds to give alternative estimates and in the future 
when algorithms are available for specific activities to revisit datasets and 
assess in more detail the types of activities that may be being undertaken. 
 The application of dominant and non-dominant wrist wear thresholds prevents 
the over-estimation of physical activity levels from devices placed on the 
dominant wrist. In this study the participants were asked which wrist they 
preferred to wear the GENEActiv accelerometer. This protocol was to ensure 
high compliance to the 24 hours wear procedure, thus increasing the sample 
size for analysis (7 days valid data was required), quality of the data and thus 
statistical power of study findings. An additional limitation of the study is that 
the accelerometer device was not placed on the non-dominant wrist for data 
collection. Recommended protocol states that wrist worn devices should be 
worn on the non-dominant hand to avoid the over-estimation of physical activity 
due to the increase use of the dominant hand in everyday activities.  
 The high participation rate (64%) limits the possibility of sampling bias thus 
producing high quality data which is not influenced by sampling bias or missing 
data. 
 Measurement of a wide range of cardiometabolic health markers which were 
determined at a commercial laboratory ensures a high level of reproducibility.  
The current study also has a number of limitations that should be noted: 
 First, this is a cross-sectional study design.  This type of study design implies 
that all measurements are taken at the same point in time, thus cause-effect 
relations cannot be determined. Intervention and prospective longitudinal 
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studies would be needed to confirm causality of the observed associations 
found between physical behaviour and cardiometabolic and inflammatory 
health markers.  
 The sub-sample of the Mitchelstown Cohort, for whom accelerometer data was 
collected, differed by gender in that women were more likely to agree to wear 
the accelerometer. Nonetheless it should be noted that there were no 
statistically significant differences in age, education or BMI between those 
included and excluded in the final analysis in both males and females. Thus 
results appear to be generalizable to both Irish males and females.  
 Furthermore, due to logistical issues subjective and objective physical activity 
data were not collected in the same week. Since MVPA levels were measured 
on different occasions (a week apart) this may affect the outcomes of results 
Chapter four. Activity levels in free-living adults have been reported to vary from 
day-to-day, seasonally and in response to environmental factors. Thus, this 
could be a potential source of bias in our study findings. More specifically, this 
could lead to significant differences between the estimates thus increasing the 
level of disagreement between the measures in relation to guideline adherence 
and relations with cardiometabolic health markers. However, weekly variation 
has not yet been examined. Furthermore, it should be noted that the GENEActiv 
accelerometer is not a gold-standard measure of physical behaviour, thus 
conclusions about the precise validity of either measure are limited. 
 It should also be highlighted that the arbitrary cut-point to classify day-time wear 
may lead to inaccurate estimates of sedentary activity. For example persons 
who sleep later than 6am will have inflated sedentary behaviour estimates while 
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those who are active before 6am or after 12 midnight will have deflated activity 
estimates.  
 In addition, different data processing methods could result in a data point being 
classified in different activity classes and thus different conclusions could be 
drawn on physical behaviour patterns. Currently there is no consensus on one 
set of thresholds in the research field for the GENEActiv accelerometers 
however the thresholds applied to the study have been derived in an Irish adult 
population so therefore are appropriate to apply to this study population. 
Nonetheless, these analyses have shown the merits of LPA and daily minute-
by-minute cumulative plots of physical behaviour for the purpose of identifying 
and describing groups of adults based on their distinct physical behaviour 
patterns throughout the week and identify segments of the day when activity 
levels differ between groups. More specifically, the application of different 
thresholds could result in different activity patterns. The GENEActiv 
accelerometer is a new tri-axial accelerometer device. New thresholds may be 
refined in the future which could alter current findings. Consequently, the 
present findings may change if different thresholds to define each physical 
behaviour intensity are applied to the data. 
 A possible limitation to the analysis is that the thresholds applied to this data 
were scaled to 100HZ and 60s epoch (threshold study measured data at 80Hz 
and at 15s epochs). While the issue of scaling thresholds to suit study epoch 
and sampling frequencies is warranted it is worth highlighting that this 
procedure is encouraged and recommended by accelerometer companies. 
Further research in this area is needed. It is debatable whether it is feasible or 
even necessary to create specific thresholds for each set of possible epochs 
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and sampling frequencies. Thus a possible alternative that has come to my 
attention are thresholds which are based on the ENMO metric (242). The metric 
is independent of sampling frequency and epoch as it uses the average 
acceleration over an epoch rather than the sum (242).  
 In Chapter 4 approximately one third of the study sample had subjective and 
objective physical behaviour levels measured at different time-point (weeks 
apart). For reliability issues these data were excluded from analysis.  Removing 
these data from analysis decreased the sample size significantly thus reducing 
the power of the analysis to detect significant associations with health outcomes 
and to measure accuracy in agreement levels between subjects for guideline 
adherence. 
 In relation to the findings of results Chapter 6, the sample sizes of comparable 
groups for analysis were small. In these cases one cannot ignore the influence 
of the lack of power on study findings. A study with low statistical power has a 
reduced chance of detecting a true effect, and also reduces the probability that 
a statistically significant finding exposes a true effect. The consequences of low 
statistical power include overestimates of effect size, low chance of detecting 
true relations between exposure and outcomes, and low reproducibility of 
results. In Chapter 6, LPA analysis found four different physical behaviour 
patterns in the population, resulting in classes 1 and 4 having small sample 
sizes (16% and 12% of the study sample respectively). Thus these groups may 
not have large enough sample sizes for sufficient statistical power to detect 
accurate association with health outcomes. It should be noted that this study 
was powered to initially examine the prevalence of diabetes and CVD in this 
population. This study was not powered for the current analysis. While some 
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researchers would expect a back calculation of power current 
recommendations however advise against this practice (243, 244).   
 Throughout the results section potential confounding factors were considered 
in the analysis to ensure that the study findings are true or whether they are 
due to another factor that is distorting the true association. Confounding factors 
distort the true relationship between an exposure and outcome. In Chapters 4 
and 6 the analysis were adjusted for possible confounders i.e. age, gender, 
employment status, BMI. In Chapter 5 this was not necessary as analysis was 
not aetiologically focused however in the final results chapter (Chapter 7) 
possible confounders could not be adjusted for. This is mainly due to the 
descriptive nature of the statistical analysis techniques used and the further 
decrease in study power associated with stratifying analysis this type of 
analysis. Thus the difference in physical behaviour patterns seen in Chapter 7 
may be due to a confounding factor and not due the METs status. In addition, 
it may be possible that not all confounders could be adjusted for in this analysis 
despite the large quantity of health variables measured 
 The study findings may also be influenced by chance. It is well known that 
chance can never be eliminated completely for research findings but it can be 
reduced through large sample sizes. As previously mentioned, analysis of 
Chapters 4, 6 and 7 may be influenced by low statistical power due to small 
samples sizes across comparable groups. While overall study sample were 
high (n=397) these sizes were reduced considerably during subgroup statistical 
analysis. For all statistical analysis 95% confidence intervals were calculated. 
Wide 95% confidence intervals indicate a high probability of chance affecting 
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study findings. Random error can be reduced in this study by averaging out the 
large number of observations 
 Finally, participants were recruited from a primary care centre and therefore 
could have more health problems or be more health conscious. In addition, the 
primary care setting may omit certain subgroups of the population such as the 
homeless, transient workers and religious groups. Thus generalizability of 
these findings could be limited. 
 
Future Research 
The purpose of the research carried out as part of this PhD thesis is to contribute to 
important research gaps related to the understanding of the relationship between 
cumulative daily and weekly interrelated patterns of physical behaviour and 
cardiometabolic health status, and consequently provide evidence that will be useful 
in refining public health physical behaviour recommendations for middle-aged adults.  
The findings of this novel research add to the limited body of literature examining the 
association between daily and weekly patterns of physical behaviour using objective 
physical behaviour measures and cardiometabolic health. Result chapters six and 
seven are the first studies to evaluate the relationship between weekly interrelated and 
daily cumulative patterns of physical behaviour and cardiometabolic health. Further 
research to determine if causal relations exist between these physical behaviour 
patterns and cardiometabolic health is warranted. Experimental, longitudinal designs 
are required to confirm causality of the associations, and to be able to determine the 
biological mechanism involved. Additional research is needed to determine whether 
the associations change when dietary, socio-demographic and lifestyle factors are 
taken into account.  
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This thesis has addressed several aspects of research that are now allowed by time-
stamped accelerometer data. However, it is pertinent to acknowledge that there 
remain many important research questions relating to physical behaviour patterns and 
cardiometabolic health that must be addressed. Some of these include the following: 
 The further examination of associations between the interrelated patterns of 
physical behaviour and health in all ages using different statistical methods, 
such as structural equation modelling, compositional data analysis and 
substitution analysis. This is necessary to strengthen existing physical 
behaviour and cardiometabolic health findings and to provide evidence which 
will aid in the development of existing physical behaviour guidelines. More 
specifically, these methods may better account for the variability of other factors 
and better assess factors that are highly correlated such as light activity and 
MVPA. 
 To develop a valid and reliable algorithm to identify sleep start and finish is 
crucial to the future use of the GENEActiv accelerometer in order to accurately 
determine the true association between physical behaviour intensities and 
health. Without such development, researchers will continue to use arbitrary 
cut-points to exclude sleep, leading to the over- or under-estimation of 
sedentary behaviour levels and the misinterpretation of relations with 
cardiometabolic health particularly as inadequate levels of sleep has been 
identified as an independent risk factor for cardiometabolic risk. If sleep time is 
under-estimated this results in the over-estimation of sedentary behaviour 
levels. Over-estimated or higher levels of sedentary behaviour would lead to 
stronger associations with cardiometabolic risk factors. Furthermore, it may 
lead to a positive association  between sedentary behaviour and 
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cardiometabolic health as the misclassification of sleep, which in adequate 
levels has a positive effect on health, as sedentary behaviour would lead to 
positive and inaccurate conclusions. 
 Future physical behaviour intervention studies should be more targeted to 
examine the impact of adapting different physical behaviour patterns, similar to 
those identified in Chapter 6, on cardiometabolic health status. Physical 
behaviour guidelines recommend at least 30 minutes of MVPA on most days of 
the week. However, for the majority of adults, especially those who are 
predisposed to adverse cardiometabolic health, MVPA is difficult to achieve. 
Thus further research involving longitudinal and intervention studies, should 
examine the role of light intensity activity and sedentary behaviour on health as 
these behaviours may be easier to change than MVPA.  
 In addition, further analysis should examine the long-term effects of substituting 
sedentary behaviour with light activity on cardiometabolic health. Promoting a 
reduction in sedentary behaviour rather than increasing MVPA should also be 
explored further.  
 Accelerometer-derived physical behaviour data appears to be more sensitive 
at revealing relationships with cardiometabolic and inflammatory health 
markers. Thus we recommend the use of objective measurement of habitual 
activity in the context of examining the relationship between habitual activity 
and health. Particularly as the technology is feasible in large-scale studies and 
use in free-living conditions is more practical, i.e. water-proofed devices that 
are easier to wear. Improved understanding of the different characteristics of 
habitual activity that are captured by accelerometers may have important public 
health implications regards identification of suitable patterns and levels of 
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activity for optimal health and more defined future physical behaviour 
guidelines. 
 Since physical activity and sedentary behaviour patterns are complex and 
interrelated, future policy development and intervention studies aiming to 
increase adult physical activity should be directed towards altering patterns of 
behaviour rather than concentrating on altering a single type of physical 
behaviour.  
 Further research in the application of physical behaviour measures in the 
primary care setting is needed. Nurse practitioners in the primary care setting 
are in an ideal position to promote health by encouraging appropriate levels of 
each physical behaviour intensity. Increased knowledge and use of physical 
behaviour measurement instruments in the clinical setting would allow nurse 
practitioners to identify and address sedentary behaviours in their patients, 
especially those with adverse cardiometabolic health.  
 Large prospective studies assessing the relationship between the long-term 
exposure of different clustering patterns to the development of obesity, CVD 
and change in inflammatory and cardiometabolic status would be useful. The 
current 5-year follow-up of the Mitchelstown study will make this possible.  
 Differences in cumulative patterns of physical activity and sedentary behaviour 
between cardiometabolically healthy and unhealthy groups highlight patterns of 
behaviour which could be adapted by those at greatest cardiometabolic risk 
with a view to improving cardiometabolic health status. The classification of 
groups of adults with similar physical behaviour patterns provides valuable 
information for the identification and tailoring of specific public health and health 
promotion messages and intervention strategies. Therefore future interventions 
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tailored to an individual’s cardiometabolic health status would be worthwhile to 
explore. 
 
Concluding Paragraph 
The role of physical activity in the prevention and treatment of many chronic diseases 
has been recognised for some time but improved methods of capturing physical 
behaviour are now allowing us to refine our knowledge. With new technological 
advancements in the area of physical behaviour measurement, complex associations 
between physical behaviour and health status can now be examined.  
This research examines the relationship between daily, minute-by-minute cumulative 
and weekly patterns of physical behaviour in relation to cardiometabolic health in 
middle-aged adults. Findings from the current research have revealed associations 
between cardiometabolic health and both daily and weekly patterns of physical 
behaviour. Since physical activity and sedentary behaviour are complex interrelated 
behaviours, public health guidelines on physical behaviour should focus on 
encouraging changing entire physical behaviour patterns opposed to just a single 
behaviour.  
Thus public health policy should focus on suggesting a broader range of physical 
behaviours that fit into everyday life rather than emphasising MVPA activity which is 
more strenuous and relatively harder to achieve among individuals predisposed to 
adverse cardiometabolic health.  
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APPENDIX ONE 
Guidelines for Accelerometry Usage – Building a Protocol 
In order to better understand accelerometry-based physical behaviour monitoring, we 
need to understand the basic concepts of the physical behaviour movement, the 
technology of these physical behaviour monitoring sensors and the processes 
involved in the collection, processing and analysing of data (83). There are many 
methodological issues to consider when processing this type of data and these will 
now be discussed further. Accelerometer usage involves both the field use of 
accelerometers “Accelerometer Field Protocol” to collect data and the processing of 
the collected data “Accelerometer Data Reduction Protocol” to produce interpretable 
units of information.  
 
Accelerometer Field Protocol 
Distribution and Collection of Accelerometer 
The distribution and collection of accelerometers in a study is largely dependent on 
study design. For larger epidemiological and intervention studies, some distribution 
and collection methods, for example face-to-face based methods, may not be feasible, 
particularly if the project has limited funding. In these circumstances, a common 
approach to accelerometer distribution and collection has been through post. In 
smaller, field-based studies the most common method of distributing and collecting 
accelerometers is on face-to-face bases.  Some studies have distributed 
accelerometers to participants on a face-to-face basis and provided a prepaid 
envelope to return the monitors by post. This approach ensures participants are 
adequately briefed about the maintenance and use of the accelerometer and avoids 
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the need for a return visit to the health centre by participants and researchers for data 
recovery (245).  
 
Placement of Accelerometer 
Accelerometer placement is largely dependent on the manufactures specifications. 
Research has reported that accelerometers should be attached as close to the body’s 
centre of mass as possible i.e. the waist (245). However, it was found that this position 
of wear lead to reduce wear-compliance. Validation studies comparing the level of 
agreement between different wear positions of an accelerometer have found wrist-
worn accelerometry data to be in high agreement with waist-worn accelerometry data 
(85).  The feasibility and subject burden of accelerometer placement should be 
carefully considered when planning an accelerometer study protocol to ensure both 
high quality data and wear compliance (245).  
Selection of Sampling Frequency 
The rate of data acquisition is determined by the sampling frequency of the 
accelerometer device. To ensure that the full range of human movement is captured, 
the sampling frequency should fulfil the Nyquist criterion (83, 246). Nyquist criterion 
specifies that the sampling frequency must be at least twice the frequency of 
movement. If this criterion is not met, measurements of rapid movements (movements 
occurring at a higher frequency domain) will be distorted. 
Number of Minutes Considered as a Measured Day 
When using accelerometers to measure physical behaviour, researchers need to 
determine whether subjects have worn the device for a sufficient period to be 
considered a representative full day of physical behaviour. Physical activity and 
sedentary behaviour levels vary throughout the day thus it is necessary to determine 
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the minimum daily wear time required to reliably estimate habitual physical behaviour. 
If the estimated monitoring time in a day is below the designated thresholds (i.e. 10 
hours), accelerometer data for that day are considered invalid. Thus the valid day 
threshold directly affects data loss (247). In general, days with less than 600 minutes 
of data recorded have been criteria for elimination (248-250), while other studies have 
used 800 minutes as elimination criteria (251).  
Number of Days Monitoring per Week 
The minimum number of days monitoring in order to reliably capture habitual 
behaviour has important implications for wear compliance, accelerometer turnover 
and overall study costs. The primary goal for researchers is to record activity for a 
sufficient period of time so that the resulting estimates reflect usual habitual behaviour 
levels (84). Physical behaviour is influenced by a range of factors including 
demographic characteristics, emotional influences and behavioural attributes (189). 
As a result, patterns of physical activity show substantial intra- and inter-individual 
variation, the extent of which plays a major role on data quality and reliability (190). 
Intra- and inter-individual variation is accelerometer dependent therefore monitoring 
frames are dependent on accelerometer type.  
Prior to this thesis, no study had examined the required number of monitoring days 
needed to accurately measure physical behaviour in adults using the GENEActiv 
accelerometer, however other accelerometers have been examined in this context 
(197, 199). These studies reported variable monitoring frames 3-5 days, 3 days,  7 
days and 4-5 days, respectively (53, 197-200). In addition, other studies have 
examined the appropriate monitoring frames to reliably estimate habitual physical 
behaviour categories separately (193, 194). Matthews et al. (2002) concluded that 3-
4 days monitoring were required to accurately measure physical activity, and that 7 
155 
 
days were needed to reliably estimate physical inactivity (193), while Scheers et al. 
(2012) recommended both Saturday and Sunday, and at least 3 weekdays were 
needed to obtain reliable estimates of habitual physical activity (194). Such conflicting 
recommendations highlight the need to determine the number of monitoring days 
required to reliably measure both habitual physical activity and sedentary behaviour 
for each accelerometer type and population under study. 
 
Accelerometer Data Reduction Protocol  
Selection of Sampling Interval  
The acceleration signal from an accelerometer monitor is sampled at a certain 
frequency and, depending on type of accelerometer, is stored for offline analysis. The 
first stage in the data reduction of accelerometry data is to collapse these data signals 
into a user-defined time interval. This time interval is commonly referred to as an epoch 
and choice of epoch can be crucial in the planning process of an accelerometer data 
reduction protocol and for data interpretation (83). Epoch lengths can vary from 1 
second to 1 minute. For longer epoch lengths, the process of data smoothing can 
potentially affect the validity of estimates of time spent in activity intensity (252, 253). 
Smoothing occurs when the epoch length is longer than the actual bout of activity or 
when the activity is split between epochs, and within each both sedentary behaviour 
and non-sedentary behaviour is considered together to determine physical behaviour 
intensity for the user-defined epoch length (254). Previous research has indicated the 
adults and children physical behaviour patterns differ in that children have shorter, 
more frequent bouts of movement  (255-257). This suggests shorter epoch lengths 
are more suitable to capture children physical behaviour levels. This issue of epoch 
length has not been systematically studied in adults. A study by Gabriel et al. (2010) 
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examined the role of epoch length on physical activity estimates in post-menopausal 
women. Differences in physical activity estimates presented as 10 seconds and 60 
second epochs were evaluated. This study suggested that shorter time sampling 
intervals would reduce misclassification error of physical behaviour estimates however 
association with health outcomes did not yield strikingly different results (258).  
Classification of Non-wear 
One main disadvantage of accelerometers is that subjects may remove them 
periodically. Accelerometers, such as the GENEActiv accelerometer, are waterproof. 
Thus there is no need for participants to remove the device at any stage during the 
monitoring time frame. Despite this, participants can remove the device.  Researchers 
need to identify these time periods of non-wear to ensure activity is classified 
accordingly.  Non-wear time definitions vary. In general, studies define non-wear as 
prolonged blocks of non-movement. Duration of these “prolonged blocks” can vary 
from ≥10 minutes to ≥60 minutes of non-movement (42, 43, 259-264) and some allow 
for brief interruptions, 1-2 minutes of movement counts (166, 249, 259, 265). The 
definition of non-movement varies by type of accelerometer (266). For some 
accelerometer, such as the ActiGraph, non-movement is recorded as zero values, 
under the rationale that accelerometer sensitivity to even small movements will result 
in the accumulation of a count value >0 if the monitor is worn correctly. However some 
studies, using different accelerometers, have applied different definitions for non-
movement. For example, Van Hees et al. (2011) applied a non-movement threshold 
estimated on the basis of the standard deviation and the value range of each 
accelerometer axis. A block was classified as non-movement if the standard deviation 
was less than 3.0 mg for at least two of the three axes or if the value range, for at least 
two of the three axes, was less than 50 mg. This threshold was based on lab 
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experiments in which thirty GENEA accelerometers were left motionless on a flat, 
stable surface for 30 minutes, showing that the standard deviation of an acceleration 
signal, which has some characteristic noise, is 2.6 mg during non-motion.  
Handling of Missing Data 
When periods of non-wear have been identified a decision has to be made as to how 
the missing data is to be handled, should it be imputed or should it be left as missing. 
The later will potentially reduce the number of valid minutes of data and can result in 
the exclusion of the day or person from the dataset. Exclusion of subject data or even 
subjects can reduce sample size and can increase the chances of sampling-bias 
influencing study outcomes (267).  
Imputation is a statistical procedure which reduces biases caused by missing data 
(268, 269). Various means of data imputation have been proposed.  The fundamental 
idea of imputation is to use observed values to assist in predicting missing values. To 
determine how missing data should be handled, we need to determine why data is 
missing. Reasons for missing data are commonly classified as: missing completely at 
random, missing at random, and missing not at random. When missing data does not 
occur at random the imputation cannot give an unbiased estimate at population level. 
Thus missing data is a major issue when it is non-random. Unfortunately it is not 
possible to objectively test whether data are missing in a random pattern in real data-
collection situations (270, 271).  
Intensity Cut-off Points 
The GENEActiv accelerometer measures and stores physical behaviour data as raw 
acceleration. Raw accelerometry counts are unitless and dimensionless and thus they 
require calibration in order to be translated and reported in ways that are biologically 
meaningful. Definitions of activity intensity are derived from calibration of a device with 
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a gold standard technique, e.g. Doubly Labelled Water technique for energy 
expenditure comparisons or direction observation and maximal oxygen consumption 
for intensity comparisons, which provides a cut-off threshold that is identified by 
specific values (85).   
Expressing and Reporting of Data 
Since physical behaviour data is measured in acceleration units a decision needs to 
be made on how physical activity and sedentary behaviour activities are to be 
quantified and expressed. Output data and summary statistics will depend firstly on 
what outcomes are of interest and secondly of which will be most interpretable (84). 
According to Ward et al. (2005) and Matthews et al. (2005), time spent in activity 
intensities, and number and average duration of bouts of activity intensities should be 
reported (272, 273). 
 
 
Figure 7: Examples of physical activity and sedentary behaviour variables 
derived from accelerometer data (274). 
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Criterion validity and calibration of the GENEActiv 
accelerometer in middle-aged adults 
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Abstract 
Introduction 
Previous thresholds applied to GENEActiv accelerometer data are based on left- and 
right-wrist wear. Ideally, due to greater use of the dominant hand in everyday activities, 
cut-points should be created for dominant and non-dominant wrist. The greater use of 
the dominant hand in everyday activities may lead to the overestimation of thresholds 
for physical activity intensities. The objective of this paper is to validate the GENEActiv 
accelerometer against energy expenditure measured by expired gas to complete a 
value calibration to develop thresholds for sedentary, light, moderate and vigorous 
activity for wrist-worn placement in adults and to perform a cross-validation for these 
thresholds. 
Methods 
The GENEActiv accelerometer was used to measure sedentary behaviour and 
physical activity during 7 structured activities in 56 adults (35 developmental, 21 cross-
validation) aged 18-65 years. VO2 and resting metabolic rate were measured using a 
portable metabolic unit (Cosmed K4B2, Rome, Italy). Data were extracted and 
collapsed into 15-second epochs. The mean value of the final 2 minutes of each 
activity was used for data analysis. Receiver operating characteristic analysis and 
Youden’s Index were used to develop intensity thresholds across activity intensities. 
Results  
Intensity thresholds (sum of the vector magnitude counts) were created for dominant 
and non-dominant wrist wear (Table 16). Sensitivity and specificity were 69-98% for 
the developed intensity thresholds.  Area under the curve (AUC) analysis were 
between 70-99% for sedentary, moderate and vigorous activity. 
Conclusion 
This is the first study to develop accelerometer cut-points for dominant and non-
dominant wrist GENEActiv accelerometer data that reflect sedentary, light, moderate 
and vigorous activity. Data suggests that the developed intensity thresholds for 
GENEActiv data are valid at determining physical behaviour intensity, but are slightly 
poorer but acceptable at estimating moderate activity in adults aged 18-65 years. 
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Introduction 
The relationship between physical behaviour and health has been studied extensively 
(5, 6, 275, 276) (2) (3) (4) (4, 7-11). Understanding the determinants of physical 
behaviour and health outcomes is essential to the design and implementation of 
intervention studies which aim to prevent morbidity and subsequent mortality. 
Questionnaires and accelerometers are widely used to assess physical behaviour in 
epidemiological studies. Self-reported questionnaires are commonly used as they are 
the most cost-effective and feasible method in large populations. However collection 
of accurate self-report physical behaviour data is difficult as measures largely depend 
on the recall abilities of participants. Objective methods are increasingly being used to 
measure physical behaviour and are now being recommended over self-reported 
measures. Accelerometers can record activity objectively reducing the effects of 
subjective limitations. They can provide detailed information on various aspects of 
physical behaviour such as intensity of activity, minutes spent in activity, breaks in 
activity transition, duration of bouts of activity between activity transitions and time of 
day when activity occurred. Accelerometers measure physical behaviour as raw 
acceleration and in order to be interpretable for public health recommendations have 
threshold values applied to them. Threshold cut-offs can be limited in that they may 
misclassify intensity levels. Some studies have dealt with this limitation by using raw 
acceleration data (137). However these results are hard to interpret and, more 
importantly, are harder to translate into physical behaviour guidelines for population 
health. Thus value calibration and validation of accelerometer devices are vital to 
obtaining accurate, interpretable physical behaviour data to quantify relationships with 
health outcomes.  
The technical reliability and validity of the GENEA accelerometer and threshold values 
for middle-aged adults have been reported (85). However these thresholds were 
developed for left- and right-hand wear and thus did not take hand dominance into 
account. Ideally, due to greater use of the dominant wrist in everyday activities, cut-
points should have been created for dominant and non-dominant hand wear (277). 
The greater use of the dominant hand in everyday activities may lead to the 
overestimation of cut-points for moderate-to-vigorous activity (MVPA), 88% of 
validation study participants were right-handed (85). In the Esliger paper, participants 
were asked to complete a number of tasks ranging from static, posture, positions to 
lifestyle and ambulatory movements. Hand dominance is not an issue in posture 
162 
 
positions or ambulatory movements such as walking and running. However, lifestyle 
activities such as window washing is generally a dominant hand activity, which leads 
to an increase in recorded acceleration signals and in turn an increase in intensity 
defining cut-points. Furthermore, not all activities carried out by participants in Esliger 
et al. (2011) were categorised into the same intensity category by both the left- and 
right-hand cut-points. According to left-hand cut-points, seated computer work was 
classified as light activity when placed on the right wrist compared to sedentary activity 
when place on the left-wrist or when right-wrist cut-points were applied. In addition, 
window washing, according to left-wrist cut-points, was classified as light when placed 
on the left wrist and moderate (close to vigorous activity) when placed on the right 
wrist and according to right-hand cut-points, is classified as moderate activity on both 
wrists. This is further evidence that hand dominance should have been accounted for 
in the current intensity thresholds for the GENEActiv accelerometer. Furthermore, 
these threshold values were based on a previous version of the GENEActiv 
accelerometer, GENEA (Unilever Discover, Colworth, UK), which had slight 
technological differences. 
The specific aims of this paper are to validate the GENEActiv accelerometer against 
energy expenditure measured by oxygen consumption and to perform a cross-
validated, value calibration of the GENEActiv accelerometer to develop thresholds for 
sedentary, light, moderate and vigorous activity in middle-aged adults.  
  
Methods 
Participants 
Participant recruitment was initiated in December 2014 in an effort to obtain a 
convenience sample of 56 volunteers aged between 18 and 65 years, free from injury 
and in good health from the University of Limerick and its surrounding area. The 
recruitment method involved an email to employees of the University of Limerick, 
Limerick, Ireland. A health and fitness report was offered as an incentive to participate. 
Data collection was undertaken between February and July 2015 after which 70 adults 
completed the study protocol. Each participant was allocated a number, and a 
randomization table was used to assign each participant to either an equation 
development group or a cross-validation group. Written informed consent was 
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obtained from each participant. The study was approved by the Faculty of Education 
and Health Sciences Research Ethics Committee at the University of Limerick. 
 
Physical Behaviour Measurement Devices 
The GENEActiv accelerometer (ActivInsights Ltd, Kimbolton, Cambridgeshire, UK) 
comprised a tri-axial STMicroelectronics accelerometer with a dynamic range of +/-8 
g (1 g= 9.81 m/s²), where ‘g’ represents ‘gravitational unit’, and was attached to both 
participants wrists with straps. Information on hand dominance was also recorded. The 
same two GENEActiv accelerometers were used on all study participants throughout 
the study. Data was sampled at a frequency of 30Hz and collapsed into 15-second 
epochs for data analysis.  
 
Metabolic Unit 
Oxygen consumption (VO2) was measured breath-by-breath, minute-by- minute, using 
a portable metabolic unit (Cosmed K4B2, Rome, Italy) with the exception of the 
measurement of resting metabolic rate (RMR) where VO2 was measured in 30-second 
blocks. The Cosmed K4B2 is a lightweight system with a heart rate receiver and has 
been deemed an appropriate criterion measure for minute-by-minute energy 
expenditure (278). Before each testing session, the device was calibrated, according 
to manufacturer standard procedures, using known gas concentrations, and flow 
sensor calibrations and environmental conditions were updated.  
 
Testing Protocol 
Participants arrived at the testing facility having fasted and refrained from consuming 
nicotine, caffeine and completing any exercise for at least 3 hours. Anthropometric 
measurements were recorded with calibrated instruments according to standardised 
protocol. Height (to the nearest 0.25 cm) and weight (to the nearest 0.1 kg) was 
measured without shoes and socks using Seca stadiometer (model 214, Seca Ltd. 
Birmingham, UK) and electronic scales (model 770, Seca Ltd. Birmingham, UK), 
respectively. Body Mass Index (BMI) was calculated as [weight (kg)/ (height (m²))]. 
The GENEActiv accelerometers and Cosmed K4B2 metabolic unit were conclusively 
fitted. The accelerometer was attached to both participant’s wrists and was initialised 
prior to the participant’s arrival and clock synchronised with the main investigator 
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computer and metabolic unit. The metabolic unit was placed over the participants 
shoulders and a mask fitted over their face. Subsequently, participants were 
introduced to the protocol of activities. Activities were completed in ascending 
intensity. Participants were instructed when to start and finish each activity by a single 
instructor. The activity category, the exact start and finish times of each activity were 
recorded by the observer. Resting VO2 was measured for 15 minutes, prior to which 
the participant lay on a bed in a darkened, quiet room for 10 minutes to ensure the 
participants were provided with an adequate amount of time to achieve resting state. 
During the sitting activity, participants were asked not to speak or take part in any other 
activities, sit looking straightforward, feet flat on the floor and hands in resting position. 
For the standing activity, participants followed similar protocol with feet shoulder width 
apart and hands held by their side. During both activities, participants were unaided. 
Participants were asked to complete each activity at a pace that was comfortable to 
them, but within each speed range: slow walking (2.5–4.5 km/hour), brisk walking 
(4.5–6.5 km/hour) and light jogging (6.5–8.5 km/hour). Prior to the study beginning, 
the upper and lower time limits required to complete each section of the track during 
each speed category were calculated. The time taken to complete each section of the 
track was then used to estimate the speed of each participant. This procedure is 
outlined in more detail elsewhere (279).  
 
Calibration Activities 
The activities in the protocol included resting VO2, sitting on a chair, standing upright 
unaided, washing dishes, sweeping the floor, slow walking (2.5-4.5km/hour), brisk 
walking (4.5-6.0km/hour) and jogging (6.5-8.5km/hour). All ambulatory activities 
included a resting period where the participant was allowed to prepare for the next 
activity and heart rate was allowed to return below 100 beats per minute. For sitting, 
standing activities, washing dishes and floor sweeping, data was collected for 5 
minutes, while 7 minutes data was collected for all remaining ambulatory activities.  
 
Data Processing 
The data was extracted using GENEActiv software in comma separated files (.csv) 
and then collapsed into 15-second epochs using the following, sum of the vector 
magnitude, equation  
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(  2 2 2 ||  x y z g   ) (85). Using Cosmed K4B
2 software, the VO2 information was 
averaged for every 15-second period. The breath-by-breath VO2 data from the 
Cosmed K4B2 and the resulting epoch-by-epoch GENEActiv accelerometer data were 
imported into customised spreadsheets and collated, ensuring start and finish times 
of each activity was synchronised for both devices. The mean value of the final 2 
minutes of each activity (excluding resting VO2) was used for data analysis, these 
durations were selected as VO2 remains stable (at a steady rate) after 3 minutes for 
light activity and after 3-5 minutes for more intense activities (280). All data was 
exported and analysed in Stata (version 12, Stata Corp, College Station, Texas, USA) 
(281). 
 
Analysis Variable Definitions 
Participant’s individual RMR were used to calculate their resting metabolism 
equivalent task (MET) values, with energy cost during activity being expressed in 
calculated METS (MET score = Activity VO2 mL∙kg-1 min-1 / Resting VO2 mL kg-1 min-
1). The VO2 data were converted to METS using the standard conversion of 1 MET = 
3.5 mL∙kg-1∙min-1 and then coded into one of four absolute-intensity categories: 
sedentary (<1.5 METS), light (1.5–2.99 METS), moderate (3.00–5.99 METS), or 
vigorous (6+ METS) activity. Subsequently, accelerometer data were recoded to 
create binary indicator variables (0 or 1) to facilitate the receiver operating 
characteristic (ROC) curve analyses. For sedentary behaviour, this related to 
sedentary activities versus more than sedentary activities. For moderate activity, this 
related to less than moderate activities versus moderate to vigorous activities. For 
vigorous activity, this related to vigorous activities versus less than vigorous activities.  
 
Statistical Analysis 
Descriptive characteristics of study participants are presented in Table 1. Table 2 
presents average intensity (METS) and average dominant and non-dominant wrist 
positioned GENEActiv output (SVMgs (g.minutes)) across the study sample. ROC 
curve analysis and Youden’s Index (j=sensitivity+specificity-1) were used to access  
area under the curve (AUC) and define thresholds which optimize sensitivity (correctly 
identified points at or above the activity intensity threshold) and specificity (correctly 
excluded activities below the activity intensity thresholds) (282). Various threshold 
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values were tested regarding sensitivity and specificity, for each intensity of activity. 
Youden’s index was used to determine optimal cut-off values (reference). The 
sedentary and moderate thresholds provided the boundaries for the light intensity 
category. Thresholds were cross-validated using ROC analysis on an independent 
group.  
 
Results 
Descriptive analysis 
Fifty-six adults (27 males: 40.5±11.6years) had valid data for all 7 activities for both 
dominant and non-dominant wrist wear.  Descriptive characteristics of study 
participants by developmental and cross-validation group are presented in Table 14. 
Overall the prevalence of obesity is 9.1% and overweight is 33.4%. Of those who were 
tested, 8% were left-handed.  
 
Value calibration 
Table 15 compares average METS and wrist specific GENEActiv output results by 
study group. Thresholds for dominant and non-dominant wrist wear were similar. Each 
activity had a suitable METS score to its relative intensity of physical activity with the 
exception of sweeping and slow walking.  Sweeping and slow walking, which were 
deemed light intensity activities, resulted in an average 3.55/3.53 and 3.21/3.98 METS 
for developmental/cross-validation group respectively. Intensity thresholds (sum of the 
vector magnitude counts) were created for dominant and non-dominant wrist wear 
(Table 16). Across dominant and non-dominant wrist wear, discrimination of sedentary 
behaviour and vigorous activity was high, with AUC ranging from 0.97-0.99. On 
account of reduced sensitivity and specificity, the discrimination of moderate activity 
was less precise, with sensitivity and specificity scores ranging 78-6-80.4% (AUC from 
0.70-0.72). The Youden Index approach identified the point on the ROC curve that 
was furthest from chance of discrimination. The optimal thresholds identified by 
Youden’s Index for sedentary, moderate and vigorous activity are presented in Table 
16.  
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Cross-Validation of Developed Thresholds  
Thresholds were cross-validated with an independent group using ROC analysis. 
Each threshold demonstrated high levels of sensitivity and specificity when cross-
validated. As the AUC for all intensity thresholds were the same the threshold with the 
highest value was selected as the optimal threshold (Table 16). An optimal threshold 
of 338/314 and 714/594 was identified for dominant/non-dominant wrist wear for 
moderate and vigorous intensity activity, while an optimal threshold of 230/190 was 
identified for sedentary behaviour.  
 
Discussion 
This is the first study to develop accelerometer cut-points for dominant and non-
dominant wrist GENEActiv accelerometer data that reflect sedentary, light, moderate 
and vigorous activity. The value calibration of raw accelerometer data provides an 
overall indicator of bodily movement which subsequently can be used to calculate time 
spent in specific activity intensities. This data can in turn be used to study the 
association between physical behaviour and health outcomes. In addition, being able 
to identify the amount of time spent in a range of intensity categories is useful to 
identify international physical activity guideline recommendations to achieve optimal 
health.  
In the present study the thresholds established for the GENEActiv accelerometer 
demonstrated excellent accuracy for classifying physical behaviour intensity across 
the activity spectrum, specifically sedentary behaviour and vigorous activity. The 
discrimination of moderate intensity activity was acceptable (AUC 0.67-0.71), but not 
as precise as sedentary and vigorous activity. Only one other study has determined 
thresholds for GENEActiv accelerometer data (85). However the cut-points presented 
by Esliger et al. (2011) were created for left- and right-wrist wear (277). The greater 
use of the dominant hand in everyday activities could lead to the overestimation of cut-
points for physical activity intensities. Hand dominance is not an issue in posture 
positions and most movements. However, lifestyle activities such as window washing 
is generally a dominant hand activity, which leads to an increase in recorded 
acceleration signals and in turn an increase in intensity defining cut-points. Other 
studies have created thresholds for the GENEActiv accelerometer however these 
have been in different populations and across intensity domains  (reference Zhang 
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and Phillips). Phillips et al. 2012 demonstrated the GENEActiv accelerometer to have 
excellent (AUC 0.94-0.99) accuracy at discriminating between physical behaviour 
activity intensities with both wrist and hip mounted devices in children. While Zhang et 
al. 2012 successfully developed an algorithm to classify physical activity into walking, 
running, household and sedentary activities. A study by Welch et al. 2013 tested the 
accuracy of previously published left-hand GENEActiv accelerometer thresholds for 
predicting intensity categories during structured bouts. Although sensitivity and 
specificity was lower than those previously reported by Esliger et al., they were within 
similar range.  
This study has a number of strengths. The GENEActiv accelerometer collects data as 
raw acceleration and stores the data as g units for offline analysis thereby allowing for 
efficient data cleaning and the application of various data processing algorithms post-
data collection. ROC analysis was used to identify optimal thresholds to discriminate 
sedentary, light, moderate and vigorous activity. This statistical method is known to be 
superior to previous value calibration methods which have used linear regression 
approaches. In addition, the choice of cut-points were determined using Youden index 
which ensures optimality of cut-points.  Thresholds were cross-validated which further 
guarantees the optimisation of the chosen threshold values. The study protocol was 
developed on a non-treadmill-based validation approach to mimic free-living activities 
by accelerometer and energy expenditure measurements. Free-living activities were 
assessed using a portable CosMed K4B2 device which objectively measures energy 
expenditure. Finally, we used individualised RMR to normalise energy cost between 
participants for each activity opposed to using a standardised RMR for the entire study 
population (reference see 36 of Kieran paper) 
Notwithstanding these strengths, a number of limitations of the study have been 
identified. The study population varied in age, gender and BMI status however due to 
the large variation between subject characteristics and small sample size (n=56) these 
thresholds may be non-representative thus further research using larger sample sizes 
are necessary. In addition, only 7 activities were used in this study protocol. These 
activities may not be representative of habitual activities of all middle-aged adults nor 
habitual activities across different cultures thus generalizability of results should be 
warranted.   
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Conclusion 
The GENEActiv accelerometer was found to have excellent accuracy for classifying 
physical behaviour intensity across the activity spectrum. This is the first study to 
develop accelerometer cut-points for dominant and non-dominant wrist wear 
GENEActiv accelerometer data that reflect sedentary, light, moderate and vigorous 
activity. Data suggests that the developed intensity thresholds for GENEActiv data are 
valid at determining physical behaviour intensity, but are slightly poorer but acceptable 
at estimating moderate activity in adults aged 18-65 years. 
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Table 14: Descriptive characteristics of study participants 
  Sample size Age Left-Handed Right-Handed BMI (kg/m2) 
 Development 
Cross-
validation 
Development 
Cross-
validation 
Development 
Cross-
validation 
Development 
Cross-
validation 
Development 
Cross-
validation 
Male 18 9 37.3 (12.6) 38.8 (9.1) 4 1 14 8 24.7 (3.5) 24.6 (3.1) 
Female 17 12 41.7 (12.4) 43.4 (10.1) 2 0 15 12 25.8 (4.2) 23.9 (4.0) 
Total 35 21 39.5 (12.5) 41.4 (10.0) 6 1 29 20 25.2 (3.8) 24.2 (3.5) 
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Table 15: Average intensity (METS), average dominant and non-dominant wrist positioned GENEActiv output (SVMgs 
(15sec epoch) at 30 Hz) 
      METS Dominant Wrist Non-dominant wrist 
Activity Grouping N Mean SD Mean SD Mean SD 
Development group         
Sitting 
Posture 
35 1.04 0.21 4.74 1.74 4.82 2.21 
Standing 35 1.12 0.19 3.62 1.26 3.45 1.37 
Washing dishes 
Ambulatory 
35 1.55 0.29 64.42 29.27 52.71 19.54 
Floor sweeping 335 3.50 0.99 132.34 48.73 102.68 44.47 
Slow walking 35 3.21 0.44 70.1 13.35 74.42 17.18 
Fast walking 35 4.17 0.85 110.66 33.54 118.36 64.16 
Jogging 35 9.48 1.58 394.7 83.39 374.9 71.81 
Cross-validation group         
Sitting 
Posture 
21 1.00 0.15 4.36 1.05 3.44 0.91 
Standing 21 0.95 0.13 3.53 1.02 2.88 0.88 
Washing dishes 
Ambulatory 
21 2.14 0.60 59.6 31.0 51.2 23.1 
Floor sweeping 21 3.53 0.90 122.2 54.9 95.5 50.7 
Slow walking 21 3.98 0.64 72.8 21.1 74.2 23.3 
Fast walking 21 4.93 0.65 127.7 49.4 129.4 53.3 
Jogging 21 8.74 0.95 441.4 134.2 378.5 110.3 
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Table 16: Sensitivity, specificity, AUC and GENEActiv cut-points based on 3 and 6 METS 
Intensity Sensitivity Specificity 
Area under the 
curve (95%CI) GENEActiv cut-points  
         (SVMgs (15s epoch)) 
Dominant wrist       30Hz 100Hz 
Sedentary 91.6 92.4 0.97 <57.5 <191.8 
Light NA NA NA 57.5-84.3 191.8-281.5 
Moderate 67.9 67.9 0.694 84.4-178.4 281.6-595 
Vigorous  97.1 97.0 0.994 >178.4 >595 
Non-dominant 
wrist           
Sedentary 92.9 92.4 0.98 <47.5 <158.5 
Light NA NA NA 47.5-78.3 158.5-261.8 
Moderate 70.5 68.6 0.716 78.4-148.5 261.9-495 
Vigorous  97.1 97.0 0.992 >148.5 >495 
* sedentary (<1.5 METS), light (1.5-2.99 METS), moderate (3.00-5.99 METS), vigorous (>6 METS) 
NA; not applicable as sedentary and moderate intensity cut-points provide the margins for light 
intensity   
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APPENDIX THREE 
SUPPLEMENTARY TABLE FOR CHAPTER 4 
Supplement Table 17: Spearman pairwise correlation coefficient of physical activity 
intensity by days of week 
 Sunda
y 
Monda
y 
Tuesda
y 
Wednesda
y 
Thursda
y 
Frida
y 
Saturda
y 
Sedentary 
behaviour 
       
Sunday 1.00       
Monday 0.59 1.00      
Tuesday 0.63 0.73 1.00     
Wednesda
y 
0.64 0.74 0.73 1.00    
Thursday 0.63 0.72 0.75 0.77 1.00   
Friday 0.68 0.72 0.73 0.75 0.79 1.00  
Saturday 0.71 0.67 0.66 0.69 0.71 0.71 1.00 
Light 
activity 
       
Sunday 1.00       
Monday 0.59 1.00      
Tuesday 0.62 0.70 1.00     
Wednesda
y 
0.65 0.71 0.77 1.00    
Thursday 0.60 0.67 0.71 0.74 1.00   
Friday 0.64 0.66 0.70 0.74 0.74 1.00  
Saturday 0.68 0.67 0.66 0.70 0.69 0.72 1.00 
Moderate 
activity 
       
Sunday 1.00       
Monday 0.59 1.00      
Tuesday 0.59 0.69 1.00     
Wednesda
y 
0.63 0.71 0.69 1.00    
Thursday 0.64 0.73 0.75 0.76 1.00   
Friday 0.68 0.72 0.71 0.72 0.77 1.00  
Saturday 0.70 0.67 0.64 0.64 0.67 0.68 1.00 
Vigorous 
activity 
       
Sunday 1.00       
Monday 0.46 1.00      
Tuesday 0.45 0.60 1.00     
Wednesda
y 
0.37 0.50 0.55 1.00    
Thursday 0.43 0.52 0.47 0.53 1.00   
Friday 0.52 0.53 0.51 0.50 0.53 1.00  
Saturday 0.48 0.49 0.40 0.43 0.47 0.48 1.00 
MVPA        
Sunday 1.00       
Monday 0.58 1.00      
Tuesday 0.60 0.70 1.00     
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Wednesda
y 
0.62 0.73 0.68 1.00    
Thursday 0.65 0.74 0.75 0.76 1.00   
Friday 0.68 0.72 0.72 0.72 0.78 1.00  
Saturday 0.69 0.67 0.64 0.64 0.68 0.68 1.00 
*All values have a significance <0.001 
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APPENDIX FOUR 
SUPPLEMENTARY TABLE FOR CHAPTER 6 
Table 18: Latent Profile Analysis; Model class probabilities  
Two-class-model 1 2    
1, n = 243 (61.4%) 0.996 0.004    
2, n = 153 (38.6%) 0.002 0.998    
Three-class-model 1 2 3   
1, n = 125 (31.6%) 0.997 0.003 0.000   
2, n = 214 (54.0%) 0.003 0.995 0.002   
3, n = 57 (14.4%) 0.000 0.012 0.988   
Four-class-model 1 2 3 4 5 
1, n = 114 (28.8%) 0.976 0.021 0.003 0.000  
2, n = 169 (42.7%) 0.004 0.992 0.009 0.004  
3, n = 66 (16.6%) 0.006 0.000 0.994 0.000  
4, n = 47 (11.9%) 0.000 0.008 0.000 0.992  
Five-class-model      
1, n = 62 (15.7%) 0.990 0.010 0.000 0.000 0.000 
2, n = 102 (25.7%) 0.002 0.982 0.013 0.000 0.002 
3, n = 161 (40.6%) 0.000 0.006 0.989 0.005 0.000 
4, n = 47 (11.9%) 0.000 0.000 0.005 0.995 0.000 
5, n= 24 (6.1%) 0.000 0.007 0.006 0.000 0.987 
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APPENDIX FIVE 
RESEARCH OUTPUTS, DISSEMINATION AND TRAINING 
Table 19: Peer-reviewed publications during PhD 
Published    
 Year Peer-reviewed journals  Citation 
Journals    
 2016 PLOS ONE  
  
Dillon C.B, 
Fitzgerald A.P, 
Kearney P.M, Perry 
I.J, Rennie K.L, 
Kozarski R, Phillips 
C.M. Number of 
days required to 
estimate habitual 
activity using 
GENEActiv 
accelerometer: A 
cross-sectional 
study. 
 2015
  
Journal of aging and physical activity. 
(epub ahead of print)  
McCullagh, R., 
Brady, N.M., Dillon, 
C., Horgan, N.F. 
and Timmons, S..A 
Review of the 
Accuracy and Utility 
of Motion Sensors 
to Measure Physical 
Activity of Frail 
Older Hospitalised 
Patients 
 2013 PLOS ONE. 2013 Oct 17; 8 (10).  
 
Phillips C.M, Dillon 
C.B, Harrington J, 
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McCarthy V.J.C, 
Kearney P.M, 
Fitzgerald A.P, 
Perry I.J. Defining 
metabolically 
healthy obesity: role 
of dietary and 
lifestyle factors. 
Abstracts    
 2015 Journal of Epidemiology and Community 
Health 
Dillon C.B, Dahly D, 
Donnelly A.E, 
Kearney P.M, Perry 
I.J, Rennie K.L, 
Phillips C.M. Cross-
sectional analysis of 
weekly levels and 
patterns of 
objectively-
measured physical 
behaviour with 
cardiometabolic 
health in middle-
aged adults. 
 2015 Journal of Epidemiology and Community 
Health 
Dillon C.B, Dahly D, 
Donnelly A.E, 
Kearney P.M, Perry 
I.J, Rennie K.L, 
Phillips C.M. Daily 
Cumulative Patterns 
of Objectively-
measured Physical 
Behaviour by 
Metabolic 
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Syndrome Health 
Profiles in Middle-
aged Adults. 
 2012 Journal of Science and Medicine in Sport 
12/2012; 15:S161-S162 
Dillon C.B, Kearney 
P.M, Perry I.J. 
McCarthy V.J.C. 
Metabolic health in 
the overweight and 
obese, what is the 
role of physical 
activity? 
Under 
review 
   
 2015 PLOS ONE Dillon C.B, 
Fitzgerald A.P, 
Donnelly A.E, 
Kearney P.M, Perry 
I.J, Rennie K.L, 
Kozarski R, Phillips 
C.M. Comparison of 
self-report and 
objective measures 
of moderate-to-
vigorous activity 
with cardiovascular 
disease risk factors 
in a population-
based cross-
sectional study 
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Table 20: Other research outputs during PhD 
Detail 
Papers (in preparation) 
McCullagh R, Dillon C.B, Horgan F, Timmons S. Accuracy of the Stepwatch Activity 
Monitor and ActivPAL3 in frail hospitalised patients. 
Phillips C.M, Dillon C.B, Otvos J.D, Perry I.J. Reducing sedentary time and 
increasing moderate physical activity modulates atherogenic dyslipidaemia in 
middle-aged adults.   
Phillips C.M, Dillon C.B, Perry I.J. Does physical activity duration or intensity 
counteract obesity and insulin resistance associated low-grade inflammation in 
middle-aged adults? 
Dillon C.B, Fitzgerald A.P, Donnelly A.E, Perry I.J, Rennie K.L, Li X, , Phillips C.M. 
Daily cumulative patterns of objectively-measured physical activity and sedentary 
behaviour by cardiometabolic health status in middle-aged adults; A cross-sectional 
analysis. 
Dillon C.B, Fitzgerald A.P, Donnelly A.E, Perry I.J, Rennie K.L, Li X, , Phillips C.M. 
Cross-sectional analysis of weekly levels and patterns of objectively-measured 
physical behaviour with cardiometabolic health in middle-aged adults. 
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Table 21: Conference presentations during PhD 
Poster presentations 
Year  Title Authors Conference  
2015 Daily Cumulative 
Patterns of 
Objectively-
measured 
Physical 
Behaviour by 
Metabolic 
Syndrome Health 
Profiles in Middle-
aged Adults. 
Dillon C.B, 
Dahly D, 
Donnelly A.E, 
Kearney P.M, 
Perry I.J, Rennie 
K.L, Phillips 
C.M. 
Society for Social Medicine 
Conference, Dublin, Ireland 
3rd-5th September 
2015 Cross-sectional 
analysis of 
weekly levels and 
patterns of 
objectively-
measured 
physical 
behaviour with 
cardiometabolic 
health in middle-
aged adults 
Dillon C.B, 
Dahly D, 
Donnelly A.E, 
Kearney P.M, 
Perry I.J, Rennie 
K.L, Phillips 
C.M. 
Society for Social Medicine 
Conference, Dublin, Ireland 
3rd-5th September 
2015 Criterion validity 
and calibration of 
the GENEActiv 
accelerometer in 
adults. 
Dillon C.B, 
Powell C, Dowd 
K, Carson B,  
Donnelly A.E,  
International Conference on 
Ambulatory Monitoring of 
Physical Activity and 
Movement. University of 
Limerick, Limerick, Ireland 
10th-11th June  
2015 Cross-sectional 
analysis of 
Dillon C.B, 
Dahly D, 
International Conference on 
Ambulatory Monitoring of 
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weekly levels and 
patterns of 
objectively-
measured 
physical 
behaviour with 
cardiometabolic 
health in middle-
aged adults 
Donnelly A.E, 
Kearney P.M, 
Perry I.J, Rennie 
K.L, Phillips 
C.M. 
Physical Activity and 
Movement. University of 
Limerick, Limerick, Ireland 
10th-11th June  
2013 Validation of the 
International 
Physical Activity 
Questionnaire-
Short Form 
against the 
GENEActiv 
accelerometer 
 
Dillon C.B, 
Fitzgerald A.P, 
Kearney P.M, 
Perry I.J, Rennie 
K.L, Kozarski R, 
Phillips C.M 
HRB Centre for Health and 
Diet Research Conference. 
Cork, Ireland. October 2013. 
2013 Validation of the 
International 
Physical Activity 
Questionnaire-
Short Form 
against the 
GENEActiv 
accelerometer 
 
Dillon C.B, 
Fitzgerald A.P, 
Kearney P.M, 
Perry I.J, Rennie 
K.L, Kozarski R, 
Phillips C.M 
HRB Clinical Research 
Facility Conference. Cork, 
Ireland. June 2013. 
2013 Number of days 
required to 
estimate habitual 
physical activity 
using GENEActiv 
accelerometer. 
Dillon C.B, 
Fitzgerald A.P, 
Kearney P.M, 
Perry I.J, Rennie 
K.L, Kozarski R, 
International Conference on 
Ambulatory Monitoring of 
Physical Activity and 
Movement. UMASS, Amherst, 
Boston, US. 17th-19th June 
2013.  
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Madden J.M, 
Phillips C.M 
 
2012 Metabolic Health 
in the Overweight 
and Obese, What 
is the Role of 
Physical Activity? 
Dillon C.B, 
McCarthy V.J.C, 
Perry I.J, 
Kearney P.M 
4th International Congress 
on Physical Activity and 
Public Health, Sydney, 
Australia 31st Oct - 3rd Nov 
2012. 
 
2012 Metabolic Health 
in the Overweight 
and Obese, What 
is the Role of 
Physical Activity? 
Dillon C.B, 
McCarthy V.J.C, 
Perry I.J, 
Kearney P.M 
The European Congress of 
Epidemiology in Porto, 
Portugal 5th-8th Sept 2012. 
 
2012 Number of days 
required to 
estimate habitual 
physical activity 
using GENEActiv 
accelerometer. 
Dillon C.B, 
Fitzgerald A.P, 
Kearney P.M, 
Perry I.J, Rennie 
K.L, Kozarski R, 
Madden J.M, 
Phillips C.M 
The Food Health Choice and 
Change conference. Cork, 
Ireland. June 2012 
2012 Number of days 
required to 
estimate habitual 
physical activity 
using GENEActiv 
accelerometer. 
Dillon C.B, 
Fitzgerald A.P, 
Kearney P.M, 
Perry I.J, Rennie 
K.L, Kozarski R, 
Madden J.M, 
Phillips C.M 
UCC Doctoral Showcase, 
semi-final. Cork, Ireland. April 
2012 
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Table 22: Training and workshops attended during PhD 
Year Course 
UCC post graduate modules 
Sept 
2012-
May 2013 
Scholarly Approaches to Teaching and Learning in Higher 
Education, University College Cork 
Jan 2012-
Jun 2012 
Teaching and Learning Module for Graduate Studies, University 
College Cork 
Apr 2011-
Jun 2011 
Systematic Reviews for the Health Sciences, University College Cork 
Feb-May 
2011 
Graduate Information Literacy Skills, University College Cork 
Oct 2010 Scientific Training for Enhanced Postgraduate Studies, University 
College Cork 
Training outside of UCC 
Nov 
2012-Jan 
2015  
Management Diploma, Pitman Training, Cork 
 
Sept 
2012 
(24th-28th) 
MRC Physical Activity Measurement Seminar, Cambridge Institute of 
Public Health, MRC Epidemiology Unit, UK 
Sept 
2008-Dec 
2008 
Managing People effectively at work, College of Commerce, Cork 
 
Other workshops, seminars and training attended 
Sept 
2015 
Forging a career in research: a survival kit, ECR Committee, Trinity 
College, Dublin 
Nov 2014 Editing and Proofreading for Professionals and Editing and 
Proofreading for Academic Purposes, University College Cork 
Oct 2014 Managing your career, University College Cork 
Sept 
2013 
Time management workshop, University College Cork 
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Oct 2012 Seven secrets of highly successful PhD students with Hugh 
Kearnes, University College Cork 
Oct 2012 Turbocharge your writing with Hugh Kearnes, University College Cork 
 
 
 
Table 23: Awards and funding 
Institution Year Detail 
Health Research 
Board 
2010-2015 PhD Scholarship 2010-2015. 
Awarded full PhD funding from the 
Health Research Board Ireland, 
tenable for 5 years at €18,000 per 
year plus fees.  
College of Medicine 
and Health Doctoral 
Student Bursaries 
2012 Awarded a travel bursary to attend 
the 5th ICPAPH conference in 
Sydney, Australia.  
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